Motif ID: Yy1_Yy2
Z-value: 3.402
Transcription factors associated with Yy1_Yy2:
| Gene Symbol | Entrez ID | Gene Name |
|---|---|---|
| Yy1 | ENSMUSG00000021264.11 | Yy1 |
| Yy2 | ENSMUSG00000091736.2 | Yy2 |
Activity-expression correlation:
| Gene Symbol | Promoter | Pearson corr. coef. | P-value | Plot |
|---|---|---|---|---|
| Yy2 | mm10_v2_chrX_-_157598642_157598655 | -0.64 | 3.6e-10 | Click! |
| Yy1 | mm10_v2_chr12_+_108792946_108792988 | -0.18 | 1.3e-01 | Click! |
Top targets:
Gene overrepresentation in biological_process category:
| Log-likelihood per target | Total log-likelihood | Term | Description |
|---|---|---|---|
| 4.3 | 13.0 | GO:0031660 | regulation of cyclin-dependent protein serine/threonine kinase activity involved in G2/M transition of mitotic cell cycle(GO:0031660) positive regulation of cyclin-dependent protein serine/threonine kinase activity involved in G2/M transition of mitotic cell cycle(GO:0031662) |
| 4.2 | 21.1 | GO:1902309 | negative regulation of peptidyl-serine dephosphorylation(GO:1902309) |
| 4.0 | 12.0 | GO:0070315 | G1 to G0 transition involved in cell differentiation(GO:0070315) |
| 3.5 | 21.1 | GO:1901837 | negative regulation of transcription of nuclear large rRNA transcript from RNA polymerase I promoter(GO:1901837) |
| 3.5 | 14.0 | GO:0006432 | phenylalanyl-tRNA aminoacylation(GO:0006432) |
| 3.4 | 10.2 | GO:1904569 | regulation of selenocysteine incorporation(GO:1904569) |
| 3.4 | 23.5 | GO:0031536 | positive regulation of exit from mitosis(GO:0031536) |
| 3.3 | 16.4 | GO:0000430 | regulation of transcription from RNA polymerase II promoter by glucose(GO:0000430) positive regulation of transcription from RNA polymerase II promoter by glucose(GO:0000432) |
| 3.2 | 9.7 | GO:0035934 | corticosterone secretion(GO:0035934) regulation of corticosterone secretion(GO:2000852) |
| 3.2 | 9.6 | GO:0006419 | alanyl-tRNA aminoacylation(GO:0006419) |
| 3.2 | 9.5 | GO:0071544 | diphosphoinositol polyphosphate catabolic process(GO:0071544) |
| 3.1 | 9.3 | GO:1905051 | regulation of base-excision repair(GO:1905051) positive regulation of base-excision repair(GO:1905053) |
| 3.0 | 12.0 | GO:0070829 | heterochromatin maintenance(GO:0070829) |
| 3.0 | 9.0 | GO:0008612 | peptidyl-lysine modification to peptidyl-hypusine(GO:0008612) |
| 3.0 | 69.0 | GO:0000028 | ribosomal small subunit assembly(GO:0000028) |
| 2.9 | 8.8 | GO:0070625 | zymogen granule exocytosis(GO:0070625) |
| 2.8 | 5.6 | GO:0072053 | renal inner medulla development(GO:0072053) renal outer medulla development(GO:0072054) |
| 2.8 | 8.3 | GO:0090274 | positive regulation of somatostatin secretion(GO:0090274) |
| 2.7 | 2.7 | GO:2000974 | negative regulation of pro-B cell differentiation(GO:2000974) |
| 2.7 | 8.2 | GO:0031204 | posttranslational protein targeting to membrane, translocation(GO:0031204) |
| 2.7 | 8.1 | GO:1902162 | regulation of DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator(GO:1902162) |
| 2.7 | 8.1 | GO:0006669 | sphinganine-1-phosphate biosynthetic process(GO:0006669) |
| 2.6 | 2.6 | GO:0045039 | protein import into mitochondrial inner membrane(GO:0045039) |
| 2.6 | 10.5 | GO:0072236 | metanephric loop of Henle development(GO:0072236) |
| 2.6 | 2.6 | GO:1902626 | assembly of large subunit precursor of preribosome(GO:1902626) |
| 2.6 | 7.8 | GO:0002014 | vasoconstriction of artery involved in ischemic response to lowering of systemic arterial blood pressure(GO:0002014) |
| 2.6 | 10.2 | GO:0006780 | uroporphyrinogen III biosynthetic process(GO:0006780) |
| 2.5 | 12.7 | GO:0015671 | oxygen transport(GO:0015671) |
| 2.5 | 12.6 | GO:0051697 | protein delipidation(GO:0051697) |
| 2.5 | 7.5 | GO:0071550 | death-inducing signaling complex assembly(GO:0071550) |
| 2.5 | 2.5 | GO:0035092 | sperm chromatin condensation(GO:0035092) |
| 2.5 | 7.4 | GO:0036090 | cleavage furrow ingression(GO:0036090) |
| 2.5 | 2.5 | GO:0042275 | error-free postreplication DNA repair(GO:0042275) |
| 2.5 | 7.4 | GO:1902445 | regulation of mitochondrial membrane permeability involved in programmed necrotic cell death(GO:1902445) |
| 2.4 | 7.3 | GO:1904274 | tricellular tight junction assembly(GO:1904274) |
| 2.4 | 7.2 | GO:0036166 | phenotypic switching(GO:0036166) |
| 2.4 | 2.4 | GO:0006434 | seryl-tRNA aminoacylation(GO:0006434) |
| 2.3 | 72.2 | GO:0034723 | DNA replication-dependent nucleosome assembly(GO:0006335) DNA replication-dependent nucleosome organization(GO:0034723) |
| 2.3 | 37.2 | GO:0043248 | proteasome assembly(GO:0043248) |
| 2.3 | 6.8 | GO:0019676 | ammonia assimilation cycle(GO:0019676) |
| 2.3 | 9.0 | GO:0071051 | polyadenylation-dependent snoRNA 3'-end processing(GO:0071051) |
| 2.3 | 13.5 | GO:1902415 | regulation of mRNA binding(GO:1902415) |
| 2.2 | 2.2 | GO:0072235 | distal convoluted tubule development(GO:0072025) metanephric distal convoluted tubule development(GO:0072221) metanephric distal tubule development(GO:0072235) |
| 2.2 | 4.4 | GO:0007386 | compartment pattern specification(GO:0007386) |
| 2.2 | 26.3 | GO:0075522 | IRES-dependent viral translational initiation(GO:0075522) |
| 2.2 | 21.8 | GO:0042989 | sequestering of actin monomers(GO:0042989) |
| 2.2 | 6.5 | GO:0046544 | development of secondary male sexual characteristics(GO:0046544) |
| 2.2 | 4.4 | GO:2000820 | negative regulation of transcription from RNA polymerase II promoter involved in smooth muscle cell differentiation(GO:2000820) |
| 2.2 | 6.5 | GO:0035574 | histone H4-K20 demethylation(GO:0035574) |
| 2.2 | 26.1 | GO:0002227 | innate immune response in mucosa(GO:0002227) |
| 2.1 | 6.4 | GO:0071898 | regulation of estrogen receptor binding(GO:0071898) negative regulation of estrogen receptor binding(GO:0071899) |
| 2.1 | 8.5 | GO:1902340 | telomeric heterochromatin assembly(GO:0031509) negative regulation of chromosome condensation(GO:1902340) |
| 2.1 | 4.2 | GO:1902174 | positive regulation of keratinocyte apoptotic process(GO:1902174) |
| 2.1 | 6.3 | GO:2000435 | regulation of protein neddylation(GO:2000434) negative regulation of protein neddylation(GO:2000435) |
| 2.1 | 8.2 | GO:0002143 | tRNA wobble position uridine thiolation(GO:0002143) |
| 2.0 | 14.3 | GO:0021555 | midbrain-hindbrain boundary morphogenesis(GO:0021555) |
| 2.0 | 6.1 | GO:0019401 | alditol biosynthetic process(GO:0019401) |
| 2.0 | 6.1 | GO:0060853 | arterial endothelial cell fate commitment(GO:0060844) blood vessel endothelial cell fate commitment(GO:0060846) endothelial cell fate specification(GO:0060847) Notch signaling pathway involved in arterial endothelial cell fate commitment(GO:0060853) blood vessel endothelial cell fate specification(GO:0097101) |
| 2.0 | 2.0 | GO:0000821 | regulation of arginine metabolic process(GO:0000821) |
| 2.0 | 2.0 | GO:0042660 | positive regulation of cell fate specification(GO:0042660) |
| 2.0 | 8.0 | GO:0018343 | protein farnesylation(GO:0018343) |
| 2.0 | 6.0 | GO:1901228 | positive regulation of transcription from RNA polymerase II promoter involved in heart development(GO:1901228) |
| 1.9 | 9.7 | GO:0046864 | retinol transport(GO:0034633) isoprenoid transport(GO:0046864) terpenoid transport(GO:0046865) alveolar primary septum development(GO:0061143) |
| 1.9 | 1.9 | GO:1900110 | negative regulation of histone H3-K9 dimethylation(GO:1900110) |
| 1.9 | 7.7 | GO:0006121 | mitochondrial electron transport, succinate to ubiquinone(GO:0006121) |
| 1.9 | 3.8 | GO:1904760 | myofibroblast differentiation(GO:0036446) regulation of myofibroblast differentiation(GO:1904760) |
| 1.9 | 7.6 | GO:0072737 | response to diamide(GO:0072737) cellular response to diamide(GO:0072738) |
| 1.9 | 13.1 | GO:0034969 | histone arginine methylation(GO:0034969) |
| 1.9 | 5.6 | GO:0032474 | otolith morphogenesis(GO:0032474) |
| 1.8 | 5.4 | GO:0046122 | purine deoxyribonucleoside metabolic process(GO:0046122) |
| 1.8 | 10.8 | GO:0060539 | diaphragm development(GO:0060539) |
| 1.8 | 1.8 | GO:0002155 | regulation of thyroid hormone mediated signaling pathway(GO:0002155) |
| 1.8 | 17.8 | GO:0033089 | positive regulation of T cell differentiation in thymus(GO:0033089) positive regulation of thymocyte aggregation(GO:2000400) |
| 1.8 | 7.1 | GO:0000957 | mitochondrial RNA catabolic process(GO:0000957) regulation of mitochondrial RNA catabolic process(GO:0000960) |
| 1.8 | 75.8 | GO:0097031 | NADH dehydrogenase complex assembly(GO:0010257) mitochondrial respiratory chain complex I assembly(GO:0032981) mitochondrial respiratory chain complex I biogenesis(GO:0097031) |
| 1.8 | 7.0 | GO:2000383 | regulation of ectoderm development(GO:2000383) negative regulation of ectoderm development(GO:2000384) |
| 1.8 | 5.3 | GO:1902310 | regulation of peptidyl-serine dephosphorylation(GO:1902308) positive regulation of peptidyl-serine dephosphorylation(GO:1902310) |
| 1.8 | 5.3 | GO:1902220 | positive regulation of intrinsic apoptotic signaling pathway in response to osmotic stress(GO:1902220) |
| 1.7 | 13.9 | GO:0043951 | negative regulation of cAMP-mediated signaling(GO:0043951) |
| 1.7 | 5.2 | GO:0045575 | basophil activation involved in immune response(GO:0002276) basophil activation(GO:0045575) |
| 1.7 | 3.5 | GO:0075525 | viral translational termination-reinitiation(GO:0075525) |
| 1.7 | 96.6 | GO:0002181 | cytoplasmic translation(GO:0002181) |
| 1.7 | 6.9 | GO:2000319 | negative regulation of T-helper 17 type immune response(GO:2000317) regulation of T-helper 17 cell differentiation(GO:2000319) negative regulation of T-helper 17 cell differentiation(GO:2000320) |
| 1.7 | 5.1 | GO:0090285 | negative regulation of protein glycosylation in Golgi(GO:0090285) |
| 1.7 | 3.4 | GO:0061030 | epithelial cell differentiation involved in mammary gland alveolus development(GO:0061030) |
| 1.7 | 28.4 | GO:0000338 | protein deneddylation(GO:0000338) |
| 1.7 | 1.7 | GO:0090201 | negative regulation of release of cytochrome c from mitochondria(GO:0090201) |
| 1.7 | 5.0 | GO:0051342 | regulation of cyclic-nucleotide phosphodiesterase activity(GO:0051342) negative regulation of cyclic-nucleotide phosphodiesterase activity(GO:0051344) |
| 1.6 | 1.6 | GO:1901857 | positive regulation of cellular respiration(GO:1901857) |
| 1.6 | 9.8 | GO:0098734 | protein depalmitoylation(GO:0002084) macromolecule depalmitoylation(GO:0098734) |
| 1.6 | 19.5 | GO:0006122 | mitochondrial electron transport, ubiquinol to cytochrome c(GO:0006122) |
| 1.6 | 4.8 | GO:0051715 | cytolysis in other organism(GO:0051715) |
| 1.6 | 4.8 | GO:0070634 | transepithelial ammonium transport(GO:0070634) |
| 1.6 | 14.3 | GO:0006123 | mitochondrial electron transport, cytochrome c to oxygen(GO:0006123) |
| 1.6 | 6.3 | GO:0006244 | pyrimidine nucleotide catabolic process(GO:0006244) pyrimidine deoxyribonucleotide catabolic process(GO:0009223) |
| 1.6 | 1.6 | GO:0003219 | cardiac right ventricle formation(GO:0003219) |
| 1.6 | 7.8 | GO:0021797 | forebrain anterior/posterior pattern specification(GO:0021797) |
| 1.6 | 3.1 | GO:0046101 | hypoxanthine metabolic process(GO:0046100) hypoxanthine biosynthetic process(GO:0046101) |
| 1.6 | 6.2 | GO:0001887 | selenium compound metabolic process(GO:0001887) selenocysteine metabolic process(GO:0016259) |
| 1.5 | 23.0 | GO:0032785 | negative regulation of DNA-templated transcription, elongation(GO:0032785) |
| 1.5 | 1.5 | GO:1903935 | response to sodium arsenite(GO:1903935) |
| 1.5 | 3.0 | GO:0006532 | aspartate biosynthetic process(GO:0006532) |
| 1.5 | 6.0 | GO:0007056 | spindle assembly involved in female meiosis(GO:0007056) |
| 1.5 | 6.0 | GO:0097211 | response to gonadotropin-releasing hormone(GO:0097210) cellular response to gonadotropin-releasing hormone(GO:0097211) |
| 1.5 | 6.0 | GO:0043328 | protein targeting to vacuole involved in ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway(GO:0043328) |
| 1.5 | 4.5 | GO:1902714 | negative regulation of interferon-gamma secretion(GO:1902714) |
| 1.5 | 4.5 | GO:0046671 | negative regulation of retinal cell programmed cell death(GO:0046671) |
| 1.5 | 10.4 | GO:0097428 | protein maturation by iron-sulfur cluster transfer(GO:0097428) |
| 1.5 | 5.9 | GO:0019287 | isopentenyl diphosphate biosynthetic process, mevalonate pathway(GO:0019287) |
| 1.5 | 4.4 | GO:1902498 | regulation of protein autoubiquitination(GO:1902498) |
| 1.5 | 1.5 | GO:0001928 | regulation of exocyst assembly(GO:0001928) |
| 1.5 | 4.4 | GO:0019343 | cysteine biosynthetic process via cystathionine(GO:0019343) cysteine biosynthetic process(GO:0019344) |
| 1.5 | 1.5 | GO:0045763 | negative regulation of cellular amino acid metabolic process(GO:0045763) |
| 1.5 | 7.3 | GO:0051151 | negative regulation of smooth muscle cell differentiation(GO:0051151) |
| 1.5 | 4.4 | GO:0046166 | glyceraldehyde-3-phosphate biosynthetic process(GO:0046166) |
| 1.4 | 12.9 | GO:0018095 | protein polyglutamylation(GO:0018095) |
| 1.4 | 4.3 | GO:1900041 | negative regulation of interleukin-2 secretion(GO:1900041) |
| 1.4 | 5.7 | GO:0032627 | interleukin-23 production(GO:0032627) regulation of interleukin-23 production(GO:0032667) |
| 1.4 | 4.2 | GO:0051602 | response to electrical stimulus(GO:0051602) |
| 1.4 | 1.4 | GO:0045900 | negative regulation of translational elongation(GO:0045900) |
| 1.4 | 5.6 | GO:0071169 | establishment of protein localization to chromatin(GO:0071169) |
| 1.4 | 6.9 | GO:1902775 | mitochondrial large ribosomal subunit assembly(GO:1902775) |
| 1.4 | 1.4 | GO:0051934 | positive regulation of neurotransmitter uptake(GO:0051582) dopamine uptake involved in synaptic transmission(GO:0051583) regulation of dopamine uptake involved in synaptic transmission(GO:0051584) positive regulation of dopamine uptake involved in synaptic transmission(GO:0051586) catecholamine uptake involved in synaptic transmission(GO:0051934) regulation of catecholamine uptake involved in synaptic transmission(GO:0051940) positive regulation of catecholamine uptake involved in synaptic transmission(GO:0051944) |
| 1.4 | 15.0 | GO:0006488 | dolichol-linked oligosaccharide biosynthetic process(GO:0006488) |
| 1.4 | 1.4 | GO:0061188 | regulation of chromatin silencing at rDNA(GO:0061187) negative regulation of chromatin silencing at rDNA(GO:0061188) |
| 1.4 | 8.1 | GO:0048105 | establishment of body hair or bristle planar orientation(GO:0048104) establishment of body hair planar orientation(GO:0048105) |
| 1.3 | 4.0 | GO:1902071 | regulation of hypoxia-inducible factor-1alpha signaling pathway(GO:1902071) |
| 1.3 | 4.0 | GO:0043686 | co-translational protein modification(GO:0043686) |
| 1.3 | 5.3 | GO:1903542 | negative regulation of exosomal secretion(GO:1903542) |
| 1.3 | 4.0 | GO:0072708 | response to sorbitol(GO:0072708) |
| 1.3 | 4.0 | GO:0036480 | neuron intrinsic apoptotic signaling pathway in response to oxidative stress(GO:0036480) regulation of oxidative stress-induced neuron intrinsic apoptotic signaling pathway(GO:1903376) |
| 1.3 | 9.2 | GO:2001199 | negative regulation of dendritic cell differentiation(GO:2001199) |
| 1.3 | 3.9 | GO:0003162 | atrioventricular node development(GO:0003162) |
| 1.3 | 2.6 | GO:0032227 | negative regulation of synaptic transmission, dopaminergic(GO:0032227) |
| 1.3 | 2.6 | GO:0046502 | uroporphyrinogen III metabolic process(GO:0046502) |
| 1.3 | 3.8 | GO:2000138 | positive regulation of cell proliferation involved in heart morphogenesis(GO:2000138) |
| 1.3 | 2.6 | GO:2000157 | regulation of protein K48-linked deubiquitination(GO:1903093) negative regulation of protein K48-linked deubiquitination(GO:1903094) negative regulation of ubiquitin-specific protease activity(GO:2000157) |
| 1.3 | 3.8 | GO:0030974 | thiamine pyrophosphate transport(GO:0030974) |
| 1.3 | 21.5 | GO:0021521 | ventral spinal cord interneuron specification(GO:0021521) cell fate specification involved in pattern specification(GO:0060573) |
| 1.3 | 3.8 | GO:0044778 | meiotic DNA integrity checkpoint(GO:0044778) |
| 1.3 | 11.3 | GO:0070475 | rRNA base methylation(GO:0070475) |
| 1.2 | 3.7 | GO:0070543 | response to linoleic acid(GO:0070543) |
| 1.2 | 28.4 | GO:0000027 | ribosomal large subunit assembly(GO:0000027) |
| 1.2 | 4.9 | GO:1902268 | negative regulation of polyamine transmembrane transport(GO:1902268) |
| 1.2 | 13.5 | GO:0007042 | lysosomal lumen acidification(GO:0007042) |
| 1.2 | 1.2 | GO:1903722 | regulation of centriole elongation(GO:1903722) |
| 1.2 | 6.1 | GO:0030214 | hyaluronan catabolic process(GO:0030214) |
| 1.2 | 3.7 | GO:1904046 | negative regulation of vascular endothelial growth factor production(GO:1904046) |
| 1.2 | 3.6 | GO:0000715 | nucleotide-excision repair, DNA damage recognition(GO:0000715) |
| 1.2 | 4.8 | GO:0003376 | sphingosine-1-phosphate signaling pathway(GO:0003376) sphingolipid mediated signaling pathway(GO:0090520) |
| 1.2 | 1.2 | GO:0090071 | negative regulation of ribosome biogenesis(GO:0090071) |
| 1.2 | 3.6 | GO:0070488 | neutrophil aggregation(GO:0070488) |
| 1.2 | 7.1 | GO:1900028 | negative regulation of ruffle assembly(GO:1900028) |
| 1.2 | 3.6 | GO:0009414 | response to water deprivation(GO:0009414) |
| 1.2 | 2.4 | GO:0032790 | ribosome disassembly(GO:0032790) |
| 1.2 | 11.8 | GO:2001269 | positive regulation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway(GO:2001269) |
| 1.2 | 10.6 | GO:0031424 | keratinization(GO:0031424) |
| 1.2 | 3.5 | GO:0097089 | methyl-branched fatty acid metabolic process(GO:0097089) |
| 1.2 | 2.3 | GO:0002309 | T cell proliferation involved in immune response(GO:0002309) |
| 1.2 | 3.5 | GO:1903225 | negative regulation of endodermal cell differentiation(GO:1903225) |
| 1.2 | 3.5 | GO:0031038 | myosin II filament organization(GO:0031038) regulation of myosin II filament organization(GO:0043519) |
| 1.1 | 12.6 | GO:0006228 | UTP biosynthetic process(GO:0006228) |
| 1.1 | 5.7 | GO:0045578 | negative regulation of B cell differentiation(GO:0045578) |
| 1.1 | 3.4 | GO:0060672 | epithelial cell differentiation involved in embryonic placenta development(GO:0060671) epithelial cell morphogenesis involved in placental branching(GO:0060672) |
| 1.1 | 1.1 | GO:0018125 | peptidyl-cysteine methylation(GO:0018125) |
| 1.1 | 3.4 | GO:0007181 | transforming growth factor beta receptor complex assembly(GO:0007181) |
| 1.1 | 5.7 | GO:0006564 | L-serine biosynthetic process(GO:0006564) |
| 1.1 | 3.4 | GO:0016242 | negative regulation of macroautophagy(GO:0016242) |
| 1.1 | 69.6 | GO:0032543 | mitochondrial translation(GO:0032543) |
| 1.1 | 3.4 | GO:1903774 | positive regulation of viral budding via host ESCRT complex(GO:1903774) |
| 1.1 | 4.4 | GO:0071224 | cellular response to peptidoglycan(GO:0071224) |
| 1.1 | 3.3 | GO:0072180 | mesonephric duct development(GO:0072177) mesonephric duct morphogenesis(GO:0072180) |
| 1.1 | 2.2 | GO:0071163 | DNA replication preinitiation complex assembly(GO:0071163) |
| 1.1 | 9.8 | GO:0097421 | liver regeneration(GO:0097421) |
| 1.1 | 6.5 | GO:0002862 | negative regulation of inflammatory response to antigenic stimulus(GO:0002862) |
| 1.1 | 2.2 | GO:1900864 | mitochondrial tRNA modification(GO:0070900) mitochondrial RNA modification(GO:1900864) |
| 1.1 | 5.4 | GO:0070197 | meiotic telomere tethering at nuclear periphery(GO:0044821) meiotic attachment of telomere to nuclear envelope(GO:0070197) chromosome attachment to the nuclear envelope(GO:0097240) |
| 1.1 | 4.3 | GO:1901475 | pyruvate transmembrane transport(GO:1901475) |
| 1.1 | 1.1 | GO:0050862 | positive regulation of T cell receptor signaling pathway(GO:0050862) |
| 1.1 | 1.1 | GO:0036324 | vascular endothelial growth factor receptor-2 signaling pathway(GO:0036324) |
| 1.1 | 1.1 | GO:0090035 | regulation of chaperone-mediated protein complex assembly(GO:0090034) positive regulation of chaperone-mediated protein complex assembly(GO:0090035) |
| 1.1 | 3.2 | GO:0097029 | mature conventional dendritic cell differentiation(GO:0097029) |
| 1.1 | 4.3 | GO:0007023 | post-chaperonin tubulin folding pathway(GO:0007023) |
| 1.1 | 4.3 | GO:0019509 | L-methionine biosynthetic process from methylthioadenosine(GO:0019509) |
| 1.1 | 1.1 | GO:2000510 | positive regulation of dendritic cell chemotaxis(GO:2000510) |
| 1.1 | 1.1 | GO:0042182 | ketone catabolic process(GO:0042182) |
| 1.1 | 3.2 | GO:0046900 | tetrahydrofolylpolyglutamate metabolic process(GO:0046900) |
| 1.1 | 5.3 | GO:0090521 | glomerular visceral epithelial cell migration(GO:0090521) |
| 1.1 | 3.2 | GO:1903313 | positive regulation of mRNA metabolic process(GO:1903313) |
| 1.0 | 13.6 | GO:0016226 | iron-sulfur cluster assembly(GO:0016226) metallo-sulfur cluster assembly(GO:0031163) |
| 1.0 | 5.2 | GO:0070171 | negative regulation of tooth mineralization(GO:0070171) |
| 1.0 | 5.2 | GO:0021678 | third ventricle development(GO:0021678) |
| 1.0 | 5.2 | GO:0034436 | glycoprotein transport(GO:0034436) |
| 1.0 | 28.6 | GO:0015985 | energy coupled proton transport, down electrochemical gradient(GO:0015985) ATP synthesis coupled proton transport(GO:0015986) |
| 1.0 | 4.1 | GO:1900220 | semaphorin-plexin signaling pathway involved in bone trabecula morphogenesis(GO:1900220) |
| 1.0 | 4.1 | GO:0010288 | response to lead ion(GO:0010288) |
| 1.0 | 3.0 | GO:0061428 | negative regulation of transcription from RNA polymerase II promoter in response to hypoxia(GO:0061428) |
| 1.0 | 7.0 | GO:0072321 | chaperone-mediated protein transport(GO:0072321) |
| 1.0 | 10.0 | GO:1904153 | negative regulation of protein exit from endoplasmic reticulum(GO:0070862) negative regulation of retrograde protein transport, ER to cytosol(GO:1904153) |
| 1.0 | 4.0 | GO:1904529 | regulation of actin filament binding(GO:1904529) regulation of actin binding(GO:1904616) |
| 1.0 | 12.0 | GO:0006977 | DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest(GO:0006977) |
| 1.0 | 14.9 | GO:0030150 | protein import into mitochondrial matrix(GO:0030150) |
| 1.0 | 3.0 | GO:0009051 | pentose-phosphate shunt, oxidative branch(GO:0009051) |
| 1.0 | 4.9 | GO:0031125 | rRNA 3'-end processing(GO:0031125) |
| 1.0 | 18.7 | GO:0071577 | zinc II ion transmembrane transport(GO:0071577) |
| 1.0 | 3.9 | GO:0060838 | lymphatic endothelial cell fate commitment(GO:0060838) |
| 1.0 | 2.9 | GO:0030578 | PML body organization(GO:0030578) |
| 1.0 | 3.9 | GO:0006776 | vitamin A metabolic process(GO:0006776) |
| 1.0 | 6.8 | GO:0006627 | protein processing involved in protein targeting to mitochondrion(GO:0006627) |
| 1.0 | 2.9 | GO:0016998 | cell wall macromolecule catabolic process(GO:0016998) |
| 1.0 | 1.0 | GO:0009182 | purine deoxyribonucleoside diphosphate metabolic process(GO:0009182) dGDP metabolic process(GO:0046066) GDP metabolic process(GO:0046710) |
| 1.0 | 1.0 | GO:0034497 | protein localization to pre-autophagosomal structure(GO:0034497) |
| 1.0 | 17.2 | GO:0015991 | energy coupled proton transmembrane transport, against electrochemical gradient(GO:0015988) ATP hydrolysis coupled proton transport(GO:0015991) |
| 1.0 | 3.8 | GO:0030576 | Cajal body organization(GO:0030576) |
| 1.0 | 1.9 | GO:0033484 | nitric oxide homeostasis(GO:0033484) |
| 1.0 | 4.8 | GO:0071557 | histone H3-K27 demethylation(GO:0071557) |
| 0.9 | 1.9 | GO:0060167 | regulation of adenosine receptor signaling pathway(GO:0060167) |
| 0.9 | 6.6 | GO:0044241 | lipid digestion(GO:0044241) |
| 0.9 | 2.8 | GO:0019046 | release from viral latency(GO:0019046) |
| 0.9 | 2.8 | GO:0016561 | protein import into peroxisome matrix, translocation(GO:0016561) |
| 0.9 | 6.5 | GO:0070317 | negative regulation of G0 to G1 transition(GO:0070317) |
| 0.9 | 4.7 | GO:1903223 | positive regulation of oxidative stress-induced neuron death(GO:1903223) positive regulation of oxidative stress-induced neuron intrinsic apoptotic signaling pathway(GO:1903378) |
| 0.9 | 1.9 | GO:0032074 | negative regulation of nuclease activity(GO:0032074) |
| 0.9 | 9.3 | GO:0070935 | 3'-UTR-mediated mRNA stabilization(GO:0070935) |
| 0.9 | 5.5 | GO:0006975 | DNA damage induced protein phosphorylation(GO:0006975) |
| 0.9 | 2.8 | GO:0060244 | negative regulation of cell proliferation involved in contact inhibition(GO:0060244) |
| 0.9 | 1.8 | GO:0070885 | negative regulation of calcineurin-NFAT signaling cascade(GO:0070885) |
| 0.9 | 6.4 | GO:0030263 | apoptotic chromosome condensation(GO:0030263) |
| 0.9 | 3.6 | GO:0070427 | nucleotide-binding oligomerization domain containing 1 signaling pathway(GO:0070427) |
| 0.9 | 4.5 | GO:0016560 | protein import into peroxisome matrix, docking(GO:0016560) |
| 0.9 | 3.6 | GO:0046604 | positive regulation of mitotic centrosome separation(GO:0046604) |
| 0.9 | 4.5 | GO:1901097 | negative regulation of autophagosome maturation(GO:1901097) |
| 0.9 | 4.5 | GO:1902255 | positive regulation of intrinsic apoptotic signaling pathway by p53 class mediator(GO:1902255) |
| 0.9 | 3.6 | GO:0045896 | regulation of transcription during mitosis(GO:0045896) positive regulation of transcription during mitosis(GO:0045897) |
| 0.9 | 3.6 | GO:0099527 | postsynapse to nucleus signaling pathway(GO:0099527) |
| 0.9 | 0.9 | GO:0015866 | ADP transport(GO:0015866) |
| 0.9 | 3.5 | GO:0006558 | L-phenylalanine metabolic process(GO:0006558) erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process(GO:1902221) |
| 0.9 | 6.2 | GO:1901977 | negative regulation of cell cycle checkpoint(GO:1901977) negative regulation of DNA damage checkpoint(GO:2000002) |
| 0.9 | 6.2 | GO:0000056 | ribosomal small subunit export from nucleus(GO:0000056) |
| 0.9 | 2.6 | GO:0061198 | fungiform papilla formation(GO:0061198) |
| 0.9 | 1.7 | GO:0035928 | RNA import into mitochondrion(GO:0035927) rRNA import into mitochondrion(GO:0035928) |
| 0.9 | 3.5 | GO:0003150 | muscular septum morphogenesis(GO:0003150) |
| 0.9 | 1.7 | GO:2000348 | regulation of CD40 signaling pathway(GO:2000348) |
| 0.9 | 6.9 | GO:0006004 | fucose metabolic process(GO:0006004) |
| 0.9 | 2.6 | GO:0046032 | ADP catabolic process(GO:0046032) |
| 0.9 | 0.9 | GO:2000642 | negative regulation of early endosome to late endosome transport(GO:2000642) |
| 0.9 | 3.4 | GO:0043973 | histone H3-K4 acetylation(GO:0043973) |
| 0.9 | 2.6 | GO:1903644 | regulation of chaperone-mediated protein folding(GO:1903644) |
| 0.9 | 7.7 | GO:0045647 | negative regulation of erythrocyte differentiation(GO:0045647) |
| 0.9 | 3.4 | GO:1900224 | positive regulation of nodal signaling pathway involved in determination of lateral mesoderm left/right asymmetry(GO:1900224) positive regulation of mesoderm development(GO:2000382) |
| 0.8 | 3.4 | GO:1904715 | negative regulation of chaperone-mediated autophagy(GO:1904715) |
| 0.8 | 2.5 | GO:0060830 | ciliary receptor clustering involved in smoothened signaling pathway(GO:0060830) |
| 0.8 | 1.7 | GO:0030240 | skeletal muscle thin filament assembly(GO:0030240) |
| 0.8 | 3.4 | GO:0046125 | pyrimidine deoxyribonucleoside metabolic process(GO:0046125) |
| 0.8 | 11.8 | GO:0006337 | nucleosome disassembly(GO:0006337) |
| 0.8 | 2.5 | GO:0051182 | coenzyme transport(GO:0051182) |
| 0.8 | 5.0 | GO:0032796 | uropod organization(GO:0032796) |
| 0.8 | 4.2 | GO:1902224 | cellular ketone body metabolic process(GO:0046950) ketone body metabolic process(GO:1902224) |
| 0.8 | 5.8 | GO:0006369 | termination of RNA polymerase II transcription(GO:0006369) |
| 0.8 | 3.3 | GO:1902023 | L-arginine transport(GO:1902023) |
| 0.8 | 1.6 | GO:0097411 | hypoxia-inducible factor-1alpha signaling pathway(GO:0097411) |
| 0.8 | 3.3 | GO:0019062 | virion attachment to host cell(GO:0019062) adhesion of symbiont to host cell(GO:0044650) |
| 0.8 | 6.5 | GO:0036444 | calcium ion transmembrane import into mitochondrion(GO:0036444) |
| 0.8 | 2.5 | GO:0003360 | brainstem development(GO:0003360) |
| 0.8 | 1.6 | GO:0090611 | ubiquitin-independent protein catabolic process via the multivesicular body sorting pathway(GO:0090611) |
| 0.8 | 4.9 | GO:0006450 | regulation of translational fidelity(GO:0006450) |
| 0.8 | 1.6 | GO:0048209 | regulation of vesicle targeting, to, from or within Golgi(GO:0048209) |
| 0.8 | 2.4 | GO:0061051 | positive regulation of cell growth involved in cardiac muscle cell development(GO:0061051) |
| 0.8 | 2.4 | GO:0010936 | negative regulation of macrophage cytokine production(GO:0010936) |
| 0.8 | 27.4 | GO:0000387 | spliceosomal snRNP assembly(GO:0000387) |
| 0.8 | 1.6 | GO:0097274 | urea homeostasis(GO:0097274) |
| 0.8 | 4.0 | GO:0021514 | ventral spinal cord interneuron differentiation(GO:0021514) |
| 0.8 | 0.8 | GO:0036115 | fatty-acyl-CoA catabolic process(GO:0036115) |
| 0.8 | 4.0 | GO:0072530 | purine-containing compound transmembrane transport(GO:0072530) |
| 0.8 | 0.8 | GO:1903608 | protein localization to cytoplasmic stress granule(GO:1903608) |
| 0.8 | 4.7 | GO:0036123 | histone H3-K9 dimethylation(GO:0036123) |
| 0.8 | 18.0 | GO:0055012 | ventricular cardiac muscle cell differentiation(GO:0055012) |
| 0.8 | 0.8 | GO:0048852 | diencephalon morphogenesis(GO:0048852) |
| 0.8 | 17.7 | GO:0042775 | mitochondrial ATP synthesis coupled electron transport(GO:0042775) |
| 0.8 | 3.1 | GO:0030860 | regulation of polarized epithelial cell differentiation(GO:0030860) |
| 0.8 | 3.8 | GO:0000054 | ribosomal subunit export from nucleus(GO:0000054) ribosome localization(GO:0033750) establishment of ribosome localization(GO:0033753) |
| 0.8 | 3.8 | GO:0001955 | blood vessel maturation(GO:0001955) |
| 0.8 | 3.1 | GO:0072272 | proximal/distal pattern formation involved in metanephric nephron development(GO:0072272) |
| 0.8 | 3.0 | GO:0010749 | regulation of nitric oxide mediated signal transduction(GO:0010749) |
| 0.8 | 1.5 | GO:0034227 | tRNA thio-modification(GO:0034227) |
| 0.8 | 1.5 | GO:0034393 | positive regulation of smooth muscle cell apoptotic process(GO:0034393) |
| 0.8 | 4.5 | GO:0009235 | cobalamin metabolic process(GO:0009235) |
| 0.8 | 6.1 | GO:0034498 | early endosome to Golgi transport(GO:0034498) |
| 0.8 | 3.0 | GO:0035902 | response to immobilization stress(GO:0035902) |
| 0.8 | 4.5 | GO:0009146 | purine nucleoside triphosphate catabolic process(GO:0009146) |
| 0.8 | 0.8 | GO:0043096 | purine nucleobase salvage(GO:0043096) |
| 0.8 | 4.5 | GO:0036089 | cleavage furrow formation(GO:0036089) |
| 0.8 | 2.3 | GO:0000185 | activation of MAPKKK activity(GO:0000185) |
| 0.7 | 2.2 | GO:0010757 | negative regulation of plasminogen activation(GO:0010757) |
| 0.7 | 1.5 | GO:0072223 | metanephric glomerular mesangium development(GO:0072223) metanephric glomerular mesangial cell proliferation involved in metanephros development(GO:0072262) |
| 0.7 | 4.5 | GO:0007258 | JUN phosphorylation(GO:0007258) |
| 0.7 | 3.7 | GO:0046826 | negative regulation of protein export from nucleus(GO:0046826) |
| 0.7 | 3.7 | GO:0030951 | establishment or maintenance of microtubule cytoskeleton polarity(GO:0030951) |
| 0.7 | 8.2 | GO:0021796 | cerebral cortex regionalization(GO:0021796) |
| 0.7 | 2.2 | GO:0007144 | female meiosis I(GO:0007144) |
| 0.7 | 3.0 | GO:1904672 | regulation of somatic stem cell population maintenance(GO:1904672) |
| 0.7 | 1.5 | GO:0032847 | positive regulation of prostaglandin biosynthetic process(GO:0031394) regulation of cellular pH reduction(GO:0032847) positive regulation of unsaturated fatty acid biosynthetic process(GO:2001280) |
| 0.7 | 0.7 | GO:0090187 | positive regulation of pancreatic juice secretion(GO:0090187) |
| 0.7 | 13.3 | GO:0045792 | negative regulation of cell size(GO:0045792) |
| 0.7 | 3.0 | GO:1903860 | negative regulation of dendrite extension(GO:1903860) regulation of neuron remodeling(GO:1904799) negative regulation of neuron remodeling(GO:1904800) |
| 0.7 | 2.2 | GO:0042908 | xenobiotic transport(GO:0042908) |
| 0.7 | 1.5 | GO:0071763 | nuclear membrane organization(GO:0071763) |
| 0.7 | 2.9 | GO:0032901 | positive regulation of neurotrophin production(GO:0032901) |
| 0.7 | 4.4 | GO:0042985 | negative regulation of amyloid precursor protein biosynthetic process(GO:0042985) |
| 0.7 | 3.7 | GO:0014886 | transition between slow and fast fiber(GO:0014886) |
| 0.7 | 2.2 | GO:0046462 | monoacylglycerol metabolic process(GO:0046462) |
| 0.7 | 30.7 | GO:0006891 | intra-Golgi vesicle-mediated transport(GO:0006891) |
| 0.7 | 5.1 | GO:0021780 | oligodendrocyte cell fate specification(GO:0021778) oligodendrocyte cell fate commitment(GO:0021779) glial cell fate specification(GO:0021780) |
| 0.7 | 0.7 | GO:1902455 | negative regulation of stem cell population maintenance(GO:1902455) |
| 0.7 | 2.2 | GO:0032800 | receptor biosynthetic process(GO:0032800) |
| 0.7 | 2.9 | GO:0046210 | regulation of growth plate cartilage chondrocyte proliferation(GO:0003420) nitrate catabolic process(GO:0043602) nitric oxide catabolic process(GO:0046210) cellular organohalogen metabolic process(GO:0090345) cellular organofluorine metabolic process(GO:0090346) |
| 0.7 | 0.7 | GO:0046600 | negative regulation of centriole replication(GO:0046600) |
| 0.7 | 1.4 | GO:0048170 | positive regulation of long-term neuronal synaptic plasticity(GO:0048170) |
| 0.7 | 3.6 | GO:0008655 | pyrimidine-containing compound salvage(GO:0008655) pyrimidine nucleoside salvage(GO:0043097) |
| 0.7 | 6.5 | GO:0070236 | negative regulation of activation-induced cell death of T cells(GO:0070236) |
| 0.7 | 2.1 | GO:0035964 | COPI-coated vesicle budding(GO:0035964) |
| 0.7 | 2.1 | GO:0030070 | insulin processing(GO:0030070) |
| 0.7 | 5.7 | GO:1900262 | regulation of DNA-directed DNA polymerase activity(GO:1900262) positive regulation of DNA-directed DNA polymerase activity(GO:1900264) |
| 0.7 | 0.7 | GO:0090400 | stress-induced premature senescence(GO:0090400) |
| 0.7 | 5.7 | GO:0038166 | angiotensin-activated signaling pathway(GO:0038166) |
| 0.7 | 12.7 | GO:0071786 | endoplasmic reticulum tubular network organization(GO:0071786) |
| 0.7 | 0.7 | GO:0072720 | response to dithiothreitol(GO:0072720) |
| 0.7 | 2.1 | GO:1902965 | regulation of protein localization to early endosome(GO:1902965) positive regulation of protein localization to early endosome(GO:1902966) |
| 0.7 | 2.1 | GO:0036015 | response to interleukin-3(GO:0036015) cellular response to interleukin-3(GO:0036016) |
| 0.7 | 9.1 | GO:0045899 | positive regulation of RNA polymerase II transcriptional preinitiation complex assembly(GO:0045899) |
| 0.7 | 4.2 | GO:0034058 | endosomal vesicle fusion(GO:0034058) |
| 0.7 | 12.5 | GO:0007530 | sex determination(GO:0007530) |
| 0.7 | 4.8 | GO:0006102 | isocitrate metabolic process(GO:0006102) |
| 0.7 | 1.4 | GO:2000812 | regulation of barbed-end actin filament capping(GO:2000812) |
| 0.7 | 1.4 | GO:0018171 | peptidyl-cysteine oxidation(GO:0018171) |
| 0.7 | 6.1 | GO:0008298 | intracellular mRNA localization(GO:0008298) |
| 0.7 | 20.4 | GO:0045746 | negative regulation of Notch signaling pathway(GO:0045746) |
| 0.7 | 1.4 | GO:0046015 | regulation of transcription by glucose(GO:0046015) |
| 0.7 | 4.1 | GO:0030913 | paranodal junction assembly(GO:0030913) |
| 0.7 | 1.4 | GO:0072092 | ureteric bud invasion(GO:0072092) |
| 0.7 | 2.7 | GO:0061073 | ciliary body morphogenesis(GO:0061073) |
| 0.7 | 0.7 | GO:0034287 | detection of carbohydrate stimulus(GO:0009730) detection of hexose stimulus(GO:0009732) detection of monosaccharide stimulus(GO:0034287) detection of glucose(GO:0051594) |
| 0.7 | 0.7 | GO:2000040 | regulation of planar cell polarity pathway involved in axis elongation(GO:2000040) negative regulation of planar cell polarity pathway involved in axis elongation(GO:2000041) |
| 0.7 | 2.7 | GO:0036091 | positive regulation of transcription from RNA polymerase II promoter in response to oxidative stress(GO:0036091) |
| 0.7 | 2.0 | GO:0043456 | regulation of pentose-phosphate shunt(GO:0043456) |
| 0.7 | 2.0 | GO:0003199 | endocardial cushion to mesenchymal transition involved in heart valve formation(GO:0003199) |
| 0.7 | 2.0 | GO:0090343 | positive regulation of cell aging(GO:0090343) positive regulation of cellular senescence(GO:2000774) |
| 0.7 | 0.7 | GO:2000850 | negative regulation of corticosteroid hormone secretion(GO:2000847) negative regulation of glucocorticoid secretion(GO:2000850) |
| 0.7 | 3.3 | GO:0019236 | response to pheromone(GO:0019236) |
| 0.6 | 2.6 | GO:2000465 | regulation of glycogen (starch) synthase activity(GO:2000465) |
| 0.6 | 3.9 | GO:0016255 | attachment of GPI anchor to protein(GO:0016255) |
| 0.6 | 1.9 | GO:2000501 | natural killer cell chemotaxis(GO:0035747) regulation of natural killer cell chemotaxis(GO:2000501) |
| 0.6 | 2.6 | GO:0006624 | vacuolar protein processing(GO:0006624) |
| 0.6 | 2.6 | GO:1990022 | RNA polymerase II complex import to nucleus(GO:0044376) RNA polymerase III complex localization to nucleus(GO:1990022) |
| 0.6 | 8.3 | GO:0042407 | cristae formation(GO:0042407) |
| 0.6 | 0.6 | GO:0045650 | negative regulation of macrophage differentiation(GO:0045650) |
| 0.6 | 1.3 | GO:0009814 | defense response, incompatible interaction(GO:0009814) |
| 0.6 | 7.6 | GO:0060159 | regulation of dopamine receptor signaling pathway(GO:0060159) |
| 0.6 | 1.9 | GO:0006546 | glycine catabolic process(GO:0006546) glycine decarboxylation via glycine cleavage system(GO:0019464) |
| 0.6 | 2.5 | GO:0097494 | regulation of vesicle size(GO:0097494) |
| 0.6 | 6.3 | GO:0001682 | tRNA 5'-leader removal(GO:0001682) |
| 0.6 | 1.9 | GO:0060754 | positive regulation of mast cell chemotaxis(GO:0060754) |
| 0.6 | 3.7 | GO:0097473 | cellular response to light intensity(GO:0071484) cellular response to high light intensity(GO:0071486) retinal rod cell apoptotic process(GO:0097473) |
| 0.6 | 4.4 | GO:0045721 | negative regulation of gluconeogenesis(GO:0045721) |
| 0.6 | 2.5 | GO:2001045 | negative regulation of integrin-mediated signaling pathway(GO:2001045) |
| 0.6 | 1.9 | GO:0035606 | peptidyl-cysteine S-trans-nitrosylation(GO:0035606) |
| 0.6 | 2.5 | GO:0009052 | pentose-phosphate shunt, non-oxidative branch(GO:0009052) |
| 0.6 | 4.9 | GO:1904667 | negative regulation of ubiquitin protein ligase activity(GO:1904667) |
| 0.6 | 2.5 | GO:0010836 | negative regulation of protein ADP-ribosylation(GO:0010836) |
| 0.6 | 4.9 | GO:0019388 | galactose catabolic process(GO:0019388) |
| 0.6 | 1.8 | GO:0016554 | cytidine to uridine editing(GO:0016554) |
| 0.6 | 2.5 | GO:0006012 | galactose metabolic process(GO:0006012) |
| 0.6 | 2.4 | GO:0045835 | negative regulation of meiotic nuclear division(GO:0045835) |
| 0.6 | 3.1 | GO:2000210 | positive regulation of anoikis(GO:2000210) |
| 0.6 | 3.7 | GO:0003431 | growth plate cartilage chondrocyte development(GO:0003431) |
| 0.6 | 1.8 | GO:0006667 | sphinganine metabolic process(GO:0006667) |
| 0.6 | 0.6 | GO:0043585 | nose morphogenesis(GO:0043585) |
| 0.6 | 2.4 | GO:0046415 | urate metabolic process(GO:0046415) |
| 0.6 | 1.2 | GO:0019042 | viral latency(GO:0019042) |
| 0.6 | 0.6 | GO:0055095 | lipoprotein particle mediated signaling(GO:0055095) low-density lipoprotein particle mediated signaling(GO:0055096) |
| 0.6 | 3.6 | GO:0018195 | peptidyl-arginine modification(GO:0018195) |
| 0.6 | 1.8 | GO:0090063 | positive regulation of microtubule nucleation(GO:0090063) |
| 0.6 | 13.6 | GO:0006783 | heme biosynthetic process(GO:0006783) |
| 0.6 | 1.2 | GO:1903243 | negative regulation of cardiac muscle hypertrophy in response to stress(GO:1903243) |
| 0.6 | 12.4 | GO:0033119 | negative regulation of RNA splicing(GO:0033119) |
| 0.6 | 1.8 | GO:0031145 | anaphase-promoting complex-dependent catabolic process(GO:0031145) |
| 0.6 | 0.6 | GO:0031498 | chromatin disassembly(GO:0031498) |
| 0.6 | 1.8 | GO:1904207 | chemokine (C-C motif) ligand 2 secretion(GO:0035926) regulation of chemokine (C-C motif) ligand 2 secretion(GO:1904207) positive regulation of chemokine (C-C motif) ligand 2 secretion(GO:1904209) |
| 0.6 | 2.9 | GO:0023041 | neuronal signal transduction(GO:0023041) |
| 0.6 | 1.8 | GO:0002940 | tRNA N2-guanine methylation(GO:0002940) |
| 0.6 | 2.3 | GO:0035720 | intraciliary anterograde transport(GO:0035720) |
| 0.6 | 2.3 | GO:0090267 | positive regulation of mitotic cell cycle spindle assembly checkpoint(GO:0090267) |
| 0.6 | 4.1 | GO:0010587 | miRNA catabolic process(GO:0010587) |
| 0.6 | 1.7 | GO:0098974 | postsynaptic actin cytoskeleton organization(GO:0098974) |
| 0.6 | 2.9 | GO:1900147 | Schwann cell migration(GO:0036135) regulation of Schwann cell migration(GO:1900147) |
| 0.6 | 4.6 | GO:0043615 | astrocyte cell migration(GO:0043615) |
| 0.6 | 2.3 | GO:0046898 | response to cycloheximide(GO:0046898) |
| 0.6 | 4.6 | GO:0071816 | tail-anchored membrane protein insertion into ER membrane(GO:0071816) |
| 0.6 | 1.7 | GO:0007227 | signal transduction downstream of smoothened(GO:0007227) positive regulation of hh target transcription factor activity(GO:0007228) |
| 0.6 | 2.3 | GO:0001778 | plasma membrane repair(GO:0001778) |
| 0.6 | 2.8 | GO:1901727 | positive regulation of histone deacetylase activity(GO:1901727) |
| 0.6 | 3.9 | GO:0019262 | N-acetylneuraminate catabolic process(GO:0019262) |
| 0.6 | 1.7 | GO:0019441 | tryptophan catabolic process(GO:0006569) aromatic amino acid family catabolic process(GO:0009074) tryptophan catabolic process to kynurenine(GO:0019441) indole-containing compound catabolic process(GO:0042436) indolalkylamine catabolic process(GO:0046218) kynurenine metabolic process(GO:0070189) |
| 0.6 | 2.8 | GO:0001731 | formation of translation preinitiation complex(GO:0001731) |
| 0.6 | 1.7 | GO:0002678 | positive regulation of chronic inflammatory response(GO:0002678) |
| 0.6 | 6.7 | GO:0000920 | cell separation after cytokinesis(GO:0000920) |
| 0.6 | 3.3 | GO:0000160 | phosphorelay signal transduction system(GO:0000160) |
| 0.6 | 17.2 | GO:0070979 | protein K11-linked ubiquitination(GO:0070979) |
| 0.6 | 2.8 | GO:0045716 | positive regulation of low-density lipoprotein particle receptor biosynthetic process(GO:0045716) |
| 0.6 | 2.2 | GO:0031580 | membrane raft polarization(GO:0001766) membrane raft distribution(GO:0031580) |
| 0.6 | 2.2 | GO:0019673 | GDP-mannose metabolic process(GO:0019673) |
| 0.5 | 1.6 | GO:0032201 | telomere maintenance via semi-conservative replication(GO:0032201) |
| 0.5 | 1.6 | GO:0015772 | disaccharide transport(GO:0015766) sucrose transport(GO:0015770) oligosaccharide transport(GO:0015772) |
| 0.5 | 1.6 | GO:0015747 | urate transport(GO:0015747) |
| 0.5 | 11.5 | GO:0048026 | positive regulation of mRNA splicing, via spliceosome(GO:0048026) |
| 0.5 | 2.2 | GO:0060316 | positive regulation of ryanodine-sensitive calcium-release channel activity(GO:0060316) |
| 0.5 | 2.7 | GO:0090666 | scaRNA localization to Cajal body(GO:0090666) |
| 0.5 | 1.6 | GO:0060741 | prostate gland stromal morphogenesis(GO:0060741) |
| 0.5 | 3.2 | GO:0090527 | actin filament reorganization(GO:0090527) |
| 0.5 | 1.6 | GO:0035864 | response to potassium ion(GO:0035864) cellular response to potassium ion(GO:0035865) |
| 0.5 | 0.5 | GO:0035622 | intrahepatic bile duct development(GO:0035622) |
| 0.5 | 1.1 | GO:0032510 | endosome to lysosome transport via multivesicular body sorting pathway(GO:0032510) |
| 0.5 | 4.3 | GO:0070874 | negative regulation of glycogen biosynthetic process(GO:0045719) negative regulation of glycogen metabolic process(GO:0070874) |
| 0.5 | 1.6 | GO:0006788 | heme oxidation(GO:0006788) |
| 0.5 | 2.7 | GO:0043314 | negative regulation of neutrophil degranulation(GO:0043314) negative regulation of blood vessel remodeling(GO:0060313) |
| 0.5 | 3.7 | GO:0006561 | proline biosynthetic process(GO:0006561) |
| 0.5 | 6.4 | GO:0021942 | radial glia guided migration of Purkinje cell(GO:0021942) |
| 0.5 | 7.4 | GO:0000083 | regulation of transcription involved in G1/S transition of mitotic cell cycle(GO:0000083) |
| 0.5 | 2.6 | GO:0000279 | M phase(GO:0000279) |
| 0.5 | 1.6 | GO:0045819 | plasmacytoid dendritic cell activation(GO:0002270) positive regulation of glycogen catabolic process(GO:0045819) |
| 0.5 | 5.8 | GO:2000580 | positive regulation of microtubule motor activity(GO:2000576) regulation of ATP-dependent microtubule motor activity, plus-end-directed(GO:2000580) positive regulation of ATP-dependent microtubule motor activity, plus-end-directed(GO:2000582) |
| 0.5 | 1.6 | GO:0050965 | detection of temperature stimulus(GO:0016048) detection of temperature stimulus involved in sensory perception(GO:0050961) detection of temperature stimulus involved in sensory perception of pain(GO:0050965) |
| 0.5 | 8.4 | GO:0010719 | negative regulation of epithelial to mesenchymal transition(GO:0010719) |
| 0.5 | 3.2 | GO:0043137 | DNA replication, removal of RNA primer(GO:0043137) |
| 0.5 | 6.8 | GO:0015937 | coenzyme A biosynthetic process(GO:0015937) |
| 0.5 | 5.2 | GO:0045624 | positive regulation of T-helper cell differentiation(GO:0045624) |
| 0.5 | 2.6 | GO:1903715 | regulation of aerobic respiration(GO:1903715) |
| 0.5 | 8.4 | GO:0046498 | S-adenosylhomocysteine metabolic process(GO:0046498) |
| 0.5 | 11.4 | GO:0071260 | cellular response to mechanical stimulus(GO:0071260) |
| 0.5 | 7.2 | GO:0006907 | pinocytosis(GO:0006907) |
| 0.5 | 5.2 | GO:0090315 | negative regulation of protein targeting to membrane(GO:0090315) |
| 0.5 | 2.1 | GO:0046909 | intermembrane transport(GO:0046909) protein transport from ciliary membrane to plasma membrane(GO:1903445) |
| 0.5 | 0.5 | GO:0071921 | establishment of sister chromatid cohesion(GO:0034085) cohesin loading(GO:0071921) regulation of cohesin loading(GO:0071922) |
| 0.5 | 2.6 | GO:0006287 | base-excision repair, gap-filling(GO:0006287) |
| 0.5 | 7.2 | GO:0001779 | natural killer cell differentiation(GO:0001779) |
| 0.5 | 5.6 | GO:0009438 | methylglyoxal metabolic process(GO:0009438) |
| 0.5 | 1.5 | GO:0030647 | polyketide metabolic process(GO:0030638) aminoglycoside antibiotic metabolic process(GO:0030647) daunorubicin metabolic process(GO:0044597) doxorubicin metabolic process(GO:0044598) |
| 0.5 | 0.5 | GO:0021593 | rhombomere morphogenesis(GO:0021593) |
| 0.5 | 4.1 | GO:0033683 | nucleotide-excision repair, DNA incision(GO:0033683) |
| 0.5 | 1.0 | GO:0021586 | pons maturation(GO:0021586) |
| 0.5 | 2.5 | GO:0043983 | histone H4-K12 acetylation(GO:0043983) |
| 0.5 | 1.0 | GO:1990253 | cellular response to leucine starvation(GO:1990253) |
| 0.5 | 1.5 | GO:0010886 | regulation of cholesterol storage(GO:0010885) positive regulation of cholesterol storage(GO:0010886) |
| 0.5 | 4.5 | GO:0035269 | protein O-linked mannosylation(GO:0035269) |
| 0.5 | 4.0 | GO:0035873 | lactate transport(GO:0015727) lactate transmembrane transport(GO:0035873) plasma membrane lactate transport(GO:0035879) |
| 0.5 | 19.4 | GO:0009060 | aerobic respiration(GO:0009060) |
| 0.5 | 2.0 | GO:0046294 | formaldehyde catabolic process(GO:0046294) |
| 0.5 | 1.5 | GO:2000255 | negative regulation of male germ cell proliferation(GO:2000255) |
| 0.5 | 9.9 | GO:0006298 | mismatch repair(GO:0006298) |
| 0.5 | 3.0 | GO:0003065 | positive regulation of heart rate by epinephrine(GO:0003065) |
| 0.5 | 1.5 | GO:0001180 | transcription initiation from RNA polymerase I promoter for nuclear large rRNA transcript(GO:0001180) |
| 0.5 | 2.0 | GO:0017183 | peptidyl-diphthamide metabolic process(GO:0017182) peptidyl-diphthamide biosynthetic process from peptidyl-histidine(GO:0017183) |
| 0.5 | 2.4 | GO:0090091 | positive regulation of extracellular matrix disassembly(GO:0090091) |
| 0.5 | 1.5 | GO:0048539 | bone marrow development(GO:0048539) |
| 0.5 | 2.9 | GO:0035360 | positive regulation of peroxisome proliferator activated receptor signaling pathway(GO:0035360) |
| 0.5 | 1.9 | GO:0060347 | heart trabecula formation(GO:0060347) |
| 0.5 | 1.9 | GO:0042360 | vitamin E metabolic process(GO:0042360) |
| 0.5 | 1.0 | GO:0060696 | regulation of phospholipid catabolic process(GO:0060696) |
| 0.5 | 1.4 | GO:1900060 | negative regulation of ceramide biosynthetic process(GO:1900060) |
| 0.5 | 0.5 | GO:1901856 | negative regulation of cellular respiration(GO:1901856) |
| 0.5 | 1.4 | GO:0043504 | mitochondrial DNA repair(GO:0043504) |
| 0.5 | 1.0 | GO:1902527 | positive regulation of protein monoubiquitination(GO:1902527) |
| 0.5 | 3.8 | GO:0006002 | fructose 6-phosphate metabolic process(GO:0006002) |
| 0.5 | 1.9 | GO:0019732 | antifungal humoral response(GO:0019732) antifungal innate immune response(GO:0061760) |
| 0.5 | 2.8 | GO:0072513 | positive regulation of secondary heart field cardioblast proliferation(GO:0072513) |
| 0.5 | 1.9 | GO:1902951 | negative regulation of dendritic spine maintenance(GO:1902951) |
| 0.5 | 1.4 | GO:0030043 | actin filament fragmentation(GO:0030043) |
| 0.5 | 2.4 | GO:0043654 | recognition of apoptotic cell(GO:0043654) |
| 0.5 | 1.4 | GO:0015712 | hexose phosphate transport(GO:0015712) glucose-6-phosphate transport(GO:0015760) |
| 0.5 | 6.1 | GO:0051016 | barbed-end actin filament capping(GO:0051016) |
| 0.5 | 0.9 | GO:0006842 | tricarboxylic acid transport(GO:0006842) citrate transport(GO:0015746) |
| 0.5 | 1.9 | GO:1905245 | regulation of aspartic-type endopeptidase activity involved in amyloid precursor protein catabolic process(GO:1902959) positive regulation of aspartic-type endopeptidase activity involved in amyloid precursor protein catabolic process(GO:1902961) regulation of aspartic-type peptidase activity(GO:1905245) positive regulation of aspartic-type peptidase activity(GO:1905247) |
| 0.5 | 3.8 | GO:0006362 | transcription elongation from RNA polymerase I promoter(GO:0006362) |
| 0.5 | 1.4 | GO:0044828 | negative regulation by host of viral process(GO:0044793) negative regulation by host of viral genome replication(GO:0044828) |
| 0.5 | 0.9 | GO:1904975 | response to bleomycin(GO:1904975) cellular response to bleomycin(GO:1904976) |
| 0.5 | 0.5 | GO:1901252 | regulation of intracellular transport of viral material(GO:1901252) |
| 0.5 | 6.0 | GO:0061179 | negative regulation of insulin secretion involved in cellular response to glucose stimulus(GO:0061179) |
| 0.5 | 5.6 | GO:0040034 | regulation of development, heterochronic(GO:0040034) |
| 0.5 | 3.2 | GO:1904263 | positive regulation of TORC1 signaling(GO:1904263) |
| 0.5 | 1.4 | GO:0070459 | prolactin secretion(GO:0070459) |
| 0.5 | 3.2 | GO:0035331 | negative regulation of hippo signaling(GO:0035331) |
| 0.5 | 1.8 | GO:0090037 | positive regulation of protein kinase C signaling(GO:0090037) |
| 0.5 | 4.6 | GO:0006268 | DNA unwinding involved in DNA replication(GO:0006268) |
| 0.5 | 7.3 | GO:0009083 | branched-chain amino acid catabolic process(GO:0009083) |
| 0.5 | 0.9 | GO:1902953 | positive regulation of ER to Golgi vesicle-mediated transport(GO:1902953) |
| 0.5 | 1.4 | GO:0001788 | antibody-dependent cellular cytotoxicity(GO:0001788) |
| 0.5 | 1.4 | GO:0043461 | proton-transporting ATP synthase complex assembly(GO:0043461) proton-transporting ATP synthase complex biogenesis(GO:0070272) |
| 0.4 | 2.7 | GO:0015670 | carbon dioxide transport(GO:0015670) |
| 0.4 | 2.7 | GO:0035635 | entry of bacterium into host cell(GO:0035635) regulation of entry of bacterium into host cell(GO:2000535) |
| 0.4 | 8.0 | GO:0000184 | nuclear-transcribed mRNA catabolic process, nonsense-mediated decay(GO:0000184) |
| 0.4 | 2.2 | GO:0030854 | positive regulation of granulocyte differentiation(GO:0030854) |
| 0.4 | 0.9 | GO:0071467 | cellular response to pH(GO:0071467) |
| 0.4 | 5.7 | GO:0045292 | mRNA cis splicing, via spliceosome(GO:0045292) |
| 0.4 | 2.2 | GO:2000491 | positive regulation of hepatic stellate cell activation(GO:2000491) |
| 0.4 | 1.7 | GO:0030049 | muscle filament sliding(GO:0030049) |
| 0.4 | 7.0 | GO:0035563 | positive regulation of chromatin binding(GO:0035563) |
| 0.4 | 3.0 | GO:0051533 | positive regulation of NFAT protein import into nucleus(GO:0051533) |
| 0.4 | 2.6 | GO:0090043 | regulation of tubulin deacetylation(GO:0090043) |
| 0.4 | 2.1 | GO:0072429 | response to intra-S DNA damage checkpoint signaling(GO:0072429) |
| 0.4 | 0.4 | GO:0014834 | skeletal muscle satellite cell maintenance involved in skeletal muscle regeneration(GO:0014834) |
| 0.4 | 2.1 | GO:0090164 | asymmetric Golgi ribbon formation(GO:0090164) |
| 0.4 | 0.9 | GO:0009106 | lipoate metabolic process(GO:0009106) |
| 0.4 | 1.3 | GO:0061101 | neuroendocrine cell differentiation(GO:0061101) |
| 0.4 | 11.0 | GO:0006754 | ATP biosynthetic process(GO:0006754) |
| 0.4 | 4.6 | GO:0043950 | positive regulation of cAMP-mediated signaling(GO:0043950) |
| 0.4 | 3.3 | GO:0006477 | protein sulfation(GO:0006477) |
| 0.4 | 3.3 | GO:0006390 | transcription from mitochondrial promoter(GO:0006390) |
| 0.4 | 1.7 | GO:0060261 | positive regulation of transcription initiation from RNA polymerase II promoter(GO:0060261) |
| 0.4 | 2.9 | GO:0016576 | histone dephosphorylation(GO:0016576) |
| 0.4 | 1.2 | GO:0006420 | arginyl-tRNA aminoacylation(GO:0006420) |
| 0.4 | 2.1 | GO:0018002 | N-terminal peptidyl-serine acetylation(GO:0017198) N-terminal peptidyl-glutamic acid acetylation(GO:0018002) peptidyl-serine acetylation(GO:0030920) |
| 0.4 | 11.5 | GO:0034260 | negative regulation of GTPase activity(GO:0034260) |
| 0.4 | 0.4 | GO:1904430 | negative regulation of t-circle formation(GO:1904430) |
| 0.4 | 7.8 | GO:0006401 | RNA catabolic process(GO:0006401) |
| 0.4 | 2.9 | GO:0034975 | protein folding in endoplasmic reticulum(GO:0034975) |
| 0.4 | 1.2 | GO:0042744 | hydrogen peroxide catabolic process(GO:0042744) |
| 0.4 | 1.2 | GO:0009249 | protein lipoylation(GO:0009249) |
| 0.4 | 0.8 | GO:1903719 | regulation of I-kappaB phosphorylation(GO:1903719) positive regulation of I-kappaB phosphorylation(GO:1903721) |
| 0.4 | 2.4 | GO:0044375 | regulation of peroxisome size(GO:0044375) |
| 0.4 | 1.2 | GO:0017055 | negative regulation of RNA polymerase II transcriptional preinitiation complex assembly(GO:0017055) |
| 0.4 | 1.2 | GO:0044313 | protein K6-linked deubiquitination(GO:0044313) |
| 0.4 | 0.4 | GO:0035459 | cargo loading into vesicle(GO:0035459) |
| 0.4 | 1.6 | GO:0090238 | positive regulation of arachidonic acid secretion(GO:0090238) |
| 0.4 | 0.4 | GO:0035799 | ureter maturation(GO:0035799) |
| 0.4 | 2.0 | GO:0033227 | dsRNA transport(GO:0033227) |
| 0.4 | 1.2 | GO:0061537 | glycine secretion(GO:0061536) glycine secretion, neurotransmission(GO:0061537) |
| 0.4 | 2.8 | GO:1904217 | regulation of CDP-diacylglycerol-serine O-phosphatidyltransferase activity(GO:1904217) positive regulation of CDP-diacylglycerol-serine O-phosphatidyltransferase activity(GO:1904219) regulation of serine C-palmitoyltransferase activity(GO:1904220) positive regulation of serine C-palmitoyltransferase activity(GO:1904222) |
| 0.4 | 0.4 | GO:0033159 | negative regulation of protein import into nucleus, translocation(GO:0033159) |
| 0.4 | 1.2 | GO:0051754 | meiotic sister chromatid cohesion, centromeric(GO:0051754) |
| 0.4 | 2.0 | GO:1901386 | negative regulation of voltage-gated calcium channel activity(GO:1901386) |
| 0.4 | 3.2 | GO:1901162 | serotonin biosynthetic process(GO:0042427) primary amino compound biosynthetic process(GO:1901162) |
| 0.4 | 0.8 | GO:0002903 | negative regulation of B cell apoptotic process(GO:0002903) |
| 0.4 | 1.6 | GO:0061743 | motor learning(GO:0061743) |
| 0.4 | 0.4 | GO:2000049 | positive regulation of cell-cell adhesion mediated by cadherin(GO:2000049) |
| 0.4 | 1.6 | GO:1904393 | regulation of skeletal muscle acetylcholine-gated channel clustering(GO:1904393) |
| 0.4 | 2.7 | GO:1901029 | negative regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway(GO:1901029) |
| 0.4 | 1.2 | GO:0010796 | regulation of multivesicular body size(GO:0010796) multivesicular body assembly(GO:0036258) |
| 0.4 | 1.2 | GO:0006751 | glutathione catabolic process(GO:0006751) |
| 0.4 | 2.7 | GO:0060837 | blood vessel endothelial cell differentiation(GO:0060837) |
| 0.4 | 1.2 | GO:0032962 | positive regulation of inositol trisphosphate biosynthetic process(GO:0032962) |
| 0.4 | 1.9 | GO:0006189 | 'de novo' IMP biosynthetic process(GO:0006189) |
| 0.4 | 1.5 | GO:0019254 | carnitine metabolic process, CoA-linked(GO:0019254) |
| 0.4 | 6.1 | GO:1901663 | quinone biosynthetic process(GO:1901663) |
| 0.4 | 2.7 | GO:0015868 | purine nucleotide transport(GO:0015865) purine ribonucleotide transport(GO:0015868) |
| 0.4 | 11.1 | GO:0032781 | positive regulation of ATPase activity(GO:0032781) |
| 0.4 | 1.1 | GO:0033364 | mast cell secretory granule organization(GO:0033364) |
| 0.4 | 2.7 | GO:0060372 | regulation of atrial cardiac muscle cell membrane repolarization(GO:0060372) |
| 0.4 | 2.3 | GO:0003084 | positive regulation of systemic arterial blood pressure(GO:0003084) |
| 0.4 | 6.0 | GO:0034389 | lipid particle organization(GO:0034389) |
| 0.4 | 3.0 | GO:0097242 | beta-amyloid clearance(GO:0097242) |
| 0.4 | 0.8 | GO:0007512 | adult heart development(GO:0007512) |
| 0.4 | 8.3 | GO:2000060 | positive regulation of protein ubiquitination involved in ubiquitin-dependent protein catabolic process(GO:2000060) |
| 0.4 | 4.9 | GO:0033599 | regulation of mammary gland epithelial cell proliferation(GO:0033599) |
| 0.4 | 0.4 | GO:0036466 | synaptic vesicle recycling via endosome(GO:0036466) |
| 0.4 | 4.5 | GO:0048096 | chromatin-mediated maintenance of transcription(GO:0048096) |
| 0.4 | 1.9 | GO:0016246 | RNA interference(GO:0016246) |
| 0.4 | 2.2 | GO:0048149 | behavioral response to ethanol(GO:0048149) |
| 0.4 | 1.5 | GO:0015889 | cobalamin transport(GO:0015889) |
| 0.4 | 4.8 | GO:0048387 | negative regulation of retinoic acid receptor signaling pathway(GO:0048387) |
| 0.4 | 2.2 | GO:0031665 | negative regulation of lipopolysaccharide-mediated signaling pathway(GO:0031665) |
| 0.4 | 1.1 | GO:0051084 | 'de novo' posttranslational protein folding(GO:0051084) |
| 0.4 | 1.4 | GO:0000492 | box C/D snoRNP assembly(GO:0000492) |
| 0.4 | 1.4 | GO:0015786 | UDP-glucose transport(GO:0015786) |
| 0.4 | 4.0 | GO:0006614 | SRP-dependent cotranslational protein targeting to membrane(GO:0006614) |
| 0.4 | 0.7 | GO:0060467 | negative regulation of fertilization(GO:0060467) |
| 0.4 | 18.6 | GO:0045454 | cell redox homeostasis(GO:0045454) |
| 0.4 | 9.7 | GO:0043171 | peptide catabolic process(GO:0043171) |
| 0.4 | 1.4 | GO:0046645 | positive regulation of gamma-delta T cell differentiation(GO:0045588) positive regulation of gamma-delta T cell activation(GO:0046645) |
| 0.4 | 0.7 | GO:1904936 | cerebral cortex GABAergic interneuron migration(GO:0021853) interneuron migration(GO:1904936) |
| 0.4 | 0.7 | GO:0006083 | acetate metabolic process(GO:0006083) |
| 0.4 | 3.2 | GO:0051352 | negative regulation of ligase activity(GO:0051352) negative regulation of ubiquitin-protein transferase activity(GO:0051444) |
| 0.4 | 7.0 | GO:0046622 | positive regulation of organ growth(GO:0046622) |
| 0.4 | 0.7 | GO:0048318 | axial mesoderm development(GO:0048318) |
| 0.3 | 1.7 | GO:0008635 | activation of cysteine-type endopeptidase activity involved in apoptotic process by cytochrome c(GO:0008635) |
| 0.3 | 2.8 | GO:0030970 | retrograde protein transport, ER to cytosol(GO:0030970) |
| 0.3 | 1.4 | GO:0042796 | snRNA transcription from RNA polymerase III promoter(GO:0042796) |
| 0.3 | 1.0 | GO:0045059 | positive thymic T cell selection(GO:0045059) |
| 0.3 | 1.4 | GO:0015817 | histidine transport(GO:0015817) |
| 0.3 | 0.3 | GO:0000448 | cleavage in ITS2 between 5.8S rRNA and LSU-rRNA of tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)(GO:0000448) |
| 0.3 | 2.4 | GO:0018243 | protein O-linked glycosylation via threonine(GO:0018243) |
| 0.3 | 3.4 | GO:1901741 | positive regulation of myoblast fusion(GO:1901741) |
| 0.3 | 2.4 | GO:0043569 | negative regulation of insulin-like growth factor receptor signaling pathway(GO:0043569) |
| 0.3 | 1.0 | GO:0006597 | spermine biosynthetic process(GO:0006597) |
| 0.3 | 2.0 | GO:0006452 | translational frameshifting(GO:0006452) positive regulation of translational termination(GO:0045905) |
| 0.3 | 2.4 | GO:0008063 | Toll signaling pathway(GO:0008063) |
| 0.3 | 3.4 | GO:0035414 | negative regulation of catenin import into nucleus(GO:0035414) |
| 0.3 | 2.0 | GO:0021978 | telencephalon regionalization(GO:0021978) |
| 0.3 | 0.3 | GO:0030321 | transepithelial chloride transport(GO:0030321) |
| 0.3 | 3.0 | GO:0060670 | branching involved in labyrinthine layer morphogenesis(GO:0060670) |
| 0.3 | 1.0 | GO:0036481 | intrinsic apoptotic signaling pathway in response to hydrogen peroxide(GO:0036481) |
| 0.3 | 0.3 | GO:1901355 | response to rapamycin(GO:1901355) |
| 0.3 | 1.7 | GO:0032060 | bleb assembly(GO:0032060) |
| 0.3 | 2.3 | GO:0023021 | termination of signal transduction(GO:0023021) |
| 0.3 | 1.0 | GO:0034638 | phosphatidylcholine catabolic process(GO:0034638) |
| 0.3 | 4.3 | GO:0051085 | chaperone mediated protein folding requiring cofactor(GO:0051085) |
| 0.3 | 0.3 | GO:0032650 | regulation of interleukin-1 alpha production(GO:0032650) positive regulation of interleukin-1 alpha production(GO:0032730) |
| 0.3 | 1.3 | GO:1901165 | positive regulation of trophoblast cell migration(GO:1901165) |
| 0.3 | 3.3 | GO:0010586 | miRNA metabolic process(GO:0010586) |
| 0.3 | 1.6 | GO:0060216 | definitive hemopoiesis(GO:0060216) |
| 0.3 | 19.3 | GO:0006635 | fatty acid beta-oxidation(GO:0006635) |
| 0.3 | 0.7 | GO:0002924 | negative regulation of humoral immune response mediated by circulating immunoglobulin(GO:0002924) |
| 0.3 | 0.3 | GO:1904354 | negative regulation of telomere capping(GO:1904354) |
| 0.3 | 0.6 | GO:0090272 | negative regulation of fibroblast growth factor production(GO:0090272) |
| 0.3 | 0.3 | GO:0035795 | negative regulation of mitochondrial membrane permeability(GO:0035795) |
| 0.3 | 3.9 | GO:0006654 | phosphatidic acid biosynthetic process(GO:0006654) |
| 0.3 | 1.9 | GO:0098909 | regulation of cardiac muscle cell action potential involved in regulation of contraction(GO:0098909) |
| 0.3 | 1.3 | GO:0002639 | positive regulation of immunoglobulin production(GO:0002639) |
| 0.3 | 2.5 | GO:2001140 | regulation of phospholipid transport(GO:2001138) positive regulation of phospholipid transport(GO:2001140) |
| 0.3 | 2.5 | GO:0071802 | negative regulation of podosome assembly(GO:0071802) |
| 0.3 | 2.2 | GO:1900745 | positive regulation of p38MAPK cascade(GO:1900745) |
| 0.3 | 0.6 | GO:0046110 | xanthine metabolic process(GO:0046110) |
| 0.3 | 1.3 | GO:0033689 | negative regulation of osteoblast proliferation(GO:0033689) |
| 0.3 | 2.8 | GO:0045047 | protein targeting to ER(GO:0045047) |
| 0.3 | 1.2 | GO:0002002 | regulation of angiotensin levels in blood(GO:0002002) |
| 0.3 | 2.2 | GO:0032288 | myelin assembly(GO:0032288) |
| 0.3 | 1.6 | GO:0052428 | modulation of molecular function in other organism(GO:0044359) negative regulation of molecular function in other organism(GO:0044362) negative regulation of molecular function in other organism involved in symbiotic interaction(GO:0052204) modulation of molecular function in other organism involved in symbiotic interaction(GO:0052205) negative regulation by host of symbiont molecular function(GO:0052405) modification by host of symbiont molecular function(GO:0052428) |
| 0.3 | 2.2 | GO:0014010 | Schwann cell proliferation(GO:0014010) |
| 0.3 | 1.2 | GO:0031053 | primary miRNA processing(GO:0031053) |
| 0.3 | 0.9 | GO:0031293 | membrane protein intracellular domain proteolysis(GO:0031293) |
| 0.3 | 0.6 | GO:0001920 | negative regulation of receptor recycling(GO:0001920) |
| 0.3 | 1.5 | GO:0051560 | mitochondrial calcium ion homeostasis(GO:0051560) |
| 0.3 | 2.7 | GO:0001574 | ganglioside biosynthetic process(GO:0001574) |
| 0.3 | 2.1 | GO:1901030 | positive regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway(GO:1901030) |
| 0.3 | 0.3 | GO:0001869 | regulation of complement activation, lectin pathway(GO:0001868) negative regulation of complement activation, lectin pathway(GO:0001869) |
| 0.3 | 0.3 | GO:1902172 | keratinocyte apoptotic process(GO:0097283) regulation of keratinocyte apoptotic process(GO:1902172) |
| 0.3 | 1.8 | GO:2000254 | regulation of male germ cell proliferation(GO:2000254) |
| 0.3 | 1.2 | GO:0033602 | negative regulation of dopamine secretion(GO:0033602) |
| 0.3 | 1.2 | GO:0035584 | calcium-mediated signaling using intracellular calcium source(GO:0035584) |
| 0.3 | 7.2 | GO:1903146 | regulation of mitophagy(GO:1903146) |
| 0.3 | 1.2 | GO:1904694 | negative regulation of vascular smooth muscle contraction(GO:1904694) |
| 0.3 | 0.6 | GO:0001767 | establishment of lymphocyte polarity(GO:0001767) establishment of T cell polarity(GO:0001768) |
| 0.3 | 1.2 | GO:0030728 | ovulation(GO:0030728) |
| 0.3 | 0.9 | GO:0060217 | hemangioblast cell differentiation(GO:0060217) |
| 0.3 | 2.0 | GO:1903301 | positive regulation of glucokinase activity(GO:0033133) positive regulation of hexokinase activity(GO:1903301) |
| 0.3 | 1.7 | GO:0034080 | CENP-A containing nucleosome assembly(GO:0034080) CENP-A containing chromatin organization(GO:0061641) |
| 0.3 | 43.6 | GO:0042254 | ribosome biogenesis(GO:0042254) |
| 0.3 | 0.9 | GO:0035552 | oxidative single-stranded DNA demethylation(GO:0035552) |
| 0.3 | 2.6 | GO:2000398 | regulation of T cell differentiation in thymus(GO:0033081) regulation of thymocyte aggregation(GO:2000398) |
| 0.3 | 11.0 | GO:0045599 | negative regulation of fat cell differentiation(GO:0045599) |
| 0.3 | 1.2 | GO:0035609 | C-terminal protein deglutamylation(GO:0035609) |
| 0.3 | 2.6 | GO:0048934 | peripheral nervous system neuron differentiation(GO:0048934) peripheral nervous system neuron development(GO:0048935) |
| 0.3 | 4.6 | GO:2001240 | negative regulation of signal transduction in absence of ligand(GO:1901099) negative regulation of extrinsic apoptotic signaling pathway in absence of ligand(GO:2001240) |
| 0.3 | 0.9 | GO:0033622 | integrin activation(GO:0033622) |
| 0.3 | 0.3 | GO:2000048 | negative regulation of cell-cell adhesion mediated by cadherin(GO:2000048) |
| 0.3 | 19.2 | GO:0006413 | translational initiation(GO:0006413) |
| 0.3 | 2.3 | GO:0006020 | inositol metabolic process(GO:0006020) |
| 0.3 | 1.1 | GO:0006851 | mitochondrial calcium ion transport(GO:0006851) |
| 0.3 | 0.9 | GO:0036509 | trimming of terminal mannose on B branch(GO:0036509) |
| 0.3 | 13.0 | GO:0070527 | platelet aggregation(GO:0070527) |
| 0.3 | 0.8 | GO:0086053 | AV node cell to bundle of His cell communication by electrical coupling(GO:0086053) |
| 0.3 | 0.3 | GO:0016479 | negative regulation of transcription from RNA polymerase I promoter(GO:0016479) |
| 0.3 | 0.6 | GO:0016264 | gap junction assembly(GO:0016264) |
| 0.3 | 2.0 | GO:0032525 | somite rostral/caudal axis specification(GO:0032525) |
| 0.3 | 1.4 | GO:0061734 | parkin-mediated mitophagy in response to mitochondrial depolarization(GO:0061734) |
| 0.3 | 7.8 | GO:0006270 | DNA replication initiation(GO:0006270) |
| 0.3 | 1.1 | GO:0007196 | adenylate cyclase-inhibiting G-protein coupled glutamate receptor signaling pathway(GO:0007196) |
| 0.3 | 1.1 | GO:1902231 | positive regulation of intrinsic apoptotic signaling pathway in response to DNA damage(GO:1902231) |
| 0.3 | 2.8 | GO:0030953 | astral microtubule organization(GO:0030953) |
| 0.3 | 0.8 | GO:0090503 | RNA phosphodiester bond hydrolysis, exonucleolytic(GO:0090503) |
| 0.3 | 5.8 | GO:0032469 | endoplasmic reticulum calcium ion homeostasis(GO:0032469) |
| 0.3 | 1.4 | GO:0010092 | specification of organ identity(GO:0010092) |
| 0.3 | 4.1 | GO:0046597 | negative regulation of viral entry into host cell(GO:0046597) |
| 0.3 | 2.5 | GO:0050832 | defense response to fungus(GO:0050832) |
| 0.3 | 0.8 | GO:0070345 | negative regulation of fat cell proliferation(GO:0070345) |
| 0.3 | 0.8 | GO:0051030 | snRNA transport(GO:0051030) |
| 0.3 | 1.1 | GO:0050957 | equilibrioception(GO:0050957) |
| 0.3 | 0.8 | GO:0071028 | nuclear RNA surveillance(GO:0071027) nuclear mRNA surveillance(GO:0071028) |
| 0.3 | 2.7 | GO:0051123 | RNA polymerase II transcriptional preinitiation complex assembly(GO:0051123) |
| 0.3 | 2.4 | GO:0031017 | exocrine pancreas development(GO:0031017) |
| 0.3 | 1.3 | GO:0007320 | insemination(GO:0007320) |
| 0.3 | 1.1 | GO:0061450 | trophoblast cell migration(GO:0061450) regulation of trophoblast cell migration(GO:1901163) |
| 0.3 | 2.7 | GO:0060340 | positive regulation of type I interferon-mediated signaling pathway(GO:0060340) |
| 0.3 | 0.3 | GO:0070633 | transepithelial transport(GO:0070633) |
| 0.3 | 1.9 | GO:0051974 | negative regulation of telomerase activity(GO:0051974) |
| 0.3 | 1.3 | GO:0043568 | positive regulation of insulin-like growth factor receptor signaling pathway(GO:0043568) |
| 0.3 | 0.5 | GO:0046967 | cytosol to ER transport(GO:0046967) |
| 0.3 | 1.1 | GO:0021773 | striatal medium spiny neuron differentiation(GO:0021773) |
| 0.3 | 1.3 | GO:0080184 | response to stilbenoid(GO:0035634) response to phenylpropanoid(GO:0080184) |
| 0.3 | 1.8 | GO:0032486 | Rap protein signal transduction(GO:0032486) |
| 0.3 | 1.6 | GO:0032464 | positive regulation of protein homooligomerization(GO:0032464) |
| 0.3 | 2.8 | GO:0006353 | DNA-templated transcription, termination(GO:0006353) |
| 0.3 | 1.0 | GO:0002484 | antigen processing and presentation of endogenous peptide antigen via MHC class I via ER pathway(GO:0002484) antigen processing and presentation of endogenous peptide antigen via MHC class I via ER pathway, TAP-dependent(GO:0002485) |
| 0.3 | 0.3 | GO:0071707 | immunoglobulin heavy chain V-D-J recombination(GO:0071707) |
| 0.3 | 1.0 | GO:0046102 | inosine metabolic process(GO:0046102) |
| 0.3 | 1.8 | GO:0043982 | histone H4-K5 acetylation(GO:0043981) histone H4-K8 acetylation(GO:0043982) |
| 0.3 | 1.8 | GO:1990440 | positive regulation of transcription from RNA polymerase II promoter in response to endoplasmic reticulum stress(GO:1990440) |
| 0.3 | 2.5 | GO:1905098 | negative regulation of guanyl-nucleotide exchange factor activity(GO:1905098) |
| 0.3 | 1.0 | GO:0006741 | NADP biosynthetic process(GO:0006741) |
| 0.2 | 1.7 | GO:0009451 | RNA modification(GO:0009451) |
| 0.2 | 0.5 | GO:1902262 | apoptotic process involved in patterning of blood vessels(GO:1902262) |
| 0.2 | 1.2 | GO:0043162 | ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway(GO:0043162) |
| 0.2 | 0.7 | GO:0072344 | rescue of stalled ribosome(GO:0072344) |
| 0.2 | 0.7 | GO:0060011 | Sertoli cell proliferation(GO:0060011) |
| 0.2 | 2.0 | GO:0097034 | mitochondrial respiratory chain complex IV assembly(GO:0033617) mitochondrial respiratory chain complex IV biogenesis(GO:0097034) |
| 0.2 | 0.5 | GO:2000672 | negative regulation of motor neuron apoptotic process(GO:2000672) |
| 0.2 | 0.5 | GO:0006659 | phosphatidylserine biosynthetic process(GO:0006659) |
| 0.2 | 1.0 | GO:2000643 | positive regulation of vacuolar transport(GO:1903337) positive regulation of early endosome to late endosome transport(GO:2000643) |
| 0.2 | 1.0 | GO:0030091 | protein repair(GO:0030091) |
| 0.2 | 0.5 | GO:0002408 | myeloid dendritic cell chemotaxis(GO:0002408) |
| 0.2 | 0.7 | GO:0070934 | CRD-mediated mRNA stabilization(GO:0070934) |
| 0.2 | 1.2 | GO:0032056 | positive regulation of translation in response to stress(GO:0032056) |
| 0.2 | 3.4 | GO:0001886 | endothelial cell morphogenesis(GO:0001886) |
| 0.2 | 7.5 | GO:0035914 | skeletal muscle cell differentiation(GO:0035914) |
| 0.2 | 5.1 | GO:0005978 | glycogen biosynthetic process(GO:0005978) glucan biosynthetic process(GO:0009250) |
| 0.2 | 2.6 | GO:0030262 | cellular component disassembly involved in execution phase of apoptosis(GO:0006921) apoptotic nuclear changes(GO:0030262) |
| 0.2 | 2.1 | GO:0046085 | adenosine metabolic process(GO:0046085) |
| 0.2 | 1.4 | GO:0006729 | tetrahydrobiopterin biosynthetic process(GO:0006729) tetrahydrobiopterin metabolic process(GO:0046146) |
| 0.2 | 5.9 | GO:0051310 | metaphase plate congression(GO:0051310) |
| 0.2 | 1.2 | GO:0070257 | positive regulation of mucus secretion(GO:0070257) |
| 0.2 | 0.9 | GO:0036265 | RNA (guanine-N7)-methylation(GO:0036265) |
| 0.2 | 1.9 | GO:0034501 | protein localization to kinetochore(GO:0034501) |
| 0.2 | 2.1 | GO:0010715 | regulation of extracellular matrix disassembly(GO:0010715) |
| 0.2 | 1.2 | GO:0032439 | endosome localization(GO:0032439) |
| 0.2 | 1.4 | GO:0021527 | spinal cord association neuron differentiation(GO:0021527) |
| 0.2 | 2.8 | GO:0035970 | peptidyl-threonine dephosphorylation(GO:0035970) |
| 0.2 | 0.2 | GO:0030836 | positive regulation of actin filament depolymerization(GO:0030836) |
| 0.2 | 0.9 | GO:1903553 | positive regulation of extracellular exosome assembly(GO:1903553) |
| 0.2 | 0.5 | GO:0032286 | central nervous system myelin maintenance(GO:0032286) |
| 0.2 | 1.1 | GO:0071712 | ER-associated misfolded protein catabolic process(GO:0071712) |
| 0.2 | 0.9 | GO:0072675 | osteoclast fusion(GO:0072675) |
| 0.2 | 0.7 | GO:1901978 | positive regulation of cell cycle checkpoint(GO:1901978) |
| 0.2 | 0.2 | GO:0060017 | parathyroid gland development(GO:0060017) |
| 0.2 | 0.4 | GO:0060023 | soft palate development(GO:0060023) |
| 0.2 | 0.7 | GO:0048478 | replication fork protection(GO:0048478) |
| 0.2 | 3.7 | GO:2000785 | regulation of autophagosome assembly(GO:2000785) |
| 0.2 | 0.7 | GO:0034729 | histone H3-K79 methylation(GO:0034729) |
| 0.2 | 0.9 | GO:0032287 | peripheral nervous system myelin maintenance(GO:0032287) |
| 0.2 | 0.9 | GO:0000379 | tRNA-type intron splice site recognition and cleavage(GO:0000379) |
| 0.2 | 4.5 | GO:0045070 | positive regulation of viral genome replication(GO:0045070) |
| 0.2 | 1.9 | GO:0070842 | aggresome assembly(GO:0070842) |
| 0.2 | 1.5 | GO:0000423 | macromitophagy(GO:0000423) response to mitochondrial depolarisation(GO:0098780) |
| 0.2 | 1.7 | GO:0042574 | retinal metabolic process(GO:0042574) |
| 0.2 | 0.9 | GO:0090245 | axis elongation involved in somitogenesis(GO:0090245) |
| 0.2 | 0.4 | GO:0051231 | spindle elongation(GO:0051231) |
| 0.2 | 0.4 | GO:0071287 | cellular response to manganese ion(GO:0071287) |
| 0.2 | 0.6 | GO:0042126 | nitrate metabolic process(GO:0042126) |
| 0.2 | 0.8 | GO:0015936 | coenzyme A metabolic process(GO:0015936) |
| 0.2 | 2.1 | GO:0009062 | fatty acid catabolic process(GO:0009062) |
| 0.2 | 0.6 | GO:0014049 | positive regulation of glutamate secretion(GO:0014049) |
| 0.2 | 0.4 | GO:0009794 | regulation of mitotic cell cycle, embryonic(GO:0009794) mitotic cell cycle, embryonic(GO:0045448) |
| 0.2 | 0.4 | GO:0061009 | common bile duct development(GO:0061009) |
| 0.2 | 0.8 | GO:0001842 | neural fold formation(GO:0001842) |
| 0.2 | 0.4 | GO:0019087 | transformation of host cell by virus(GO:0019087) |
| 0.2 | 4.3 | GO:0001706 | endoderm formation(GO:0001706) |
| 0.2 | 0.4 | GO:0008295 | spermidine biosynthetic process(GO:0008295) |
| 0.2 | 0.4 | GO:1904020 | regulation of G-protein coupled receptor internalization(GO:1904020) |
| 0.2 | 2.0 | GO:0034308 | primary alcohol metabolic process(GO:0034308) |
| 0.2 | 0.4 | GO:0034382 | chylomicron remnant clearance(GO:0034382) positive regulation of lipoprotein lipase activity(GO:0051006) positive regulation of triglyceride lipase activity(GO:0061365) triglyceride-rich lipoprotein particle clearance(GO:0071830) |
| 0.2 | 0.8 | GO:0010804 | negative regulation of tumor necrosis factor-mediated signaling pathway(GO:0010804) |
| 0.2 | 1.6 | GO:0060294 | cilium movement involved in cell motility(GO:0060294) |
| 0.2 | 0.8 | GO:0007096 | regulation of exit from mitosis(GO:0007096) |
| 0.2 | 0.8 | GO:0006689 | ganglioside catabolic process(GO:0006689) |
| 0.2 | 2.7 | GO:0031295 | lymphocyte costimulation(GO:0031294) T cell costimulation(GO:0031295) |
| 0.2 | 4.6 | GO:0006414 | translational elongation(GO:0006414) |
| 0.2 | 0.8 | GO:0006529 | asparagine biosynthetic process(GO:0006529) |
| 0.2 | 0.6 | GO:0006266 | DNA ligation(GO:0006266) |
| 0.2 | 0.4 | GO:0016064 | immunoglobulin mediated immune response(GO:0016064) |
| 0.2 | 0.4 | GO:0033598 | mammary gland epithelial cell proliferation(GO:0033598) |
| 0.2 | 1.1 | GO:0051438 | regulation of ubiquitin-protein transferase activity(GO:0051438) |
| 0.2 | 0.4 | GO:1902218 | regulation of intrinsic apoptotic signaling pathway in response to osmotic stress(GO:1902218) |
| 0.2 | 0.2 | GO:2000195 | negative regulation of female gonad development(GO:2000195) |
| 0.2 | 0.7 | GO:0019885 | antigen processing and presentation of endogenous peptide antigen via MHC class I(GO:0019885) |
| 0.2 | 5.0 | GO:0006383 | transcription from RNA polymerase III promoter(GO:0006383) |
| 0.2 | 6.0 | GO:0007218 | neuropeptide signaling pathway(GO:0007218) |
| 0.2 | 4.0 | GO:0006890 | retrograde vesicle-mediated transport, Golgi to ER(GO:0006890) |
| 0.2 | 0.4 | GO:0072014 | proximal tubule development(GO:0072014) |
| 0.2 | 0.4 | GO:0070417 | cellular response to cold(GO:0070417) |
| 0.2 | 2.0 | GO:0009615 | response to virus(GO:0009615) |
| 0.2 | 2.4 | GO:0006516 | glycoprotein catabolic process(GO:0006516) |
| 0.2 | 2.6 | GO:0070207 | protein homotrimerization(GO:0070207) |
| 0.2 | 0.5 | GO:0006884 | cell volume homeostasis(GO:0006884) |
| 0.2 | 0.3 | GO:0000393 | spliceosomal conformational changes to generate catalytic conformation(GO:0000393) |
| 0.2 | 1.2 | GO:0045601 | regulation of endothelial cell differentiation(GO:0045601) |
| 0.2 | 0.2 | GO:0048294 | negative regulation of isotype switching(GO:0045829) negative regulation of isotype switching to IgE isotypes(GO:0048294) |
| 0.2 | 0.7 | GO:0015705 | iodide transport(GO:0015705) |
| 0.2 | 3.0 | GO:0033235 | positive regulation of protein sumoylation(GO:0033235) |
| 0.2 | 0.3 | GO:1903984 | regulation of TRAIL-activated apoptotic signaling pathway(GO:1903121) positive regulation of TRAIL-activated apoptotic signaling pathway(GO:1903984) regulation of metalloendopeptidase activity(GO:1904683) negative regulation of metalloendopeptidase activity(GO:1904684) negative regulation of metallopeptidase activity(GO:1905049) |
| 0.2 | 0.3 | GO:0060334 | regulation of interferon-gamma-mediated signaling pathway(GO:0060334) |
| 0.2 | 0.8 | GO:0034472 | snRNA 3'-end processing(GO:0034472) |
| 0.2 | 0.2 | GO:0033239 | negative regulation of cellular amine metabolic process(GO:0033239) |
| 0.2 | 1.1 | GO:0097345 | mitochondrial outer membrane permeabilization(GO:0097345) |
| 0.2 | 0.6 | GO:0045136 | development of secondary sexual characteristics(GO:0045136) |
| 0.2 | 0.8 | GO:0030828 | positive regulation of cGMP biosynthetic process(GO:0030828) |
| 0.2 | 0.3 | GO:1900738 | positive regulation of phospholipase C-activating G-protein coupled receptor signaling pathway(GO:1900738) |
| 0.2 | 1.3 | GO:0032331 | negative regulation of chondrocyte differentiation(GO:0032331) |
| 0.2 | 5.4 | GO:0042475 | odontogenesis of dentin-containing tooth(GO:0042475) |
| 0.2 | 2.2 | GO:0045662 | negative regulation of myoblast differentiation(GO:0045662) |
| 0.2 | 2.5 | GO:0010718 | positive regulation of epithelial to mesenchymal transition(GO:0010718) |
| 0.2 | 0.5 | GO:1903909 | excitatory chemical synaptic transmission(GO:0098976) positive regulation of postsynaptic membrane organization(GO:1901628) regulation of receptor clustering(GO:1903909) positive regulation of receptor clustering(GO:1903911) regulation of AMPA glutamate receptor clustering(GO:1904717) positive regulation of AMPA glutamate receptor clustering(GO:1904719) |
| 0.2 | 0.3 | GO:0051156 | glucose 6-phosphate metabolic process(GO:0051156) |
| 0.2 | 0.3 | GO:1901072 | chitin metabolic process(GO:0006030) chitin catabolic process(GO:0006032) glucosamine-containing compound catabolic process(GO:1901072) |
| 0.2 | 0.2 | GO:1902570 | protein localization to nucleolus(GO:1902570) |
| 0.2 | 1.1 | GO:0031643 | positive regulation of myelination(GO:0031643) |
| 0.2 | 2.6 | GO:0045116 | protein neddylation(GO:0045116) |
| 0.2 | 0.9 | GO:0021516 | dorsal spinal cord development(GO:0021516) |
| 0.2 | 0.5 | GO:0001867 | complement activation, lectin pathway(GO:0001867) |
| 0.2 | 1.4 | GO:0061154 | endothelial tube morphogenesis(GO:0061154) |
| 0.2 | 0.6 | GO:1904953 | Wnt signaling pathway involved in midbrain dopaminergic neuron differentiation(GO:1904953) |
| 0.1 | 0.3 | GO:1902177 | positive regulation of oxidative stress-induced intrinsic apoptotic signaling pathway(GO:1902177) |
| 0.1 | 1.0 | GO:0031584 | activation of phospholipase D activity(GO:0031584) |
| 0.1 | 0.6 | GO:1903031 | regulation of microtubule plus-end binding(GO:1903031) positive regulation of microtubule plus-end binding(GO:1903033) |
| 0.1 | 0.3 | GO:0042756 | negative regulation of gamma-aminobutyric acid secretion(GO:0014053) drinking behavior(GO:0042756) |
| 0.1 | 0.6 | GO:0032804 | negative regulation of low-density lipoprotein particle receptor catabolic process(GO:0032804) dibasic protein processing(GO:0090472) negative regulation of receptor catabolic process(GO:2000645) |
| 0.1 | 4.4 | GO:0045494 | photoreceptor cell maintenance(GO:0045494) |
| 0.1 | 0.9 | GO:0070203 | regulation of establishment of protein localization to telomere(GO:0070203) regulation of protein localization to chromosome, telomeric region(GO:1904814) positive regulation of protein localization to chromosome, telomeric region(GO:1904816) positive regulation of establishment of protein localization to telomere(GO:1904851) |
| 0.1 | 1.3 | GO:0030279 | negative regulation of ossification(GO:0030279) |
| 0.1 | 1.7 | GO:0032515 | negative regulation of phosphoprotein phosphatase activity(GO:0032515) |
| 0.1 | 0.8 | GO:0060179 | male mating behavior(GO:0060179) |
| 0.1 | 3.5 | GO:0035458 | cellular response to interferon-beta(GO:0035458) |
| 0.1 | 0.3 | GO:0042270 | protection from natural killer cell mediated cytotoxicity(GO:0042270) |
| 0.1 | 0.6 | GO:0033580 | protein glycosylation at cell surface(GO:0033575) protein galactosylation at cell surface(GO:0033580) protein galactosylation(GO:0042125) |
| 0.1 | 2.8 | GO:0010972 | negative regulation of G2/M transition of mitotic cell cycle(GO:0010972) |
| 0.1 | 0.5 | GO:0090394 | negative regulation of excitatory postsynaptic potential(GO:0090394) |
| 0.1 | 0.5 | GO:1901678 | iron coordination entity transport(GO:1901678) |
| 0.1 | 2.7 | GO:0071384 | cellular response to corticosteroid stimulus(GO:0071384) cellular response to glucocorticoid stimulus(GO:0071385) |
| 0.1 | 0.5 | GO:0042832 | defense response to protozoan(GO:0042832) |
| 0.1 | 0.4 | GO:0009186 | deoxyribonucleoside diphosphate metabolic process(GO:0009186) |
| 0.1 | 0.4 | GO:0043490 | malate-aspartate shuttle(GO:0043490) |
| 0.1 | 0.7 | GO:0033211 | adiponectin-activated signaling pathway(GO:0033211) |
| 0.1 | 0.5 | GO:0035751 | regulation of lysosomal lumen pH(GO:0035751) |
| 0.1 | 1.7 | GO:0034067 | protein localization to Golgi apparatus(GO:0034067) |
| 0.1 | 0.4 | GO:1902592 | viral budding(GO:0046755) multi-organism organelle organization(GO:1902590) multi-organism membrane budding(GO:1902592) |
| 0.1 | 0.5 | GO:0044342 | type B pancreatic cell proliferation(GO:0044342) |
| 0.1 | 0.5 | GO:0097503 | sialylation(GO:0097503) |
| 0.1 | 2.9 | GO:0006284 | base-excision repair(GO:0006284) |
| 0.1 | 1.8 | GO:0000578 | embryonic axis specification(GO:0000578) |
| 0.1 | 1.3 | GO:2000009 | negative regulation of protein localization to cell surface(GO:2000009) |
| 0.1 | 2.3 | GO:0006958 | complement activation, classical pathway(GO:0006958) |
| 0.1 | 0.4 | GO:1904888 | cranial skeletal system development(GO:1904888) |
| 0.1 | 1.1 | GO:0030224 | monocyte differentiation(GO:0030224) |
| 0.1 | 6.4 | GO:0042147 | retrograde transport, endosome to Golgi(GO:0042147) |
| 0.1 | 0.4 | GO:0031642 | negative regulation of myelination(GO:0031642) |
| 0.1 | 1.6 | GO:0033344 | cholesterol efflux(GO:0033344) |
| 0.1 | 1.0 | GO:0006213 | pyrimidine nucleoside metabolic process(GO:0006213) |
| 0.1 | 1.9 | GO:0042982 | amyloid precursor protein metabolic process(GO:0042982) |
| 0.1 | 0.7 | GO:0070294 | renal sodium ion transport(GO:0003096) renal sodium ion absorption(GO:0070294) |
| 0.1 | 1.9 | GO:0007614 | short-term memory(GO:0007614) |
| 0.1 | 0.2 | GO:1900126 | negative regulation of hyaluronan biosynthetic process(GO:1900126) |
| 0.1 | 1.9 | GO:0072337 | modified amino acid transport(GO:0072337) |
| 0.1 | 4.9 | GO:1903749 | positive regulation of establishment of protein localization to mitochondrion(GO:1903749) positive regulation of protein targeting to mitochondrion(GO:1903955) |
| 0.1 | 0.6 | GO:0098700 | neurotransmitter loading into synaptic vesicle(GO:0098700) |
| 0.1 | 1.2 | GO:0032482 | Rab protein signal transduction(GO:0032482) |
| 0.1 | 1.0 | GO:0045907 | positive regulation of vasoconstriction(GO:0045907) |
| 0.1 | 0.2 | GO:1901491 | negative regulation of lymphangiogenesis(GO:1901491) |
| 0.1 | 0.3 | GO:0033326 | cerebrospinal fluid secretion(GO:0033326) |
| 0.1 | 0.3 | GO:0070168 | negative regulation of syncytium formation by plasma membrane fusion(GO:0034242) negative regulation of biomineral tissue development(GO:0070168) |
| 0.1 | 0.3 | GO:0050850 | positive regulation of calcium-mediated signaling(GO:0050850) |
| 0.1 | 0.5 | GO:0034312 | diol biosynthetic process(GO:0034312) |
| 0.1 | 1.6 | GO:0001921 | positive regulation of receptor recycling(GO:0001921) |
| 0.1 | 0.3 | GO:0071918 | urea transmembrane transport(GO:0071918) |
| 0.1 | 0.4 | GO:2000772 | regulation of cellular senescence(GO:2000772) |
| 0.1 | 0.3 | GO:0046341 | CDP-diacylglycerol metabolic process(GO:0046341) |
| 0.1 | 0.4 | GO:0045646 | regulation of erythrocyte differentiation(GO:0045646) |
| 0.1 | 0.6 | GO:0006283 | transcription-coupled nucleotide-excision repair(GO:0006283) |
| 0.1 | 0.7 | GO:0033299 | secretion of lysosomal enzymes(GO:0033299) |
| 0.1 | 0.4 | GO:0015744 | succinate transport(GO:0015744) |
| 0.1 | 0.1 | GO:0060525 | prostate glandular acinus development(GO:0060525) |
| 0.1 | 0.7 | GO:0032959 | inositol trisphosphate biosynthetic process(GO:0032959) |
| 0.1 | 0.9 | GO:0001539 | cilium or flagellum-dependent cell motility(GO:0001539) cilium-dependent cell motility(GO:0060285) |
| 0.1 | 0.4 | GO:0000972 | transcription-dependent tethering of RNA polymerase II gene DNA at nuclear periphery(GO:0000972) |
| 0.1 | 0.2 | GO:0003356 | regulation of cilium movement(GO:0003352) regulation of cilium beat frequency(GO:0003356) |
| 0.1 | 0.3 | GO:0071243 | cellular response to arsenic-containing substance(GO:0071243) |
| 0.1 | 0.3 | GO:0045204 | MAPK export from nucleus(GO:0045204) |
| 0.1 | 0.4 | GO:0032229 | negative regulation of synaptic transmission, GABAergic(GO:0032229) |
| 0.1 | 0.6 | GO:0006621 | protein retention in ER lumen(GO:0006621) |
| 0.1 | 0.1 | GO:0040001 | establishment of mitotic spindle localization(GO:0040001) |
| 0.1 | 1.0 | GO:0006491 | N-glycan processing(GO:0006491) |
| 0.1 | 0.2 | GO:1901661 | quinone metabolic process(GO:1901661) |
| 0.1 | 0.5 | GO:0042403 | thyroid hormone metabolic process(GO:0042403) |
| 0.1 | 0.4 | GO:0031033 | myosin filament organization(GO:0031033) |
| 0.1 | 0.4 | GO:1990481 | mRNA pseudouridine synthesis(GO:1990481) |
| 0.1 | 0.6 | GO:0032688 | negative regulation of interferon-beta production(GO:0032688) |
| 0.1 | 0.4 | GO:0045198 | establishment of epithelial cell apical/basal polarity(GO:0045198) |
| 0.1 | 1.0 | GO:0009263 | deoxyribonucleotide biosynthetic process(GO:0009263) |
| 0.1 | 0.1 | GO:0051004 | regulation of lipoprotein lipase activity(GO:0051004) |
| 0.1 | 0.6 | GO:0002052 | positive regulation of neuroblast proliferation(GO:0002052) |
| 0.1 | 0.8 | GO:0030206 | chondroitin sulfate biosynthetic process(GO:0030206) |
| 0.1 | 0.2 | GO:1902202 | regulation of hepatocyte growth factor receptor signaling pathway(GO:1902202) |
| 0.1 | 0.2 | GO:0060330 | regulation of response to interferon-gamma(GO:0060330) |
| 0.1 | 0.4 | GO:0001837 | epithelial to mesenchymal transition(GO:0001837) |
| 0.1 | 0.5 | GO:0046855 | inositol phosphate dephosphorylation(GO:0046855) |
| 0.1 | 0.2 | GO:1900016 | negative regulation of cytokine production involved in inflammatory response(GO:1900016) |
| 0.1 | 0.3 | GO:0007130 | synaptonemal complex assembly(GO:0007130) |
| 0.1 | 0.3 | GO:1904565 | response to 1-oleoyl-sn-glycerol 3-phosphate(GO:1904565) cellular response to 1-oleoyl-sn-glycerol 3-phosphate(GO:1904566) |
| 0.1 | 0.6 | GO:0014742 | positive regulation of cardiac muscle hypertrophy(GO:0010613) positive regulation of muscle hypertrophy(GO:0014742) |
| 0.1 | 0.6 | GO:0051451 | myoblast migration(GO:0051451) |
| 0.1 | 0.9 | GO:0051573 | negative regulation of histone H3-K9 methylation(GO:0051573) |
| 0.1 | 0.5 | GO:0002467 | germinal center formation(GO:0002467) |
| 0.1 | 0.8 | GO:2001243 | negative regulation of intrinsic apoptotic signaling pathway(GO:2001243) |
| 0.1 | 0.4 | GO:0006048 | UDP-N-acetylglucosamine biosynthetic process(GO:0006048) |
| 0.1 | 0.7 | GO:1904321 | response to forskolin(GO:1904321) cellular response to forskolin(GO:1904322) |
| 0.1 | 0.3 | GO:0007617 | mating behavior(GO:0007617) multi-organism reproductive behavior(GO:0044705) |
| 0.1 | 0.4 | GO:0051608 | histamine transport(GO:0051608) |
| 0.1 | 1.6 | GO:0030512 | negative regulation of transforming growth factor beta receptor signaling pathway(GO:0030512) negative regulation of cellular response to transforming growth factor beta stimulus(GO:1903845) |
| 0.1 | 0.2 | GO:0097066 | response to thyroid hormone(GO:0097066) |
| 0.1 | 0.1 | GO:0021940 | positive regulation of cerebellar granule cell precursor proliferation(GO:0021940) |
| 0.1 | 0.9 | GO:0016191 | synaptic vesicle uncoating(GO:0016191) |
| 0.1 | 1.0 | GO:0071391 | cellular response to estrogen stimulus(GO:0071391) |
| 0.1 | 1.1 | GO:0001829 | trophectodermal cell differentiation(GO:0001829) |
| 0.1 | 0.2 | GO:1903504 | regulation of mitotic cell cycle spindle assembly checkpoint(GO:0090266) regulation of mitotic spindle checkpoint(GO:1903504) |
| 0.1 | 0.2 | GO:0008216 | spermidine metabolic process(GO:0008216) |
| 0.1 | 0.8 | GO:0033120 | positive regulation of RNA splicing(GO:0033120) |
| 0.1 | 0.3 | GO:0006817 | phosphate ion transport(GO:0006817) |
| 0.1 | 0.1 | GO:0008626 | granzyme-mediated apoptotic signaling pathway(GO:0008626) |
| 0.1 | 0.1 | GO:0033148 | positive regulation of intracellular estrogen receptor signaling pathway(GO:0033148) |
| 0.1 | 0.3 | GO:0007197 | adenylate cyclase-inhibiting G-protein coupled acetylcholine receptor signaling pathway(GO:0007197) phospholipase C-activating G-protein coupled acetylcholine receptor signaling pathway(GO:0007207) |
| 0.1 | 0.3 | GO:0051155 | positive regulation of striated muscle cell differentiation(GO:0051155) |
| 0.1 | 0.4 | GO:0009191 | ribonucleoside diphosphate catabolic process(GO:0009191) |
| 0.1 | 0.3 | GO:0019355 | nicotinamide nucleotide biosynthetic process from aspartate(GO:0019355) 'de novo' NAD biosynthetic process(GO:0034627) 'de novo' NAD biosynthetic process from aspartate(GO:0034628) |
| 0.1 | 0.2 | GO:0035067 | negative regulation of histone acetylation(GO:0035067) |
| 0.1 | 0.2 | GO:0007288 | sperm axoneme assembly(GO:0007288) |
| 0.1 | 1.2 | GO:0061099 | negative regulation of protein tyrosine kinase activity(GO:0061099) |
| 0.1 | 3.6 | GO:0006839 | mitochondrial transport(GO:0006839) |
| 0.1 | 0.8 | GO:1902042 | negative regulation of extrinsic apoptotic signaling pathway via death domain receptors(GO:1902042) |
| 0.1 | 0.1 | GO:0051683 | establishment of Golgi localization(GO:0051683) |
| 0.1 | 0.5 | GO:0015909 | long-chain fatty acid transport(GO:0015909) |
| 0.1 | 0.3 | GO:0032695 | negative regulation of interleukin-12 production(GO:0032695) |
| 0.1 | 0.2 | GO:0060052 | neurofilament cytoskeleton organization(GO:0060052) |
| 0.1 | 0.2 | GO:0090193 | regulation of glomerular mesangial cell proliferation(GO:0072124) positive regulation of glomerular mesangial cell proliferation(GO:0072126) regulation of glomerulus development(GO:0090192) positive regulation of glomerulus development(GO:0090193) |
| 0.1 | 0.5 | GO:0045351 | type I interferon biosynthetic process(GO:0045351) |
| 0.1 | 1.6 | GO:1901998 | toxin transport(GO:1901998) |
| 0.1 | 3.3 | GO:0006334 | nucleosome assembly(GO:0006334) |
| 0.1 | 0.3 | GO:0060501 | positive regulation of epithelial cell proliferation involved in lung morphogenesis(GO:0060501) |
| 0.1 | 0.1 | GO:0010421 | hydrogen peroxide-mediated programmed cell death(GO:0010421) programmed cell death in response to reactive oxygen species(GO:0097468) regulation of hydrogen peroxide-mediated programmed cell death(GO:1901298) |
| 0.1 | 0.4 | GO:0070940 | dephosphorylation of RNA polymerase II C-terminal domain(GO:0070940) |
| 0.0 | 0.1 | GO:1903265 | positive regulation of tumor necrosis factor-mediated signaling pathway(GO:1903265) |
| 0.0 | 0.2 | GO:0046007 | negative regulation of activated T cell proliferation(GO:0046007) |
| 0.0 | 0.4 | GO:1901031 | regulation of response to reactive oxygen species(GO:1901031) |
| 0.0 | 0.3 | GO:0035428 | hexose transmembrane transport(GO:0035428) |
| 0.0 | 0.5 | GO:0042993 | positive regulation of transcription factor import into nucleus(GO:0042993) |
| 0.0 | 0.1 | GO:0019896 | axonal transport of mitochondrion(GO:0019896) |
| 0.0 | 1.0 | GO:0035315 | hair cell differentiation(GO:0035315) |
| 0.0 | 0.4 | GO:0035036 | binding of sperm to zona pellucida(GO:0007339) sperm-egg recognition(GO:0035036) |
| 0.0 | 0.3 | GO:0051126 | negative regulation of actin nucleation(GO:0051126) |
| 0.0 | 0.0 | GO:0006104 | succinyl-CoA metabolic process(GO:0006104) |
| 0.0 | 0.2 | GO:0033273 | response to vitamin(GO:0033273) |
| 0.0 | 0.4 | GO:0001833 | inner cell mass cell proliferation(GO:0001833) |
| 0.0 | 7.8 | GO:0006412 | translation(GO:0006412) |
| 0.0 | 0.4 | GO:0045747 | positive regulation of Notch signaling pathway(GO:0045747) |
| 0.0 | 0.4 | GO:0030888 | regulation of B cell proliferation(GO:0030888) |
| 0.0 | 0.2 | GO:0032020 | ISG15-protein conjugation(GO:0032020) |
| 0.0 | 0.2 | GO:0000729 | DNA double-strand break processing(GO:0000729) |
| 0.0 | 0.2 | GO:0051657 | maintenance of organelle location(GO:0051657) |
| 0.0 | 0.0 | GO:0036151 | phosphatidylcholine acyl-chain remodeling(GO:0036151) |
| 0.0 | 0.4 | GO:0003334 | keratinocyte development(GO:0003334) |
| 0.0 | 0.2 | GO:0000707 | meiotic DNA recombinase assembly(GO:0000707) |
| 0.0 | 0.2 | GO:0039703 | viral RNA genome replication(GO:0039694) RNA replication(GO:0039703) |
| 0.0 | 0.1 | GO:0045651 | positive regulation of macrophage differentiation(GO:0045651) |
| 0.0 | 0.0 | GO:0035358 | regulation of peroxisome proliferator activated receptor signaling pathway(GO:0035358) |
| 0.0 | 0.0 | GO:0034983 | peptidyl-lysine deacetylation(GO:0034983) |
| 0.0 | 1.0 | GO:0043966 | histone H3 acetylation(GO:0043966) |
| 0.0 | 0.2 | GO:0070262 | peptidyl-serine dephosphorylation(GO:0070262) |
| 0.0 | 0.1 | GO:1903795 | regulation of inorganic anion transmembrane transport(GO:1903795) |
| 0.0 | 0.1 | GO:1903689 | regulation of wound healing, spreading of epidermal cells(GO:1903689) negative regulation of wound healing, spreading of epidermal cells(GO:1903690) |
| 0.0 | 0.5 | GO:0031572 | G2 DNA damage checkpoint(GO:0031572) |
| 0.0 | 0.1 | GO:0070200 | establishment of protein localization to telomere(GO:0070200) |
| 0.0 | 0.1 | GO:0001980 | regulation of systemic arterial blood pressure by ischemic conditions(GO:0001980) |
| 0.0 | 0.3 | GO:0051601 | exocyst localization(GO:0051601) |
| 0.0 | 0.1 | GO:0006000 | fructose metabolic process(GO:0006000) |
| 0.0 | 0.8 | GO:0006749 | glutathione metabolic process(GO:0006749) |
| 0.0 | 0.1 | GO:2000650 | negative regulation of sodium ion transmembrane transporter activity(GO:2000650) |
| 0.0 | 0.3 | GO:0006682 | galactosylceramide biosynthetic process(GO:0006682) galactolipid biosynthetic process(GO:0019375) glycosylceramide biosynthetic process(GO:0046476) |
| 0.0 | 0.3 | GO:0030866 | cortical actin cytoskeleton organization(GO:0030866) |
| 0.0 | 0.1 | GO:0031117 | positive regulation of microtubule depolymerization(GO:0031117) |
| 0.0 | 0.2 | GO:0021854 | hypothalamus development(GO:0021854) |
| 0.0 | 0.0 | GO:0006544 | glycine metabolic process(GO:0006544) |
| 0.0 | 0.2 | GO:0061036 | positive regulation of cartilage development(GO:0061036) |
| 0.0 | 0.0 | GO:0044208 | 'de novo' AMP biosynthetic process(GO:0044208) |
| 0.0 | 0.0 | GO:0006560 | proline metabolic process(GO:0006560) |
| 0.0 | 0.0 | GO:1901142 | insulin metabolic process(GO:1901142) |
| 0.0 | 0.0 | GO:0070314 | G1 to G0 transition(GO:0070314) |
| 0.0 | 0.1 | GO:0009303 | rRNA transcription(GO:0009303) |
| 0.0 | 0.2 | GO:0019800 | peptide cross-linking via chondroitin 4-sulfate glycosaminoglycan(GO:0019800) |
| 0.0 | 0.1 | GO:0030220 | platelet formation(GO:0030220) |
| 0.0 | 0.9 | GO:0051607 | defense response to virus(GO:0051607) |
| 0.0 | 0.1 | GO:0016925 | protein sumoylation(GO:0016925) |
| 0.0 | 0.1 | GO:0048227 | plasma membrane to endosome transport(GO:0048227) |
| 0.0 | 0.1 | GO:0055059 | asymmetric neuroblast division(GO:0055059) |
| 0.0 | 0.3 | GO:0007257 | activation of JUN kinase activity(GO:0007257) |
| 0.0 | 0.2 | GO:0030574 | collagen catabolic process(GO:0030574) |
| 0.0 | 0.1 | GO:0016188 | synaptic vesicle maturation(GO:0016188) |
| 0.0 | 0.1 | GO:1904591 | positive regulation of protein import(GO:1904591) |
| 0.0 | 0.0 | GO:0032075 | positive regulation of nuclease activity(GO:0032075) |
| 0.0 | 0.1 | GO:2000191 | regulation of fatty acid transport(GO:2000191) |
| 0.0 | 0.0 | GO:0051309 | female meiosis chromosome segregation(GO:0016321) female meiosis chromosome separation(GO:0051309) |
| 0.0 | 0.1 | GO:0042492 | gamma-delta T cell differentiation(GO:0042492) |
| 0.0 | 0.0 | GO:0032096 | negative regulation of response to food(GO:0032096) negative regulation of appetite(GO:0032099) |
Gene overrepresentation in cellular_component category:
| Log-likelihood per target | Total log-likelihood | Term | Description |
|---|---|---|---|
| 4.0 | 19.9 | GO:0032133 | chromosome passenger complex(GO:0032133) |
| 3.2 | 9.6 | GO:0009328 | phenylalanine-tRNA ligase complex(GO:0009328) |
| 2.9 | 14.3 | GO:0005784 | Sec61 translocon complex(GO:0005784) translocon complex(GO:0071256) |
| 2.8 | 208.1 | GO:0022625 | cytosolic large ribosomal subunit(GO:0022625) |
| 2.7 | 140.6 | GO:0022627 | cytosolic small ribosomal subunit(GO:0022627) |
| 2.6 | 28.4 | GO:0008541 | proteasome regulatory particle, lid subcomplex(GO:0008541) |
| 2.6 | 18.0 | GO:0005638 | lamin filament(GO:0005638) |
| 2.4 | 2.4 | GO:0000502 | proteasome complex(GO:0000502) |
| 2.4 | 9.6 | GO:0032021 | NELF complex(GO:0032021) |
| 2.3 | 23.4 | GO:0005750 | mitochondrial respiratory chain complex III(GO:0005750) |
| 2.3 | 75.8 | GO:0000788 | nuclear nucleosome(GO:0000788) |
| 2.1 | 8.5 | GO:0045283 | mitochondrial respiratory chain complex II, succinate dehydrogenase complex (ubiquinone)(GO:0005749) succinate dehydrogenase complex (ubiquinone)(GO:0045257) respiratory chain complex II(GO:0045273) succinate dehydrogenase complex(GO:0045281) fumarate reductase complex(GO:0045283) |
| 2.1 | 6.3 | GO:0034457 | Mpp10 complex(GO:0034457) |
| 2.1 | 47.5 | GO:0005839 | proteasome core complex(GO:0005839) |
| 2.1 | 26.9 | GO:0045277 | respiratory chain complex IV(GO:0045277) |
| 2.1 | 18.5 | GO:0061574 | ASAP complex(GO:0061574) |
| 2.0 | 6.1 | GO:0043224 | nuclear SCF ubiquitin ligase complex(GO:0043224) |
| 2.0 | 6.0 | GO:0036125 | mitochondrial fatty acid beta-oxidation multienzyme complex(GO:0016507) fatty acid beta-oxidation multienzyme complex(GO:0036125) |
| 2.0 | 6.0 | GO:0000814 | ESCRT II complex(GO:0000814) |
| 2.0 | 93.4 | GO:0045271 | mitochondrial respiratory chain complex I(GO:0005747) NADH dehydrogenase complex(GO:0030964) respiratory chain complex I(GO:0045271) |
| 1.9 | 1.9 | GO:0000836 | ER ubiquitin ligase complex(GO:0000835) Hrd1p ubiquitin ligase complex(GO:0000836) |
| 1.9 | 5.7 | GO:0099573 | glutamatergic postsynaptic density(GO:0099573) |
| 1.9 | 18.8 | GO:0034709 | methylosome(GO:0034709) |
| 1.9 | 11.3 | GO:0005833 | hemoglobin complex(GO:0005833) |
| 1.8 | 5.5 | GO:0031074 | nucleocytoplasmic shuttling complex(GO:0031074) |
| 1.8 | 25.7 | GO:0000276 | mitochondrial proton-transporting ATP synthase complex, coupling factor F(o)(GO:0000276) |
| 1.8 | 16.4 | GO:0071541 | eukaryotic translation initiation factor 3 complex, eIF3m(GO:0071541) |
| 1.8 | 10.8 | GO:0033116 | endoplasmic reticulum-Golgi intermediate compartment membrane(GO:0033116) |
| 1.8 | 19.8 | GO:0031931 | TORC1 complex(GO:0031931) |
| 1.8 | 10.7 | GO:0030062 | mitochondrial tricarboxylic acid cycle enzyme complex(GO:0030062) |
| 1.8 | 10.5 | GO:0005796 | Golgi lumen(GO:0005796) |
| 1.7 | 12.1 | GO:0005687 | U4 snRNP(GO:0005687) |
| 1.7 | 5.2 | GO:1990047 | spindle matrix(GO:1990047) |
| 1.7 | 5.0 | GO:0071001 | U4/U6 snRNP(GO:0071001) |
| 1.6 | 13.2 | GO:0045261 | mitochondrial proton-transporting ATP synthase complex, catalytic core F(1)(GO:0000275) proton-transporting ATP synthase complex, catalytic core F(1)(GO:0045261) |
| 1.6 | 4.9 | GO:0005965 | protein farnesyltransferase complex(GO:0005965) |
| 1.6 | 50.3 | GO:0000314 | organellar small ribosomal subunit(GO:0000314) mitochondrial small ribosomal subunit(GO:0005763) |
| 1.6 | 3.2 | GO:0035869 | ciliary transition zone(GO:0035869) |
| 1.6 | 4.8 | GO:0044614 | nuclear pore cytoplasmic filaments(GO:0044614) |
| 1.6 | 4.8 | GO:0044302 | dentate gyrus mossy fiber(GO:0044302) |
| 1.6 | 4.7 | GO:0031510 | SUMO activating enzyme complex(GO:0031510) |
| 1.5 | 24.6 | GO:0048188 | Set1C/COMPASS complex(GO:0048188) |
| 1.5 | 85.7 | GO:0000315 | organellar large ribosomal subunit(GO:0000315) mitochondrial large ribosomal subunit(GO:0005762) |
| 1.5 | 4.5 | GO:0033186 | CAF-1 complex(GO:0033186) |
| 1.5 | 6.0 | GO:0060187 | cell pole(GO:0060187) |
| 1.5 | 13.3 | GO:0033180 | proton-transporting V-type ATPase, V1 domain(GO:0033180) |
| 1.4 | 5.7 | GO:0002189 | ribose phosphate diphosphokinase complex(GO:0002189) |
| 1.4 | 7.1 | GO:0034751 | aryl hydrocarbon receptor complex(GO:0034751) |
| 1.4 | 4.2 | GO:0031680 | G-protein beta/gamma-subunit complex(GO:0031680) |
| 1.4 | 5.6 | GO:0048237 | rough endoplasmic reticulum lumen(GO:0048237) |
| 1.4 | 11.0 | GO:0031595 | nuclear proteasome complex(GO:0031595) |
| 1.3 | 8.0 | GO:0016602 | CCAAT-binding factor complex(GO:0016602) |
| 1.3 | 14.4 | GO:0000176 | nuclear exosome (RNase complex)(GO:0000176) |
| 1.3 | 6.5 | GO:1990246 | uniplex complex(GO:1990246) |
| 1.3 | 3.9 | GO:0099631 | postsynaptic endocytic zone cytoplasmic component(GO:0099631) |
| 1.3 | 16.6 | GO:0046930 | pore complex(GO:0046930) |
| 1.3 | 5.1 | GO:0017071 | intracellular cyclic nucleotide activated cation channel complex(GO:0017071) |
| 1.3 | 3.8 | GO:0030905 | retromer, tubulation complex(GO:0030905) |
| 1.2 | 46.8 | GO:0000786 | nucleosome(GO:0000786) |
| 1.2 | 7.4 | GO:0071817 | MMXD complex(GO:0071817) |
| 1.2 | 15.8 | GO:0005862 | muscle thin filament tropomyosin(GO:0005862) |
| 1.2 | 9.7 | GO:0005838 | proteasome regulatory particle(GO:0005838) |
| 1.2 | 3.5 | GO:0042720 | mitochondrial inner membrane peptidase complex(GO:0042720) |
| 1.2 | 2.3 | GO:0000780 | condensed nuclear chromosome, centromeric region(GO:0000780) |
| 1.2 | 12.8 | GO:1990907 | beta-catenin-TCF complex(GO:1990907) |
| 1.2 | 3.5 | GO:0005588 | collagen type V trimer(GO:0005588) |
| 1.2 | 11.5 | GO:0016272 | prefoldin complex(GO:0016272) |
| 1.2 | 5.8 | GO:0001533 | cornified envelope(GO:0001533) |
| 1.1 | 3.4 | GO:1990851 | Wnt-Frizzled-LRP5/6 complex(GO:1990851) |
| 1.1 | 6.7 | GO:0061689 | tricellular tight junction(GO:0061689) |
| 1.1 | 5.5 | GO:0002193 | MAML1-RBP-Jkappa- ICN1 complex(GO:0002193) |
| 1.1 | 24.2 | GO:0005666 | DNA-directed RNA polymerase III complex(GO:0005666) |
| 1.1 | 3.2 | GO:0044391 | ribosomal subunit(GO:0044391) |
| 1.0 | 5.2 | GO:0030315 | T-tubule(GO:0030315) |
| 1.0 | 3.1 | GO:0070069 | cytochrome complex(GO:0070069) |
| 1.0 | 6.2 | GO:0000444 | MIS12/MIND type complex(GO:0000444) |
| 1.0 | 14.6 | GO:0005869 | dynactin complex(GO:0005869) |
| 1.0 | 8.1 | GO:0000127 | transcription factor TFIIIC complex(GO:0000127) |
| 1.0 | 4.1 | GO:0045098 | type III intermediate filament(GO:0045098) |
| 1.0 | 4.1 | GO:0097129 | cyclin D2-CDK4 complex(GO:0097129) |
| 1.0 | 15.0 | GO:0017119 | Golgi transport complex(GO:0017119) |
| 1.0 | 3.0 | GO:0071149 | TEAD-2-YAP complex(GO:0071149) |
| 1.0 | 11.8 | GO:0005885 | Arp2/3 protein complex(GO:0005885) |
| 1.0 | 7.7 | GO:0097136 | Bcl-2 family protein complex(GO:0097136) |
| 1.0 | 3.8 | GO:0005945 | 6-phosphofructokinase complex(GO:0005945) |
| 0.9 | 10.4 | GO:0042622 | photoreceptor outer segment membrane(GO:0042622) |
| 0.9 | 2.8 | GO:0034657 | GID complex(GO:0034657) |
| 0.9 | 10.1 | GO:0000306 | extrinsic component of vacuolar membrane(GO:0000306) |
| 0.9 | 21.9 | GO:0005680 | anaphase-promoting complex(GO:0005680) |
| 0.9 | 2.7 | GO:0097057 | TRAF2-GSTP1 complex(GO:0097057) |
| 0.9 | 5.5 | GO:0032299 | ribonuclease H2 complex(GO:0032299) |
| 0.9 | 5.3 | GO:0097504 | Gemini of coiled bodies(GO:0097504) |
| 0.9 | 2.6 | GO:0044194 | cytolytic granule(GO:0044194) |
| 0.9 | 13.7 | GO:0031143 | pseudopodium(GO:0031143) |
| 0.9 | 3.4 | GO:1903349 | omegasome membrane(GO:1903349) |
| 0.9 | 4.3 | GO:0000313 | organellar ribosome(GO:0000313) mitochondrial ribosome(GO:0005761) |
| 0.8 | 3.4 | GO:0071942 | XPC complex(GO:0071942) |
| 0.8 | 0.8 | GO:0032433 | filopodium tip(GO:0032433) |
| 0.8 | 0.8 | GO:0033178 | proton-transporting two-sector ATPase complex, catalytic domain(GO:0033178) |
| 0.8 | 2.5 | GO:1990730 | VCP-NSFL1C complex(GO:1990730) |
| 0.8 | 22.9 | GO:0031305 | integral component of mitochondrial inner membrane(GO:0031305) |
| 0.8 | 3.3 | GO:0045251 | mitochondrial electron transfer flavoprotein complex(GO:0017133) electron transfer flavoprotein complex(GO:0045251) |
| 0.8 | 2.5 | GO:0097059 | CNTFR-CLCF1 complex(GO:0097059) |
| 0.8 | 13.3 | GO:0031090 | organelle membrane(GO:0031090) |
| 0.8 | 5.4 | GO:0035985 | senescence-associated heterochromatin focus(GO:0035985) |
| 0.8 | 4.6 | GO:0005742 | mitochondrial outer membrane translocase complex(GO:0005742) |
| 0.8 | 3.1 | GO:0089717 | spanning component of plasma membrane(GO:0044214) spanning component of membrane(GO:0089717) |
| 0.8 | 11.4 | GO:0030127 | COPII vesicle coat(GO:0030127) |
| 0.8 | 4.5 | GO:0044530 | supraspliceosomal complex(GO:0044530) |
| 0.8 | 10.5 | GO:0017101 | aminoacyl-tRNA synthetase multienzyme complex(GO:0017101) |
| 0.7 | 6.0 | GO:0005851 | eukaryotic translation initiation factor 2B complex(GO:0005851) |
| 0.7 | 5.9 | GO:0070938 | contractile ring(GO:0070938) |
| 0.7 | 0.7 | GO:0097361 | CIA complex(GO:0097361) |
| 0.7 | 7.8 | GO:0032426 | stereocilium tip(GO:0032426) |
| 0.7 | 2.1 | GO:0043204 | perikaryon(GO:0043204) |
| 0.7 | 30.4 | GO:0008180 | COP9 signalosome(GO:0008180) |
| 0.7 | 2.8 | GO:0000942 | condensed nuclear chromosome outer kinetochore(GO:0000942) |
| 0.7 | 2.1 | GO:0036488 | CHOP-C/EBP complex(GO:0036488) |
| 0.7 | 9.8 | GO:0000974 | Prp19 complex(GO:0000974) |
| 0.7 | 4.1 | GO:0042406 | extrinsic component of endoplasmic reticulum membrane(GO:0042406) |
| 0.7 | 2.0 | GO:0000243 | commitment complex(GO:0000243) |
| 0.7 | 4.0 | GO:0030896 | checkpoint clamp complex(GO:0030896) |
| 0.7 | 3.3 | GO:0033276 | transcription factor TFTC complex(GO:0033276) |
| 0.7 | 2.6 | GO:1902937 | inward rectifier potassium channel complex(GO:1902937) |
| 0.7 | 4.6 | GO:0071818 | BAT3 complex(GO:0071818) ER membrane insertion complex(GO:0072379) |
| 0.6 | 3.9 | GO:0042765 | GPI-anchor transamidase complex(GO:0042765) |
| 0.6 | 6.4 | GO:0098800 | inner mitochondrial membrane protein complex(GO:0098800) |
| 0.6 | 5.7 | GO:0031390 | Ctf18 RFC-like complex(GO:0031390) |
| 0.6 | 3.8 | GO:0071986 | Ragulator complex(GO:0071986) |
| 0.6 | 4.4 | GO:0016580 | Sin3 complex(GO:0016580) |
| 0.6 | 3.1 | GO:0033503 | HULC complex(GO:0033503) |
| 0.6 | 1.9 | GO:0070552 | BRISC complex(GO:0070552) |
| 0.6 | 11.7 | GO:0046540 | U4/U6 x U5 tri-snRNP complex(GO:0046540) |
| 0.6 | 3.1 | GO:0030496 | midbody(GO:0030496) |
| 0.6 | 22.1 | GO:0005758 | mitochondrial intermembrane space(GO:0005758) |
| 0.6 | 2.5 | GO:0000322 | storage vacuole(GO:0000322) |
| 0.6 | 3.0 | GO:0005834 | heterotrimeric G-protein complex(GO:0005834) |
| 0.6 | 4.8 | GO:0005786 | signal recognition particle, endoplasmic reticulum targeting(GO:0005786) |
| 0.6 | 3.0 | GO:0044611 | nuclear pore inner ring(GO:0044611) |
| 0.6 | 2.4 | GO:0035339 | SPOTS complex(GO:0035339) |
| 0.6 | 2.9 | GO:1990131 | Gtr1-Gtr2 GTPase complex(GO:1990131) |
| 0.6 | 2.9 | GO:1990745 | EARP complex(GO:1990745) |
| 0.6 | 8.5 | GO:0042555 | MCM complex(GO:0042555) |
| 0.6 | 13.6 | GO:0005689 | U12-type spliceosomal complex(GO:0005689) |
| 0.6 | 2.8 | GO:0048476 | Holliday junction resolvase complex(GO:0048476) |
| 0.6 | 0.6 | GO:0071598 | neuronal ribonucleoprotein granule(GO:0071598) |
| 0.6 | 5.6 | GO:0030677 | ribonuclease P complex(GO:0030677) multimeric ribonuclease P complex(GO:0030681) |
| 0.6 | 23.3 | GO:0042645 | nucleoid(GO:0009295) mitochondrial nucleoid(GO:0042645) |
| 0.6 | 5.0 | GO:0036157 | outer dynein arm(GO:0036157) |
| 0.6 | 2.2 | GO:0034719 | SMN-Sm protein complex(GO:0034719) |
| 0.5 | 5.5 | GO:0000815 | ESCRT III complex(GO:0000815) |
| 0.5 | 11.5 | GO:0030914 | STAGA complex(GO:0030914) |
| 0.5 | 2.1 | GO:0008537 | proteasome activator complex(GO:0008537) |
| 0.5 | 3.2 | GO:0070847 | core mediator complex(GO:0070847) |
| 0.5 | 2.1 | GO:0030289 | protein phosphatase 4 complex(GO:0030289) |
| 0.5 | 5.2 | GO:0016460 | myosin II complex(GO:0016460) |
| 0.5 | 2.6 | GO:0033553 | rDNA heterochromatin(GO:0033553) |
| 0.5 | 3.6 | GO:0097550 | transcriptional preinitiation complex(GO:0097550) |
| 0.5 | 5.0 | GO:0008290 | F-actin capping protein complex(GO:0008290) |
| 0.5 | 5.5 | GO:0033179 | proton-transporting V-type ATPase, V0 domain(GO:0033179) |
| 0.5 | 5.0 | GO:0031462 | Cul2-RING ubiquitin ligase complex(GO:0031462) |
| 0.5 | 1.0 | GO:0005577 | fibrinogen complex(GO:0005577) |
| 0.5 | 17.3 | GO:0016592 | mediator complex(GO:0016592) |
| 0.5 | 4.4 | GO:0032982 | myosin filament(GO:0032982) |
| 0.5 | 1.5 | GO:0036156 | inner dynein arm(GO:0036156) |
| 0.5 | 0.5 | GO:0030991 | intraciliary transport particle A(GO:0030991) |
| 0.5 | 1.9 | GO:0032127 | dense core granule membrane(GO:0032127) |
| 0.5 | 4.9 | GO:0030057 | desmosome(GO:0030057) |
| 0.5 | 2.4 | GO:0000177 | cytoplasmic exosome (RNase complex)(GO:0000177) |
| 0.5 | 1.5 | GO:0030906 | retromer, cargo-selective complex(GO:0030906) |
| 0.5 | 2.9 | GO:0005664 | origin recognition complex(GO:0000808) nuclear origin of replication recognition complex(GO:0005664) |
| 0.5 | 1.4 | GO:0036387 | nuclear pre-replicative complex(GO:0005656) pre-replicative complex(GO:0036387) |
| 0.5 | 1.0 | GO:0017059 | serine C-palmitoyltransferase complex(GO:0017059) endoplasmic reticulum palmitoyltransferase complex(GO:0031211) |
| 0.5 | 2.9 | GO:0033256 | I-kappaB/NF-kappaB complex(GO:0033256) |
| 0.5 | 0.9 | GO:0002177 | manchette(GO:0002177) |
| 0.5 | 6.6 | GO:0030126 | COPI vesicle coat(GO:0030126) |
| 0.5 | 132.8 | GO:0005743 | mitochondrial inner membrane(GO:0005743) |
| 0.5 | 7.0 | GO:0097539 | ciliary transition fiber(GO:0097539) |
| 0.5 | 0.9 | GO:0048786 | presynaptic active zone(GO:0048786) |
| 0.5 | 3.2 | GO:0033588 | Elongator holoenzyme complex(GO:0033588) |
| 0.4 | 2.7 | GO:0005677 | chromatin silencing complex(GO:0005677) |
| 0.4 | 4.9 | GO:0005652 | nuclear lamina(GO:0005652) |
| 0.4 | 2.2 | GO:0060091 | kinocilium(GO:0060091) |
| 0.4 | 6.1 | GO:0005922 | connexon complex(GO:0005922) |
| 0.4 | 3.5 | GO:0005902 | microvillus(GO:0005902) |
| 0.4 | 2.1 | GO:0031262 | Ndc80 complex(GO:0031262) |
| 0.4 | 3.8 | GO:0097197 | tetraspanin-enriched microdomain(GO:0097197) |
| 0.4 | 3.3 | GO:0097413 | Lewy body(GO:0097413) |
| 0.4 | 3.3 | GO:0031105 | septin complex(GO:0031105) |
| 0.4 | 12.6 | GO:0046658 | anchored component of plasma membrane(GO:0046658) |
| 0.4 | 2.0 | GO:0035976 | AP1 complex(GO:0035976) |
| 0.4 | 2.8 | GO:0097255 | R2TP complex(GO:0097255) |
| 0.4 | 9.0 | GO:0016581 | NuRD complex(GO:0016581) CHD-type complex(GO:0090545) |
| 0.4 | 8.6 | GO:0005782 | peroxisomal matrix(GO:0005782) microbody lumen(GO:0031907) |
| 0.4 | 1.6 | GO:0014802 | terminal cisterna(GO:0014802) |
| 0.4 | 6.6 | GO:0016010 | dystrophin-associated glycoprotein complex(GO:0016010) glycoprotein complex(GO:0090665) |
| 0.4 | 31.2 | GO:0072562 | blood microparticle(GO:0072562) |
| 0.4 | 8.8 | GO:0035145 | exon-exon junction complex(GO:0035145) |
| 0.4 | 0.4 | GO:0098830 | presynaptic endosome(GO:0098830) |
| 0.4 | 2.2 | GO:0098837 | postsynaptic recycling endosome(GO:0098837) |
| 0.4 | 0.7 | GO:0034274 | Atg12-Atg5-Atg16 complex(GO:0034274) |
| 0.4 | 1.8 | GO:1990454 | L-type voltage-gated calcium channel complex(GO:1990454) |
| 0.4 | 1.8 | GO:0042583 | chromaffin granule(GO:0042583) |
| 0.4 | 5.8 | GO:0036038 | MKS complex(GO:0036038) |
| 0.4 | 2.9 | GO:0005787 | signal peptidase complex(GO:0005787) |
| 0.4 | 2.2 | GO:0044322 | endoplasmic reticulum quality control compartment(GO:0044322) |
| 0.4 | 4.3 | GO:0030123 | AP-3 adaptor complex(GO:0030123) |
| 0.4 | 1.4 | GO:0031254 | uropod(GO:0001931) cell trailing edge(GO:0031254) |
| 0.4 | 1.8 | GO:0030689 | Noc complex(GO:0030689) |
| 0.4 | 1.8 | GO:0070776 | H3 histone acetyltransferase complex(GO:0070775) MOZ/MORF histone acetyltransferase complex(GO:0070776) |
| 0.4 | 1.1 | GO:0043540 | 6-phosphofructo-2-kinase/fructose-2,6-biphosphatase complex(GO:0043540) |
| 0.3 | 2.1 | GO:0032983 | kainate selective glutamate receptor complex(GO:0032983) |
| 0.3 | 10.0 | GO:0043005 | neuron projection(GO:0043005) |
| 0.3 | 7.5 | GO:0030285 | integral component of synaptic vesicle membrane(GO:0030285) intrinsic component of synaptic vesicle membrane(GO:0098563) |
| 0.3 | 5.5 | GO:0044300 | cerebellar mossy fiber(GO:0044300) |
| 0.3 | 1.7 | GO:0000839 | Hrd1p ubiquitin ligase ERAD-L complex(GO:0000839) |
| 0.3 | 4.4 | GO:0005665 | DNA-directed RNA polymerase II, core complex(GO:0005665) |
| 0.3 | 1.0 | GO:0016533 | cyclin-dependent protein kinase 5 holoenzyme complex(GO:0016533) |
| 0.3 | 1.3 | GO:0005672 | transcription factor TFIIA complex(GO:0005672) |
| 0.3 | 1.0 | GO:0097433 | dense body(GO:0097433) |
| 0.3 | 2.3 | GO:0042824 | MHC class I peptide loading complex(GO:0042824) |
| 0.3 | 2.7 | GO:0016281 | eukaryotic translation initiation factor 4F complex(GO:0016281) |
| 0.3 | 1.3 | GO:0005594 | collagen type IX trimer(GO:0005594) |
| 0.3 | 2.6 | GO:0000812 | Swr1 complex(GO:0000812) |
| 0.3 | 1.0 | GO:0030670 | phagocytic vesicle membrane(GO:0030670) |
| 0.3 | 1.0 | GO:0044439 | peroxisomal membrane(GO:0005778) microbody membrane(GO:0031903) microbody part(GO:0044438) peroxisomal part(GO:0044439) |
| 0.3 | 4.5 | GO:0031083 | BLOC-1 complex(GO:0031083) |
| 0.3 | 3.2 | GO:0043235 | receptor complex(GO:0043235) |
| 0.3 | 1.6 | GO:0008622 | epsilon DNA polymerase complex(GO:0008622) |
| 0.3 | 2.8 | GO:0032584 | growth cone membrane(GO:0032584) |
| 0.3 | 1.9 | GO:0002178 | palmitoyltransferase complex(GO:0002178) |
| 0.3 | 3.7 | GO:0005911 | cell-cell junction(GO:0005911) |
| 0.3 | 4.0 | GO:0005719 | nuclear euchromatin(GO:0005719) |
| 0.3 | 3.4 | GO:0005642 | annulate lamellae(GO:0005642) |
| 0.3 | 1.2 | GO:0031467 | Cul7-RING ubiquitin ligase complex(GO:0031467) |
| 0.3 | 3.0 | GO:0005662 | DNA replication factor A complex(GO:0005662) |
| 0.3 | 3.6 | GO:0002199 | zona pellucida receptor complex(GO:0002199) |
| 0.3 | 1.2 | GO:0031983 | vesicle lumen(GO:0031983) |
| 0.3 | 0.9 | GO:0033193 | Lsd1/2 complex(GO:0033193) |
| 0.3 | 2.0 | GO:0035686 | sperm fibrous sheath(GO:0035686) |
| 0.3 | 2.0 | GO:0005640 | nuclear outer membrane(GO:0005640) |
| 0.3 | 2.6 | GO:0000137 | Golgi cis cisterna(GO:0000137) |
| 0.3 | 2.3 | GO:0072669 | tRNA-splicing ligase complex(GO:0072669) |
| 0.3 | 12.6 | GO:0005840 | ribosome(GO:0005840) |
| 0.3 | 1.1 | GO:0042588 | zymogen granule(GO:0042588) |
| 0.3 | 1.7 | GO:0005853 | eukaryotic translation elongation factor 1 complex(GO:0005853) |
| 0.3 | 1.1 | GO:1990769 | proximal neuron projection(GO:1990769) |
| 0.3 | 1.9 | GO:0045254 | pyruvate dehydrogenase complex(GO:0045254) |
| 0.3 | 0.3 | GO:0030891 | VCB complex(GO:0030891) |
| 0.3 | 1.6 | GO:0005956 | protein kinase CK2 complex(GO:0005956) |
| 0.3 | 23.9 | GO:0000932 | cytoplasmic mRNA processing body(GO:0000932) |
| 0.3 | 2.1 | GO:0005736 | DNA-directed RNA polymerase I complex(GO:0005736) |
| 0.3 | 1.6 | GO:0031527 | filopodium membrane(GO:0031527) |
| 0.3 | 4.9 | GO:0071564 | npBAF complex(GO:0071564) |
| 0.3 | 1.0 | GO:0071014 | post-mRNA release spliceosomal complex(GO:0071014) |
| 0.3 | 5.3 | GO:0005771 | multivesicular body(GO:0005771) |
| 0.3 | 4.3 | GO:0016459 | myosin complex(GO:0016459) |
| 0.3 | 0.8 | GO:0072357 | PTW/PP1 phosphatase complex(GO:0072357) |
| 0.2 | 2.5 | GO:0044754 | secondary lysosome(GO:0005767) autolysosome(GO:0044754) |
| 0.2 | 1.2 | GO:0038039 | G-protein coupled receptor heterodimeric complex(GO:0038039) |
| 0.2 | 0.7 | GO:0032156 | septin cytoskeleton(GO:0032156) |
| 0.2 | 0.7 | GO:0002944 | cyclin K-CDK12 complex(GO:0002944) |
| 0.2 | 5.1 | GO:0000159 | protein phosphatase type 2A complex(GO:0000159) |
| 0.2 | 0.9 | GO:0035032 | phosphatidylinositol 3-kinase complex, class III(GO:0035032) |
| 0.2 | 12.0 | GO:0005793 | endoplasmic reticulum-Golgi intermediate compartment(GO:0005793) |
| 0.2 | 1.4 | GO:0048787 | presynaptic active zone membrane(GO:0048787) |
| 0.2 | 2.2 | GO:0043205 | microfibril(GO:0001527) fibril(GO:0043205) |
| 0.2 | 4.3 | GO:0031306 | intrinsic component of mitochondrial outer membrane(GO:0031306) |
| 0.2 | 9.0 | GO:0097546 | ciliary base(GO:0097546) |
| 0.2 | 0.6 | GO:0046696 | lipopolysaccharide receptor complex(GO:0046696) |
| 0.2 | 1.9 | GO:0030686 | 90S preribosome(GO:0030686) |
| 0.2 | 0.4 | GO:0005915 | zonula adherens(GO:0005915) |
| 0.2 | 0.8 | GO:0031298 | replication fork protection complex(GO:0031298) |
| 0.2 | 1.5 | GO:0005790 | smooth endoplasmic reticulum(GO:0005790) |
| 0.2 | 1.7 | GO:0033269 | internode region of axon(GO:0033269) |
| 0.2 | 0.8 | GO:0090537 | CERF complex(GO:0090537) |
| 0.2 | 0.6 | GO:0005775 | vacuolar lumen(GO:0005775) |
| 0.2 | 1.4 | GO:0042599 | lamellar body(GO:0042599) |
| 0.2 | 3.0 | GO:0060170 | ciliary membrane(GO:0060170) |
| 0.2 | 14.4 | GO:0005759 | mitochondrial matrix(GO:0005759) |
| 0.2 | 19.7 | GO:0005741 | mitochondrial outer membrane(GO:0005741) |
| 0.2 | 2.0 | GO:0070545 | PeBoW complex(GO:0070545) |
| 0.2 | 1.8 | GO:0034518 | mRNA cap binding complex(GO:0005845) RNA cap binding complex(GO:0034518) |
| 0.2 | 0.8 | GO:0032389 | MutLalpha complex(GO:0032389) |
| 0.2 | 1.0 | GO:0005971 | ribonucleoside-diphosphate reductase complex(GO:0005971) |
| 0.2 | 1.5 | GO:0005883 | neurofilament(GO:0005883) |
| 0.2 | 0.9 | GO:0043527 | tRNA methyltransferase complex(GO:0043527) |
| 0.2 | 0.9 | GO:1990761 | growth cone lamellipodium(GO:1990761) growth cone filopodium(GO:1990812) |
| 0.2 | 7.4 | GO:0005740 | mitochondrial envelope(GO:0005740) |
| 0.2 | 5.5 | GO:0031902 | late endosome membrane(GO:0031902) |
| 0.2 | 1.5 | GO:0071437 | invadopodium(GO:0071437) |
| 0.2 | 1.5 | GO:0097427 | microtubule bundle(GO:0097427) |
| 0.2 | 1.4 | GO:0005682 | U5 snRNP(GO:0005682) |
| 0.2 | 4.9 | GO:0043209 | myelin sheath(GO:0043209) |
| 0.2 | 2.0 | GO:0031011 | Ino80 complex(GO:0031011) |
| 0.2 | 0.7 | GO:0031095 | platelet dense tubular network membrane(GO:0031095) |
| 0.2 | 174.2 | GO:0005739 | mitochondrion(GO:0005739) |
| 0.2 | 0.7 | GO:0005658 | alpha DNA polymerase:primase complex(GO:0005658) |
| 0.2 | 1.0 | GO:0042582 | primary lysosome(GO:0005766) azurophil granule(GO:0042582) |
| 0.2 | 1.0 | GO:0001520 | outer dense fiber(GO:0001520) |
| 0.2 | 2.8 | GO:0090544 | BAF-type complex(GO:0090544) |
| 0.2 | 2.3 | GO:0008023 | transcription elongation factor complex(GO:0008023) |
| 0.2 | 10.3 | GO:0005581 | collagen trimer(GO:0005581) |
| 0.2 | 1.9 | GO:0043189 | NuA4 histone acetyltransferase complex(GO:0035267) H4/H2A histone acetyltransferase complex(GO:0043189) H4 histone acetyltransferase complex(GO:1902562) |
| 0.2 | 3.8 | GO:0032040 | small-subunit processome(GO:0032040) |
| 0.2 | 0.9 | GO:0032806 | carboxy-terminal domain protein kinase complex(GO:0032806) |
| 0.2 | 4.7 | GO:0032420 | stereocilium(GO:0032420) |
| 0.2 | 2.4 | GO:0030904 | retromer complex(GO:0030904) |
| 0.2 | 5.3 | GO:0030173 | integral component of Golgi membrane(GO:0030173) intrinsic component of Golgi membrane(GO:0031228) |
| 0.1 | 0.4 | GO:0070937 | CRD-mediated mRNA stability complex(GO:0070937) |
| 0.1 | 10.9 | GO:0005795 | Golgi stack(GO:0005795) |
| 0.1 | 1.9 | GO:0032045 | guanyl-nucleotide exchange factor complex(GO:0032045) |
| 0.1 | 0.9 | GO:0000214 | tRNA-intron endonuclease complex(GO:0000214) |
| 0.1 | 1.3 | GO:0036452 | ESCRT complex(GO:0036452) |
| 0.1 | 1.9 | GO:0097225 | sperm midpiece(GO:0097225) |
| 0.1 | 2.1 | GO:0005868 | cytoplasmic dynein complex(GO:0005868) |
| 0.1 | 0.5 | GO:0030687 | preribosome, large subunit precursor(GO:0030687) |
| 0.1 | 1.7 | GO:0035327 | transcriptionally active chromatin(GO:0035327) |
| 0.1 | 0.6 | GO:1990909 | Wnt signalosome(GO:1990909) |
| 0.1 | 4.8 | GO:0045171 | intercellular bridge(GO:0045171) |
| 0.1 | 0.3 | GO:1904115 | axon cytoplasm(GO:1904115) |
| 0.1 | 0.7 | GO:0009897 | external side of plasma membrane(GO:0009897) |
| 0.1 | 0.3 | GO:0000801 | central element(GO:0000801) |
| 0.1 | 1.5 | GO:0000506 | glycosylphosphatidylinositol-N-acetylglucosaminyltransferase (GPI-GnT) complex(GO:0000506) |
| 0.1 | 1.9 | GO:0031526 | brush border membrane(GO:0031526) |
| 0.1 | 1.4 | GO:0005788 | endoplasmic reticulum lumen(GO:0005788) |
| 0.1 | 0.8 | GO:0042382 | paraspeckles(GO:0042382) |
| 0.1 | 3.0 | GO:0031941 | filamentous actin(GO:0031941) |
| 0.1 | 0.4 | GO:0032588 | trans-Golgi network membrane(GO:0032588) |
| 0.1 | 0.2 | GO:0020018 | ciliary pocket(GO:0020016) ciliary pocket membrane(GO:0020018) |
| 0.1 | 0.3 | GO:0031265 | CD95 death-inducing signaling complex(GO:0031265) |
| 0.1 | 1.2 | GO:0031229 | integral component of nuclear inner membrane(GO:0005639) intrinsic component of nuclear inner membrane(GO:0031229) nuclear membrane part(GO:0044453) |
| 0.1 | 1.0 | GO:0005697 | telomerase holoenzyme complex(GO:0005697) |
| 0.1 | 0.9 | GO:0001739 | sex chromatin(GO:0001739) |
| 0.1 | 0.6 | GO:0070187 | telosome(GO:0070187) |
| 0.1 | 0.8 | GO:0000015 | phosphopyruvate hydratase complex(GO:0000015) |
| 0.1 | 3.2 | GO:0034707 | chloride channel complex(GO:0034707) |
| 0.1 | 1.4 | GO:0015030 | Cajal body(GO:0015030) |
| 0.1 | 0.6 | GO:0042470 | melanosome(GO:0042470) pigment granule(GO:0048770) |
| 0.1 | 6.6 | GO:0043195 | terminal bouton(GO:0043195) |
| 0.1 | 0.6 | GO:0032593 | insulin-responsive compartment(GO:0032593) |
| 0.1 | 0.9 | GO:0043218 | compact myelin(GO:0043218) |
| 0.1 | 3.1 | GO:0000307 | cyclin-dependent protein kinase holoenzyme complex(GO:0000307) |
| 0.1 | 0.6 | GO:0046581 | intercellular canaliculus(GO:0046581) |
| 0.1 | 4.6 | GO:0098852 | lysosomal membrane(GO:0005765) lytic vacuole membrane(GO:0098852) |
| 0.1 | 8.9 | GO:0044452 | nucleolar part(GO:0044452) |
| 0.1 | 0.3 | GO:0097443 | sorting endosome(GO:0097443) |
| 0.1 | 0.3 | GO:1990635 | proximal dendrite(GO:1990635) |
| 0.1 | 0.5 | GO:0000109 | nucleotide-excision repair complex(GO:0000109) |
| 0.1 | 1.3 | GO:0005903 | brush border(GO:0005903) |
| 0.1 | 1.5 | GO:0005791 | rough endoplasmic reticulum(GO:0005791) |
| 0.1 | 0.3 | GO:0005827 | polar microtubule(GO:0005827) |
| 0.1 | 0.3 | GO:0010369 | chromocenter(GO:0010369) |
| 0.1 | 1.0 | GO:0019005 | SCF ubiquitin ligase complex(GO:0019005) |
| 0.1 | 0.5 | GO:0072546 | ER membrane protein complex(GO:0072546) |
| 0.1 | 0.9 | GO:0008074 | guanylate cyclase complex, soluble(GO:0008074) |
| 0.1 | 0.2 | GO:0033063 | Rad51B-Rad51C-Rad51D-XRCC2 complex(GO:0033063) |
| 0.0 | 0.1 | GO:1990130 | Iml1 complex(GO:1990130) |
| 0.0 | 0.5 | GO:0020005 | symbiont-containing vacuole(GO:0020003) symbiont-containing vacuole membrane(GO:0020005) extracellular membrane-bounded organelle(GO:0065010) |
| 0.0 | 0.9 | GO:0031901 | early endosome membrane(GO:0031901) |
| 0.0 | 0.1 | GO:0034673 | inhibin-betaglycan-ActRII complex(GO:0034673) |
| 0.0 | 35.9 | GO:0005615 | extracellular space(GO:0005615) |
| 0.0 | 0.3 | GO:0005921 | gap junction(GO:0005921) |
| 0.0 | 0.1 | GO:1990423 | RZZ complex(GO:1990423) |
| 0.0 | 0.1 | GO:0001673 | male germ cell nucleus(GO:0001673) |
| 0.0 | 0.4 | GO:0031080 | nuclear pore outer ring(GO:0031080) |
| 0.0 | 2.6 | GO:0045121 | membrane raft(GO:0045121) membrane microdomain(GO:0098857) |
| 0.0 | 0.4 | GO:0009925 | basal plasma membrane(GO:0009925) |
| 0.0 | 1.0 | GO:0000123 | histone acetyltransferase complex(GO:0000123) |
| 0.0 | 0.3 | GO:0036513 | Derlin-1 retrotranslocation complex(GO:0036513) |
| 0.0 | 0.1 | GO:0097512 | cardiac myofibril(GO:0097512) |
| 0.0 | 0.2 | GO:0090571 | RNA polymerase II transcription repressor complex(GO:0090571) |
| 0.0 | 0.9 | GO:0032993 | protein-DNA complex(GO:0032993) |
| 0.0 | 0.3 | GO:0031252 | cell leading edge(GO:0031252) |
| 0.0 | 0.1 | GO:0036396 | MIS complex(GO:0036396) mRNA editing complex(GO:0045293) |
| 0.0 | 1.1 | GO:0031514 | motile cilium(GO:0031514) |
| 0.0 | 0.3 | GO:0031201 | SNARE complex(GO:0031201) |
| 0.0 | 0.0 | GO:0070939 | Dsl1p complex(GO:0070939) |
| 0.0 | 0.2 | GO:0000164 | protein phosphatase type 1 complex(GO:0000164) |
| 0.0 | 1.4 | GO:0031227 | intrinsic component of endoplasmic reticulum membrane(GO:0031227) |
| 0.0 | 0.1 | GO:0070876 | SOSS complex(GO:0070876) |
| 0.0 | 0.3 | GO:0000118 | histone deacetylase complex(GO:0000118) |
| 0.0 | 0.1 | GO:0030478 | actin cap(GO:0030478) |
| 0.0 | 0.4 | GO:0005801 | cis-Golgi network(GO:0005801) |
| 0.0 | 0.1 | GO:0071144 | SMAD2-SMAD3 protein complex(GO:0071144) |
Gene overrepresentation in molecular_function category:
| Log-likelihood per target | Total log-likelihood | Term | Description |
|---|---|---|---|
| 6.4 | 19.3 | GO:0015140 | malate transmembrane transporter activity(GO:0015140) |
| 4.3 | 13.0 | GO:0008534 | oxidized purine nucleobase lesion DNA N-glycosylase activity(GO:0008534) |
| 3.6 | 10.8 | GO:0004489 | methylenetetrahydrofolate reductase (NAD(P)H) activity(GO:0004489) |
| 3.2 | 9.6 | GO:0004813 | alanine-tRNA ligase activity(GO:0004813) |
| 3.1 | 12.3 | GO:0061575 | cyclin-dependent protein serine/threonine kinase activator activity(GO:0061575) |
| 2.8 | 8.5 | GO:0008177 | succinate dehydrogenase (ubiquinone) activity(GO:0008177) |
| 2.8 | 11.2 | GO:0070740 | tubulin-glutamic acid ligase activity(GO:0070740) |
| 2.8 | 14.0 | GO:0004826 | phenylalanine-tRNA ligase activity(GO:0004826) |
| 2.6 | 7.9 | GO:0004647 | phosphoserine phosphatase activity(GO:0004647) |
| 2.6 | 7.7 | GO:0004994 | somatostatin receptor activity(GO:0004994) |
| 2.5 | 12.7 | GO:0005344 | oxygen transporter activity(GO:0005344) |
| 2.5 | 7.6 | GO:0030519 | snoRNP binding(GO:0030519) |
| 2.5 | 452.8 | GO:0003735 | structural constituent of ribosome(GO:0003735) |
| 2.4 | 9.7 | GO:0005093 | Rab GDP-dissociation inhibitor activity(GO:0005093) |
| 2.2 | 8.8 | GO:0044020 | histone methyltransferase activity (H4-R3 specific)(GO:0044020) |
| 2.2 | 6.5 | GO:0035575 | histone demethylase activity (H4-K20 specific)(GO:0035575) |
| 2.1 | 45.6 | GO:0004298 | threonine-type endopeptidase activity(GO:0004298) threonine-type peptidase activity(GO:0070003) |
| 2.1 | 12.4 | GO:0019784 | NEDD8-specific protease activity(GO:0019784) |
| 2.1 | 22.7 | GO:0050815 | phosphoserine binding(GO:0050815) |
| 2.0 | 10.2 | GO:0005134 | interleukin-2 receptor binding(GO:0005134) |
| 2.0 | 8.1 | GO:0048408 | epidermal growth factor binding(GO:0048408) |
| 2.0 | 8.1 | GO:0017050 | sphinganine kinase activity(GO:0008481) D-erythro-sphingosine kinase activity(GO:0017050) |
| 2.0 | 2.0 | GO:0005110 | frizzled-2 binding(GO:0005110) |
| 2.0 | 19.7 | GO:0004886 | 9-cis retinoic acid receptor activity(GO:0004886) |
| 1.9 | 11.3 | GO:0004852 | uroporphyrinogen-III synthase activity(GO:0004852) |
| 1.9 | 16.9 | GO:0000774 | adenyl-nucleotide exchange factor activity(GO:0000774) |
| 1.8 | 5.3 | GO:0004731 | purine-nucleoside phosphorylase activity(GO:0004731) |
| 1.7 | 5.1 | GO:0030629 | U6 snRNA 3'-end binding(GO:0030629) |
| 1.7 | 5.1 | GO:0000033 | alpha-1,3-mannosyltransferase activity(GO:0000033) |
| 1.7 | 10.1 | GO:0001069 | regulatory region RNA binding(GO:0001069) |
| 1.7 | 6.7 | GO:0003696 | satellite DNA binding(GO:0003696) |
| 1.7 | 5.0 | GO:0036004 | GAF domain binding(GO:0036004) |
| 1.7 | 23.1 | GO:0070742 | C2H2 zinc finger domain binding(GO:0070742) |
| 1.7 | 6.6 | GO:0016508 | long-chain-enoyl-CoA hydratase activity(GO:0016508) |
| 1.7 | 5.0 | GO:0004658 | propionyl-CoA carboxylase activity(GO:0004658) |
| 1.6 | 4.9 | GO:0004660 | protein farnesyltransferase activity(GO:0004660) |
| 1.6 | 8.1 | GO:0004719 | protein-L-isoaspartate (D-aspartate) O-methyltransferase activity(GO:0004719) |
| 1.6 | 4.8 | GO:0046624 | sphingolipid transporter activity(GO:0046624) |
| 1.6 | 9.5 | GO:0000298 | endopolyphosphatase activity(GO:0000298) diphosphoinositol-polyphosphate diphosphatase activity(GO:0008486) bis(5'-adenosyl)-hexaphosphatase activity(GO:0034431) bis(5'-adenosyl)-pentaphosphatase activity(GO:0034432) |
| 1.6 | 20.4 | GO:0070513 | death domain binding(GO:0070513) |
| 1.6 | 4.7 | GO:0000992 | polymerase III regulatory region sequence-specific DNA binding(GO:0000992) RNA polymerase III type 1 promoter sequence-specific DNA binding(GO:0001002) RNA polymerase III type 2 promoter sequence-specific DNA binding(GO:0001003) RNA polymerase III transcription factor activity, sequence-specific DNA binding(GO:0001034) |
| 1.5 | 6.2 | GO:0042806 | fucose binding(GO:0042806) |
| 1.5 | 4.6 | GO:0008330 | protein tyrosine/threonine phosphatase activity(GO:0008330) |
| 1.5 | 6.1 | GO:0004415 | hyalurononglucosaminidase activity(GO:0004415) |
| 1.5 | 6.1 | GO:0004045 | aminoacyl-tRNA hydrolase activity(GO:0004045) |
| 1.5 | 33.5 | GO:0004129 | cytochrome-c oxidase activity(GO:0004129) heme-copper terminal oxidase activity(GO:0015002) oxidoreductase activity, acting on a heme group of donors, oxygen as acceptor(GO:0016676) |
| 1.5 | 10.5 | GO:0005094 | Rho GDP-dissociation inhibitor activity(GO:0005094) |
| 1.5 | 6.0 | GO:0031800 | type 3 metabotropic glutamate receptor binding(GO:0031800) |
| 1.5 | 10.3 | GO:0036402 | proteasome-activating ATPase activity(GO:0036402) |
| 1.5 | 11.8 | GO:0008121 | ubiquinol-cytochrome-c reductase activity(GO:0008121) oxidoreductase activity, acting on diphenols and related substances as donors(GO:0016679) oxidoreductase activity, acting on diphenols and related substances as donors, cytochrome as acceptor(GO:0016681) |
| 1.5 | 5.9 | GO:0016833 | oxo-acid-lyase activity(GO:0016833) |
| 1.5 | 5.9 | GO:0008967 | phosphoglycolate phosphatase activity(GO:0008967) |
| 1.4 | 5.7 | GO:0004749 | ribose phosphate diphosphokinase activity(GO:0004749) |
| 1.4 | 10.0 | GO:0015288 | porin activity(GO:0015288) |
| 1.4 | 4.2 | GO:1990050 | phosphatidic acid transporter activity(GO:1990050) |
| 1.4 | 43.1 | GO:0003954 | NADH dehydrogenase activity(GO:0003954) |
| 1.4 | 12.5 | GO:1990446 | U1 snRNP binding(GO:1990446) |
| 1.4 | 4.1 | GO:0035174 | histone serine kinase activity(GO:0035174) |
| 1.4 | 4.1 | GO:0043533 | inositol 1,3,4,5 tetrakisphosphate binding(GO:0043533) |
| 1.4 | 65.4 | GO:0031492 | nucleosomal DNA binding(GO:0031492) |
| 1.4 | 4.1 | GO:0004140 | dephospho-CoA kinase activity(GO:0004140) |
| 1.4 | 1.4 | GO:0032454 | histone demethylase activity (H3-K9 specific)(GO:0032454) |
| 1.3 | 6.7 | GO:0004165 | dodecenoyl-CoA delta-isomerase activity(GO:0004165) |
| 1.3 | 1.3 | GO:0050693 | LBD domain binding(GO:0050693) |
| 1.3 | 13.2 | GO:0008474 | palmitoyl-(protein) hydrolase activity(GO:0008474) palmitoyl hydrolase activity(GO:0098599) |
| 1.3 | 22.3 | GO:0046933 | proton-transporting ATP synthase activity, rotational mechanism(GO:0046933) |
| 1.3 | 7.8 | GO:0035368 | selenocysteine insertion sequence binding(GO:0035368) |
| 1.3 | 10.4 | GO:1990715 | mRNA CDS binding(GO:1990715) |
| 1.2 | 6.2 | GO:0003857 | 3-hydroxyacyl-CoA dehydrogenase activity(GO:0003857) |
| 1.2 | 3.7 | GO:0070892 | lipoteichoic acid receptor activity(GO:0070892) |
| 1.2 | 4.9 | GO:0008073 | ornithine decarboxylase inhibitor activity(GO:0008073) |
| 1.2 | 3.7 | GO:0034437 | glycoprotein transporter activity(GO:0034437) |
| 1.2 | 4.8 | GO:0017077 | oxidative phosphorylation uncoupler activity(GO:0017077) |
| 1.2 | 6.0 | GO:0005052 | peroxisome matrix targeting signal-1 binding(GO:0005052) |
| 1.2 | 23.9 | GO:0001056 | RNA polymerase III activity(GO:0001056) |
| 1.2 | 3.5 | GO:0004774 | succinate-CoA ligase activity(GO:0004774) |
| 1.2 | 4.7 | GO:0000268 | peroxisome targeting sequence binding(GO:0000268) |
| 1.2 | 3.5 | GO:0004828 | serine-tRNA ligase activity(GO:0004828) |
| 1.2 | 4.7 | GO:0016971 | flavin-linked sulfhydryl oxidase activity(GO:0016971) |
| 1.2 | 3.5 | GO:0031685 | adenosine receptor binding(GO:0031685) |
| 1.2 | 4.7 | GO:0019136 | deoxynucleoside kinase activity(GO:0019136) |
| 1.2 | 12.7 | GO:0019992 | diacylglycerol binding(GO:0019992) |
| 1.2 | 2.3 | GO:1990829 | C-rich single-stranded DNA binding(GO:1990829) |
| 1.1 | 3.4 | GO:0004616 | phosphogluconate dehydrogenase (decarboxylating) activity(GO:0004616) |
| 1.1 | 4.6 | GO:0016842 | amidine-lyase activity(GO:0016842) |
| 1.1 | 5.7 | GO:0008097 | 5S rRNA binding(GO:0008097) |
| 1.1 | 3.4 | GO:0000253 | 3-keto sterol reductase activity(GO:0000253) |
| 1.1 | 4.4 | GO:0008802 | betaine-aldehyde dehydrogenase activity(GO:0008802) |
| 1.1 | 19.9 | GO:0055103 | ligase regulator activity(GO:0055103) |
| 1.1 | 4.4 | GO:2001069 | glycogen binding(GO:2001069) |
| 1.1 | 3.3 | GO:0004069 | L-aspartate:2-oxoglutarate aminotransferase activity(GO:0004069) |
| 1.1 | 1.1 | GO:0051538 | 3 iron, 4 sulfur cluster binding(GO:0051538) |
| 1.1 | 17.4 | GO:0008253 | 5'-nucleotidase activity(GO:0008253) |
| 1.1 | 4.3 | GO:0050833 | pyruvate transmembrane transporter activity(GO:0050833) |
| 1.0 | 15.7 | GO:0016805 | dipeptidase activity(GO:0016805) |
| 1.0 | 3.1 | GO:0016501 | prostacyclin receptor activity(GO:0016501) |
| 1.0 | 4.1 | GO:0003998 | acylphosphatase activity(GO:0003998) |
| 1.0 | 7.2 | GO:0015266 | protein channel activity(GO:0015266) |
| 1.0 | 14.4 | GO:0003688 | DNA replication origin binding(GO:0003688) |
| 1.0 | 3.0 | GO:0004743 | pyruvate kinase activity(GO:0004743) |
| 1.0 | 3.0 | GO:0036132 | 13-prostaglandin reductase activity(GO:0036132) 15-oxoprostaglandin 13-oxidase activity(GO:0047522) |
| 1.0 | 3.0 | GO:0004769 | steroid delta-isomerase activity(GO:0004769) |
| 1.0 | 4.0 | GO:1990460 | leptin receptor binding(GO:1990460) |
| 1.0 | 8.0 | GO:0001162 | RNA polymerase II intronic transcription regulatory region sequence-specific DNA binding(GO:0001162) |
| 1.0 | 5.0 | GO:0030621 | U4 snRNA binding(GO:0030621) |
| 1.0 | 7.9 | GO:0019788 | NEDD8 transferase activity(GO:0019788) |
| 1.0 | 3.0 | GO:0003996 | acyl-CoA ligase activity(GO:0003996) |
| 1.0 | 2.0 | GO:0032422 | purine-rich negative regulatory element binding(GO:0032422) |
| 1.0 | 3.0 | GO:0030549 | acetylcholine receptor activator activity(GO:0030549) |
| 1.0 | 2.0 | GO:0031752 | D5 dopamine receptor binding(GO:0031752) |
| 1.0 | 2.9 | GO:0003796 | lysozyme activity(GO:0003796) |
| 1.0 | 1.0 | GO:0044715 | 8-oxo-dGDP phosphatase activity(GO:0044715) |
| 1.0 | 11.5 | GO:0016783 | sulfurtransferase activity(GO:0016783) |
| 1.0 | 3.8 | GO:0003872 | 6-phosphofructokinase activity(GO:0003872) |
| 0.9 | 3.8 | GO:0071558 | histone demethylase activity (H3-K27 specific)(GO:0071558) |
| 0.9 | 3.8 | GO:0003844 | 1,4-alpha-glucan branching enzyme activity(GO:0003844) |
| 0.9 | 3.8 | GO:0015143 | urate transmembrane transporter activity(GO:0015143) salt transmembrane transporter activity(GO:1901702) |
| 0.9 | 3.7 | GO:0004735 | pyrroline-5-carboxylate reductase activity(GO:0004735) |
| 0.9 | 8.4 | GO:0043522 | leucine zipper domain binding(GO:0043522) |
| 0.9 | 5.6 | GO:0046912 | transferase activity, transferring acyl groups, acyl groups converted into alkyl on transfer(GO:0046912) |
| 0.9 | 25.1 | GO:0003785 | actin monomer binding(GO:0003785) |
| 0.9 | 2.8 | GO:0030337 | DNA polymerase processivity factor activity(GO:0030337) |
| 0.9 | 3.7 | GO:0008449 | N-acetylglucosamine-6-sulfatase activity(GO:0008449) |
| 0.9 | 11.1 | GO:0009931 | calcium-dependent protein serine/threonine kinase activity(GO:0009931) |
| 0.9 | 7.3 | GO:0016846 | carbon-sulfur lyase activity(GO:0016846) |
| 0.9 | 7.3 | GO:0004865 | protein serine/threonine phosphatase inhibitor activity(GO:0004865) |
| 0.9 | 2.7 | GO:0016880 | acid-ammonia (or amide) ligase activity(GO:0016880) |
| 0.9 | 11.8 | GO:0031386 | protein tag(GO:0031386) |
| 0.9 | 1.8 | GO:0051575 | 5'-deoxyribose-5-phosphate lyase activity(GO:0051575) |
| 0.9 | 1.8 | GO:0071532 | ankyrin repeat binding(GO:0071532) |
| 0.9 | 3.5 | GO:0004921 | interleukin-11 receptor activity(GO:0004921) interleukin-11 binding(GO:0019970) |
| 0.9 | 7.9 | GO:0043023 | ribosomal large subunit binding(GO:0043023) |
| 0.9 | 4.3 | GO:0008494 | translation activator activity(GO:0008494) |
| 0.9 | 2.6 | GO:0010698 | acetyltransferase activator activity(GO:0010698) |
| 0.9 | 13.6 | GO:0003680 | AT DNA binding(GO:0003680) |
| 0.8 | 3.3 | GO:0045131 | pre-mRNA branch point binding(GO:0045131) |
| 0.8 | 2.5 | GO:0043199 | sulfate binding(GO:0043199) |
| 0.8 | 5.8 | GO:0005047 | signal recognition particle binding(GO:0005047) |
| 0.8 | 2.5 | GO:0030368 | interleukin-17 receptor activity(GO:0030368) |
| 0.8 | 4.9 | GO:0001972 | retinoic acid binding(GO:0001972) |
| 0.8 | 2.5 | GO:0004335 | galactokinase activity(GO:0004335) |
| 0.8 | 17.1 | GO:0044769 | ATPase activity, coupled to transmembrane movement of ions, rotational mechanism(GO:0044769) proton-transporting ATPase activity, rotational mechanism(GO:0046961) |
| 0.8 | 4.0 | GO:0046974 | histone methyltransferase activity (H3-K9 specific)(GO:0046974) |
| 0.8 | 4.8 | GO:0070883 | pre-miRNA binding(GO:0070883) |
| 0.8 | 2.4 | GO:0004449 | isocitrate dehydrogenase (NAD+) activity(GO:0004449) |
| 0.8 | 4.0 | GO:0015129 | lactate transmembrane transporter activity(GO:0015129) |
| 0.8 | 0.8 | GO:0033677 | DNA/RNA helicase activity(GO:0033677) |
| 0.8 | 3.1 | GO:0036435 | K48-linked polyubiquitin binding(GO:0036435) |
| 0.8 | 3.8 | GO:0017070 | U6 snRNA binding(GO:0017070) |
| 0.8 | 2.3 | GO:0031779 | melanocortin receptor binding(GO:0031779) type 3 melanocortin receptor binding(GO:0031781) type 4 melanocortin receptor binding(GO:0031782) |
| 0.8 | 0.8 | GO:0002060 | purine nucleobase binding(GO:0002060) |
| 0.8 | 3.8 | GO:0001165 | RNA polymerase I upstream control element sequence-specific DNA binding(GO:0001165) |
| 0.7 | 14.7 | GO:0004550 | nucleoside diphosphate kinase activity(GO:0004550) |
| 0.7 | 2.2 | GO:0008113 | peptide-methionine (S)-S-oxide reductase activity(GO:0008113) |
| 0.7 | 13.9 | GO:0048027 | mRNA 5'-UTR binding(GO:0048027) |
| 0.7 | 2.9 | GO:0001851 | complement component C3b binding(GO:0001851) |
| 0.7 | 2.9 | GO:0016708 | nitric oxide dioxygenase activity(GO:0008941) oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, NAD(P)H as one donor, and incorporation of two atoms of oxygen into one donor(GO:0016708) iron-cytochrome-c reductase activity(GO:0047726) |
| 0.7 | 3.6 | GO:0004849 | uridine kinase activity(GO:0004849) |
| 0.7 | 0.7 | GO:0005087 | Ran guanyl-nucleotide exchange factor activity(GO:0005087) |
| 0.7 | 1.4 | GO:0034739 | histone deacetylase activity (H4-K16 specific)(GO:0034739) |
| 0.7 | 4.9 | GO:0004614 | phosphoglucomutase activity(GO:0004614) |
| 0.7 | 3.5 | GO:0019828 | aspartic-type endopeptidase inhibitor activity(GO:0019828) |
| 0.7 | 7.7 | GO:0030306 | ADP-ribosylation factor binding(GO:0030306) |
| 0.7 | 3.5 | GO:1990188 | euchromatin binding(GO:1990188) |
| 0.7 | 19.6 | GO:0019843 | rRNA binding(GO:0019843) |
| 0.7 | 2.1 | GO:0000700 | mismatch base pair DNA N-glycosylase activity(GO:0000700) |
| 0.7 | 2.8 | GO:0050220 | prostaglandin-E synthase activity(GO:0050220) |
| 0.7 | 8.9 | GO:0030169 | low-density lipoprotein particle binding(GO:0030169) |
| 0.7 | 11.0 | GO:1990226 | histone methyltransferase binding(GO:1990226) |
| 0.7 | 3.4 | GO:0004839 | ubiquitin activating enzyme activity(GO:0004839) |
| 0.7 | 2.0 | GO:0046538 | bisphosphoglycerate mutase activity(GO:0004082) phosphoglycerate mutase activity(GO:0004619) 2,3-bisphosphoglycerate-dependent phosphoglycerate mutase activity(GO:0046538) |
| 0.7 | 3.3 | GO:0042610 | CD8 receptor binding(GO:0042610) |
| 0.7 | 5.3 | GO:0086008 | voltage-gated potassium channel activity involved in cardiac muscle cell action potential repolarization(GO:0086008) |
| 0.7 | 2.0 | GO:0018738 | S-formylglutathione hydrolase activity(GO:0018738) |
| 0.7 | 5.3 | GO:0042500 | aspartic endopeptidase activity, intramembrane cleaving(GO:0042500) |
| 0.6 | 14.3 | GO:0003746 | translation elongation factor activity(GO:0003746) |
| 0.6 | 5.2 | GO:0047429 | nucleoside-triphosphate diphosphatase activity(GO:0047429) |
| 0.6 | 3.2 | GO:0004724 | magnesium-dependent protein serine/threonine phosphatase activity(GO:0004724) |
| 0.6 | 3.9 | GO:0003923 | GPI-anchor transamidase activity(GO:0003923) |
| 0.6 | 1.9 | GO:0001591 | dopamine neurotransmitter receptor activity, coupled via Gi/Go(GO:0001591) |
| 0.6 | 4.5 | GO:0030957 | Tat protein binding(GO:0030957) |
| 0.6 | 15.2 | GO:0051537 | 2 iron, 2 sulfur cluster binding(GO:0051537) |
| 0.6 | 3.8 | GO:0015234 | thiamine transmembrane transporter activity(GO:0015234) |
| 0.6 | 3.8 | GO:0016453 | acetyl-CoA C-acetyltransferase activity(GO:0003985) C-acetyltransferase activity(GO:0016453) |
| 0.6 | 1.3 | GO:0000702 | oxidized base lesion DNA N-glycosylase activity(GO:0000702) |
| 0.6 | 1.9 | GO:0004758 | serine C-palmitoyltransferase activity(GO:0004758) C-palmitoyltransferase activity(GO:0016454) |
| 0.6 | 4.4 | GO:0016714 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced pteridine as one donor, and incorporation of one atom of oxygen(GO:0016714) |
| 0.6 | 1.2 | GO:0043139 | 5'-3' DNA helicase activity(GO:0043139) |
| 0.6 | 3.1 | GO:0070815 | peptidyl-lysine 5-dioxygenase activity(GO:0070815) |
| 0.6 | 2.5 | GO:1902379 | chemoattractant activity involved in axon guidance(GO:1902379) |
| 0.6 | 1.8 | GO:0004126 | cytidine deaminase activity(GO:0004126) |
| 0.6 | 2.5 | GO:0004897 | ciliary neurotrophic factor receptor activity(GO:0004897) |
| 0.6 | 2.4 | GO:0035242 | histone-arginine N-methyltransferase activity(GO:0008469) protein-arginine omega-N asymmetric methyltransferase activity(GO:0035242) |
| 0.6 | 0.6 | GO:0034511 | U3 snoRNA binding(GO:0034511) |
| 0.6 | 6.5 | GO:0016861 | intramolecular oxidoreductase activity, interconverting aldoses and ketoses(GO:0016861) |
| 0.6 | 13.5 | GO:0097602 | cullin family protein binding(GO:0097602) |
| 0.6 | 15.2 | GO:0051183 | vitamin transporter activity(GO:0051183) |
| 0.6 | 9.9 | GO:0071855 | neuropeptide receptor binding(GO:0071855) |
| 0.6 | 2.3 | GO:0036468 | aromatic-L-amino-acid decarboxylase activity(GO:0004058) L-dopa decarboxylase activity(GO:0036468) |
| 0.6 | 3.5 | GO:0070182 | DNA polymerase binding(GO:0070182) |
| 0.6 | 1.7 | GO:0008158 | hedgehog receptor activity(GO:0008158) |
| 0.6 | 2.3 | GO:0035473 | lipase binding(GO:0035473) |
| 0.6 | 6.3 | GO:0004526 | ribonuclease P activity(GO:0004526) |
| 0.6 | 4.0 | GO:0030274 | LIM domain binding(GO:0030274) |
| 0.6 | 0.6 | GO:0005280 | hydrogen:amino acid symporter activity(GO:0005280) |
| 0.6 | 1.1 | GO:0010385 | double-stranded methylated DNA binding(GO:0010385) |
| 0.6 | 0.6 | GO:0016715 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced ascorbate as one donor, and incorporation of one atom of oxygen(GO:0016715) |
| 0.6 | 6.1 | GO:0016624 | oxidoreductase activity, acting on the aldehyde or oxo group of donors, disulfide as acceptor(GO:0016624) |
| 0.6 | 5.5 | GO:0004185 | serine-type carboxypeptidase activity(GO:0004185) |
| 0.5 | 1.6 | GO:0008515 | sucrose:proton symporter activity(GO:0008506) sucrose transmembrane transporter activity(GO:0008515) disaccharide transmembrane transporter activity(GO:0015154) oligosaccharide transmembrane transporter activity(GO:0015157) |
| 0.5 | 2.2 | GO:0000099 | sulfur amino acid transmembrane transporter activity(GO:0000099) |
| 0.5 | 5.5 | GO:0015035 | protein disulfide oxidoreductase activity(GO:0015035) |
| 0.5 | 1.6 | GO:0043008 | ATP-dependent protein binding(GO:0043008) |
| 0.5 | 3.8 | GO:0008242 | omega peptidase activity(GO:0008242) |
| 0.5 | 2.2 | GO:0001161 | intronic transcription regulatory region sequence-specific DNA binding(GO:0001161) |
| 0.5 | 3.8 | GO:0004523 | RNA-DNA hybrid ribonuclease activity(GO:0004523) |
| 0.5 | 11.8 | GO:0004602 | glutathione peroxidase activity(GO:0004602) |
| 0.5 | 1.6 | GO:0010861 | thyroid hormone receptor activator activity(GO:0010861) |
| 0.5 | 2.1 | GO:0070891 | peptidoglycan binding(GO:0042834) lipoteichoic acid binding(GO:0070891) |
| 0.5 | 1.6 | GO:0003692 | left-handed Z-DNA binding(GO:0003692) |
| 0.5 | 3.2 | GO:0003910 | DNA ligase activity(GO:0003909) DNA ligase (ATP) activity(GO:0003910) |
| 0.5 | 1.6 | GO:0000402 | open form four-way junction DNA binding(GO:0000401) crossed form four-way junction DNA binding(GO:0000402) |
| 0.5 | 14.2 | GO:0005385 | zinc ion transmembrane transporter activity(GO:0005385) |
| 0.5 | 12.5 | GO:0003899 | DNA-directed RNA polymerase activity(GO:0003899) |
| 0.5 | 5.7 | GO:0003689 | DNA clamp loader activity(GO:0003689) protein-DNA loading ATPase activity(GO:0033170) |
| 0.5 | 6.7 | GO:0051861 | glycolipid binding(GO:0051861) |
| 0.5 | 3.1 | GO:0008467 | [heparan sulfate]-glucosamine 3-sulfotransferase 1 activity(GO:0008467) |
| 0.5 | 4.6 | GO:0008420 | CTD phosphatase activity(GO:0008420) |
| 0.5 | 2.0 | GO:0008309 | double-stranded DNA exodeoxyribonuclease activity(GO:0008309) |
| 0.5 | 3.6 | GO:0097322 | 7SK snRNA binding(GO:0097322) |
| 0.5 | 1.0 | GO:0004096 | catalase activity(GO:0004096) |
| 0.5 | 2.5 | GO:0047134 | protein-disulfide reductase activity(GO:0047134) |
| 0.5 | 3.0 | GO:0008479 | queuine tRNA-ribosyltransferase activity(GO:0008479) |
| 0.5 | 2.0 | GO:0004322 | ferroxidase activity(GO:0004322) oxidoreductase activity, oxidizing metal ions, oxygen as acceptor(GO:0016724) |
| 0.5 | 2.5 | GO:0072542 | protein phosphatase activator activity(GO:0072542) |
| 0.5 | 1.5 | GO:0004667 | prostaglandin-D synthase activity(GO:0004667) |
| 0.5 | 2.0 | GO:0004784 | superoxide dismutase activity(GO:0004784) oxidoreductase activity, acting on superoxide radicals as acceptor(GO:0016721) |
| 0.5 | 3.5 | GO:0051184 | cofactor transporter activity(GO:0051184) |
| 0.5 | 2.0 | GO:0008853 | exodeoxyribonuclease III activity(GO:0008853) |
| 0.5 | 3.4 | GO:0019871 | sodium channel inhibitor activity(GO:0019871) |
| 0.5 | 1.5 | GO:0022865 | transmembrane electron transfer carrier(GO:0022865) |
| 0.5 | 9.2 | GO:0001158 | enhancer sequence-specific DNA binding(GO:0001158) |
| 0.5 | 1.0 | GO:0046403 | polynucleotide 3'-phosphatase activity(GO:0046403) |
| 0.5 | 4.3 | GO:0005338 | nucleotide-sugar transmembrane transporter activity(GO:0005338) |
| 0.5 | 2.9 | GO:0043426 | MRF binding(GO:0043426) |
| 0.5 | 1.9 | GO:0004706 | JUN kinase kinase kinase activity(GO:0004706) |
| 0.5 | 1.9 | GO:0004525 | ribonuclease III activity(GO:0004525) double-stranded RNA-specific ribonuclease activity(GO:0032296) |
| 0.5 | 38.0 | GO:0005200 | structural constituent of cytoskeleton(GO:0005200) |
| 0.5 | 3.8 | GO:0061133 | endopeptidase activator activity(GO:0061133) |
| 0.5 | 10.8 | GO:0042813 | Wnt-activated receptor activity(GO:0042813) |
| 0.5 | 3.7 | GO:0008641 | small protein activating enzyme activity(GO:0008641) |
| 0.5 | 10.2 | GO:0017049 | GTP-Rho binding(GO:0017049) |
| 0.5 | 0.9 | GO:0070053 | thrombospondin receptor activity(GO:0070053) |
| 0.5 | 7.7 | GO:0070628 | proteasome binding(GO:0070628) |
| 0.5 | 1.4 | GO:0004448 | isocitrate dehydrogenase activity(GO:0004448) |
| 0.4 | 3.6 | GO:0000339 | RNA cap binding(GO:0000339) |
| 0.4 | 2.2 | GO:0050265 | RNA uridylyltransferase activity(GO:0050265) |
| 0.4 | 0.9 | GO:0008312 | 7S RNA binding(GO:0008312) |
| 0.4 | 7.1 | GO:0005078 | MAP-kinase scaffold activity(GO:0005078) |
| 0.4 | 7.5 | GO:0008327 | methyl-CpG binding(GO:0008327) |
| 0.4 | 1.8 | GO:0004427 | inorganic diphosphatase activity(GO:0004427) |
| 0.4 | 1.3 | GO:0047751 | 3-oxo-5-alpha-steroid 4-dehydrogenase activity(GO:0003865) steroid dehydrogenase activity, acting on the CH-CH group of donors(GO:0033765) enone reductase activity(GO:0035671) cholestenone 5-alpha-reductase activity(GO:0047751) |
| 0.4 | 1.7 | GO:0031893 | vasopressin receptor binding(GO:0031893) |
| 0.4 | 2.6 | GO:0047631 | ADP-ribose diphosphatase activity(GO:0047631) |
| 0.4 | 4.3 | GO:0035198 | miRNA binding(GO:0035198) |
| 0.4 | 1.7 | GO:0000832 | inositol hexakisphosphate kinase activity(GO:0000828) inositol hexakisphosphate 5-kinase activity(GO:0000832) inositol hexakisphosphate 1-kinase activity(GO:0052723) inositol hexakisphosphate 3-kinase activity(GO:0052724) |
| 0.4 | 0.4 | GO:0043682 | copper-exporting ATPase activity(GO:0004008) copper-transporting ATPase activity(GO:0043682) |
| 0.4 | 2.1 | GO:0043734 | DNA-N1-methyladenine dioxygenase activity(GO:0043734) |
| 0.4 | 2.5 | GO:0045322 | unmethylated CpG binding(GO:0045322) |
| 0.4 | 13.4 | GO:0043425 | bHLH transcription factor binding(GO:0043425) |
| 0.4 | 0.8 | GO:0032356 | oxidized DNA binding(GO:0032356) |
| 0.4 | 2.1 | GO:0097493 | structural molecule activity conferring elasticity(GO:0097493) |
| 0.4 | 2.5 | GO:0016813 | hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in linear amidines(GO:0016813) |
| 0.4 | 0.8 | GO:0031493 | nucleosomal histone binding(GO:0031493) |
| 0.4 | 2.1 | GO:1990190 | peptide-glutamate-N-acetyltransferase activity(GO:1990190) |
| 0.4 | 28.3 | GO:0000980 | RNA polymerase II distal enhancer sequence-specific DNA binding(GO:0000980) |
| 0.4 | 7.0 | GO:0015605 | organophosphate ester transmembrane transporter activity(GO:0015605) |
| 0.4 | 1.2 | GO:0004487 | methylenetetrahydrofolate dehydrogenase (NAD+) activity(GO:0004487) |
| 0.4 | 5.7 | GO:0071837 | HMG box domain binding(GO:0071837) |
| 0.4 | 4.0 | GO:0000983 | transcription factor activity, RNA polymerase II core promoter sequence-specific(GO:0000983) |
| 0.4 | 1.2 | GO:0044213 | intronic transcription regulatory region DNA binding(GO:0044213) |
| 0.4 | 1.6 | GO:0004392 | heme oxygenase (decyclizing) activity(GO:0004392) |
| 0.4 | 2.0 | GO:0003945 | N-acetyllactosamine synthase activity(GO:0003945) |
| 0.4 | 2.4 | GO:0050544 | arachidonic acid binding(GO:0050544) |
| 0.4 | 0.4 | GO:0009041 | uridylate kinase activity(GO:0009041) |
| 0.4 | 1.6 | GO:0004345 | glucose-6-phosphate dehydrogenase activity(GO:0004345) |
| 0.4 | 5.1 | GO:0015174 | basic amino acid transmembrane transporter activity(GO:0015174) |
| 0.4 | 2.7 | GO:0001163 | RNA polymerase I regulatory region sequence-specific DNA binding(GO:0001163) RNA polymerase I CORE element sequence-specific DNA binding(GO:0001164) |
| 0.4 | 1.6 | GO:0097003 | adiponectin binding(GO:0055100) adipokinetic hormone receptor activity(GO:0097003) |
| 0.4 | 23.7 | GO:0003743 | translation initiation factor activity(GO:0003743) |
| 0.4 | 1.5 | GO:0004092 | carnitine O-acetyltransferase activity(GO:0004092) |
| 0.4 | 14.3 | GO:0042162 | telomeric DNA binding(GO:0042162) |
| 0.4 | 4.6 | GO:0015926 | glucosidase activity(GO:0015926) |
| 0.4 | 3.4 | GO:0004416 | hydroxyacylglutathione hydrolase activity(GO:0004416) |
| 0.4 | 1.5 | GO:0046923 | ER retention sequence binding(GO:0046923) |
| 0.4 | 0.7 | GO:0046978 | TAP1 binding(GO:0046978) TAP2 binding(GO:0046979) |
| 0.4 | 13.2 | GO:0044390 | ubiquitin-like protein conjugating enzyme binding(GO:0044390) |
| 0.4 | 0.7 | GO:0017166 | vinculin binding(GO:0017166) |
| 0.4 | 5.1 | GO:0031698 | beta-2 adrenergic receptor binding(GO:0031698) |
| 0.4 | 1.4 | GO:0003810 | protein-glutamine gamma-glutamyltransferase activity(GO:0003810) |
| 0.4 | 20.8 | GO:0000979 | RNA polymerase II core promoter sequence-specific DNA binding(GO:0000979) |
| 0.4 | 8.6 | GO:0017025 | TBP-class protein binding(GO:0017025) |
| 0.4 | 2.1 | GO:0050072 | m7G(5')pppN diphosphatase activity(GO:0050072) |
| 0.4 | 2.8 | GO:0008821 | crossover junction endodeoxyribonuclease activity(GO:0008821) |
| 0.4 | 1.1 | GO:0030160 | GKAP/Homer scaffold activity(GO:0030160) |
| 0.4 | 1.4 | GO:0003976 | UDP-N-acetylglucosamine-lysosomal-enzyme N-acetylglucosaminephosphotransferase activity(GO:0003976) |
| 0.4 | 6.4 | GO:0050321 | tau-protein kinase activity(GO:0050321) |
| 0.4 | 1.1 | GO:0070095 | fructose-6-phosphate binding(GO:0070095) |
| 0.3 | 1.7 | GO:0004382 | guanosine-diphosphatase activity(GO:0004382) |
| 0.3 | 3.1 | GO:0015037 | peptide disulfide oxidoreductase activity(GO:0015037) |
| 0.3 | 2.1 | GO:0015277 | kainate selective glutamate receptor activity(GO:0015277) |
| 0.3 | 13.8 | GO:0008536 | Ran GTPase binding(GO:0008536) |
| 0.3 | 2.1 | GO:0017040 | ceramidase activity(GO:0017040) |
| 0.3 | 1.7 | GO:0004301 | epoxide hydrolase activity(GO:0004301) |
| 0.3 | 5.3 | GO:0070888 | E-box binding(GO:0070888) |
| 0.3 | 1.0 | GO:0016748 | succinyltransferase activity(GO:0016748) |
| 0.3 | 3.3 | GO:0008379 | thioredoxin peroxidase activity(GO:0008379) |
| 0.3 | 3.3 | GO:0097371 | MDM2/MDM4 family protein binding(GO:0097371) |
| 0.3 | 1.3 | GO:0004814 | arginine-tRNA ligase activity(GO:0004814) |
| 0.3 | 4.9 | GO:0008519 | ammonium transmembrane transporter activity(GO:0008519) |
| 0.3 | 2.3 | GO:0051400 | BH domain binding(GO:0051400) |
| 0.3 | 12.0 | GO:0001965 | G-protein alpha-subunit binding(GO:0001965) |
| 0.3 | 1.6 | GO:0051920 | peroxiredoxin activity(GO:0051920) |
| 0.3 | 1.0 | GO:0004699 | calcium-independent protein kinase C activity(GO:0004699) |
| 0.3 | 2.3 | GO:0048273 | mitogen-activated protein kinase p38 binding(GO:0048273) |
| 0.3 | 0.6 | GO:0030151 | molybdenum ion binding(GO:0030151) |
| 0.3 | 4.8 | GO:0016290 | palmitoyl-CoA hydrolase activity(GO:0016290) |
| 0.3 | 4.4 | GO:0017154 | semaphorin receptor activity(GO:0017154) |
| 0.3 | 0.9 | GO:0008176 | tRNA (guanine-N7-)-methyltransferase activity(GO:0008176) |
| 0.3 | 1.3 | GO:0004032 | alditol:NADP+ 1-oxidoreductase activity(GO:0004032) |
| 0.3 | 2.8 | GO:0005168 | neurotrophin TRKA receptor binding(GO:0005168) |
| 0.3 | 1.9 | GO:0004521 | endoribonuclease activity(GO:0004521) |
| 0.3 | 3.4 | GO:0070403 | NAD+ binding(GO:0070403) |
| 0.3 | 1.5 | GO:0016655 | oxidoreductase activity, acting on NAD(P)H, quinone or similar compound as acceptor(GO:0016655) |
| 0.3 | 0.9 | GO:0015183 | L-aspartate transmembrane transporter activity(GO:0015183) |
| 0.3 | 1.2 | GO:0030984 | kininogen binding(GO:0030984) |
| 0.3 | 1.5 | GO:0051425 | PTB domain binding(GO:0051425) |
| 0.3 | 1.2 | GO:0004740 | pyruvate dehydrogenase (acetyl-transferring) kinase activity(GO:0004740) |
| 0.3 | 3.3 | GO:0031996 | thioesterase binding(GO:0031996) |
| 0.3 | 0.3 | GO:1903135 | cupric ion binding(GO:1903135) |
| 0.3 | 3.3 | GO:0004622 | lysophospholipase activity(GO:0004622) |
| 0.3 | 0.3 | GO:0035651 | AP-3 adaptor complex binding(GO:0035651) |
| 0.3 | 0.9 | GO:0042284 | sphingolipid delta-4 desaturase activity(GO:0042284) |
| 0.3 | 2.4 | GO:0004767 | sphingomyelin phosphodiesterase activity(GO:0004767) |
| 0.3 | 2.6 | GO:0004445 | inositol-polyphosphate 5-phosphatase activity(GO:0004445) inositol trisphosphate phosphatase activity(GO:0046030) |
| 0.3 | 3.8 | GO:0015197 | peptide transporter activity(GO:0015197) |
| 0.3 | 0.6 | GO:0016868 | intramolecular transferase activity, phosphotransferases(GO:0016868) |
| 0.3 | 4.9 | GO:0004707 | MAP kinase activity(GO:0004707) |
| 0.3 | 8.7 | GO:0044183 | protein binding involved in protein folding(GO:0044183) |
| 0.3 | 0.6 | GO:0004887 | thyroid hormone receptor activity(GO:0004887) |
| 0.3 | 0.9 | GO:0031434 | mitogen-activated protein kinase kinase binding(GO:0031434) |
| 0.3 | 1.4 | GO:0003917 | DNA topoisomerase type I activity(GO:0003917) |
| 0.3 | 0.3 | GO:0035240 | dopamine binding(GO:0035240) |
| 0.3 | 0.8 | GO:0086077 | gap junction channel activity involved in AV node cell-bundle of His cell electrical coupling(GO:0086077) |
| 0.3 | 1.1 | GO:0004169 | dolichyl-phosphate-mannose-protein mannosyltransferase activity(GO:0004169) |
| 0.3 | 0.3 | GO:0097677 | STAT family protein binding(GO:0097677) |
| 0.3 | 0.6 | GO:0017108 | 5'-flap endonuclease activity(GO:0017108) |
| 0.3 | 1.4 | GO:0004128 | cytochrome-b5 reductase activity, acting on NAD(P)H(GO:0004128) |
| 0.3 | 2.0 | GO:0031748 | D1 dopamine receptor binding(GO:0031748) |
| 0.3 | 1.1 | GO:0001640 | adenylate cyclase inhibiting G-protein coupled glutamate receptor activity(GO:0001640) |
| 0.3 | 5.8 | GO:0003841 | 1-acylglycerol-3-phosphate O-acyltransferase activity(GO:0003841) |
| 0.3 | 3.1 | GO:0004861 | cyclin-dependent protein serine/threonine kinase inhibitor activity(GO:0004861) |
| 0.3 | 1.9 | GO:0015016 | [heparan sulfate]-glucosamine N-sulfotransferase activity(GO:0015016) |
| 0.3 | 3.6 | GO:0022889 | L-serine transmembrane transporter activity(GO:0015194) serine transmembrane transporter activity(GO:0022889) |
| 0.3 | 3.3 | GO:0032050 | clathrin heavy chain binding(GO:0032050) |
| 0.3 | 0.8 | GO:0015036 | disulfide oxidoreductase activity(GO:0015036) |
| 0.3 | 2.7 | GO:0050733 | RS domain binding(GO:0050733) |
| 0.3 | 3.0 | GO:0070679 | inositol 1,4,5 trisphosphate binding(GO:0070679) |
| 0.3 | 0.8 | GO:0043532 | angiostatin binding(GO:0043532) |
| 0.3 | 9.7 | GO:0019212 | phosphatase inhibitor activity(GO:0019212) |
| 0.3 | 0.8 | GO:0051428 | peptide hormone receptor binding(GO:0051428) |
| 0.3 | 1.1 | GO:0008190 | eukaryotic initiation factor 4E binding(GO:0008190) |
| 0.3 | 6.2 | GO:0031491 | nucleosome binding(GO:0031491) |
| 0.3 | 1.3 | GO:0031995 | insulin-like growth factor II binding(GO:0031995) |
| 0.3 | 4.8 | GO:0004653 | polypeptide N-acetylgalactosaminyltransferase activity(GO:0004653) |
| 0.3 | 0.8 | GO:0030976 | thiamine pyrophosphate binding(GO:0030976) |
| 0.3 | 2.9 | GO:0030346 | protein phosphatase 2B binding(GO:0030346) |
| 0.3 | 1.0 | GO:0005021 | vascular endothelial growth factor-activated receptor activity(GO:0005021) |
| 0.3 | 1.0 | GO:0030275 | LRR domain binding(GO:0030275) |
| 0.3 | 3.6 | GO:0031701 | angiotensin receptor binding(GO:0031701) |
| 0.3 | 9.1 | GO:0016876 | aminoacyl-tRNA ligase activity(GO:0004812) ligase activity, forming carbon-oxygen bonds(GO:0016875) ligase activity, forming aminoacyl-tRNA and related compounds(GO:0016876) |
| 0.3 | 1.6 | GO:0016300 | tRNA (uracil) methyltransferase activity(GO:0016300) |
| 0.3 | 4.1 | GO:0008483 | transaminase activity(GO:0008483) |
| 0.3 | 2.1 | GO:0005243 | gap junction channel activity(GO:0005243) wide pore channel activity(GO:0022829) |
| 0.3 | 12.0 | GO:0004722 | protein serine/threonine phosphatase activity(GO:0004722) |
| 0.3 | 10.1 | GO:0048487 | beta-tubulin binding(GO:0048487) |
| 0.3 | 0.8 | GO:0030226 | apolipoprotein receptor activity(GO:0030226) apolipoprotein A-I receptor activity(GO:0034188) phosphatidylserine-translocating ATPase activity(GO:0090556) |
| 0.2 | 0.7 | GO:0019776 | Atg8 ligase activity(GO:0019776) |
| 0.2 | 1.5 | GO:0005520 | insulin-like growth factor binding(GO:0005520) |
| 0.2 | 3.7 | GO:0004180 | carboxypeptidase activity(GO:0004180) |
| 0.2 | 1.5 | GO:1904264 | ubiquitin protein ligase activity involved in ERAD pathway(GO:1904264) |
| 0.2 | 1.0 | GO:0033743 | peptide-methionine (R)-S-oxide reductase activity(GO:0033743) |
| 0.2 | 0.2 | GO:0034714 | type III transforming growth factor beta receptor binding(GO:0034714) |
| 0.2 | 5.3 | GO:0030374 | ligand-dependent nuclear receptor transcription coactivator activity(GO:0030374) |
| 0.2 | 0.9 | GO:0019213 | deacetylase activity(GO:0019213) |
| 0.2 | 0.7 | GO:0016405 | CoA-ligase activity(GO:0016405) |
| 0.2 | 2.1 | GO:0038062 | protein tyrosine kinase collagen receptor activity(GO:0038062) |
| 0.2 | 10.3 | GO:0061631 | ubiquitin conjugating enzyme activity(GO:0061631) ubiquitin-like protein conjugating enzyme activity(GO:0061650) |
| 0.2 | 1.4 | GO:0031730 | CCR5 chemokine receptor binding(GO:0031730) |
| 0.2 | 0.7 | GO:0047179 | platelet-activating factor acetyltransferase activity(GO:0047179) |
| 0.2 | 2.3 | GO:0015245 | fatty acid transporter activity(GO:0015245) |
| 0.2 | 5.8 | GO:0015078 | hydrogen ion transmembrane transporter activity(GO:0015078) |
| 0.2 | 0.7 | GO:0003963 | RNA-3'-phosphate cyclase activity(GO:0003963) |
| 0.2 | 0.9 | GO:0004645 | phosphorylase activity(GO:0004645) |
| 0.2 | 1.6 | GO:0015187 | glycine transmembrane transporter activity(GO:0015187) |
| 0.2 | 1.6 | GO:0047499 | calcium-independent phospholipase A2 activity(GO:0047499) |
| 0.2 | 1.1 | GO:0000403 | Y-form DNA binding(GO:0000403) |
| 0.2 | 2.7 | GO:0031418 | L-ascorbic acid binding(GO:0031418) |
| 0.2 | 2.0 | GO:0019215 | intermediate filament binding(GO:0019215) |
| 0.2 | 0.7 | GO:0001758 | retinal dehydrogenase activity(GO:0001758) |
| 0.2 | 0.7 | GO:0032137 | guanine/thymine mispair binding(GO:0032137) |
| 0.2 | 1.8 | GO:0048403 | brain-derived neurotrophic factor binding(GO:0048403) |
| 0.2 | 2.7 | GO:0017017 | MAP kinase tyrosine/serine/threonine phosphatase activity(GO:0017017) |
| 0.2 | 0.7 | GO:0009881 | photoreceptor activity(GO:0009881) |
| 0.2 | 12.4 | GO:0019003 | GDP binding(GO:0019003) |
| 0.2 | 3.7 | GO:0005351 | sugar:proton symporter activity(GO:0005351) |
| 0.2 | 3.7 | GO:0003995 | acyl-CoA dehydrogenase activity(GO:0003995) |
| 0.2 | 1.3 | GO:0070016 | armadillo repeat domain binding(GO:0070016) |
| 0.2 | 2.1 | GO:0009055 | electron carrier activity(GO:0009055) |
| 0.2 | 0.8 | GO:0050347 | trans-hexaprenyltranstransferase activity(GO:0000010) trans-octaprenyltranstransferase activity(GO:0050347) |
| 0.2 | 0.2 | GO:0004145 | diamine N-acetyltransferase activity(GO:0004145) |
| 0.2 | 0.8 | GO:0019808 | polyamine binding(GO:0019808) |
| 0.2 | 9.0 | GO:0004693 | cyclin-dependent protein serine/threonine kinase activity(GO:0004693) |
| 0.2 | 0.6 | GO:0035650 | AP-1 adaptor complex binding(GO:0035650) |
| 0.2 | 2.5 | GO:0005314 | high-affinity glutamate transmembrane transporter activity(GO:0005314) |
| 0.2 | 1.2 | GO:0004726 | non-membrane spanning protein tyrosine phosphatase activity(GO:0004726) |
| 0.2 | 1.0 | GO:0019770 | IgG receptor activity(GO:0019770) |
| 0.2 | 1.2 | GO:0004965 | G-protein coupled GABA receptor activity(GO:0004965) |
| 0.2 | 0.6 | GO:0030983 | mismatched DNA binding(GO:0030983) |
| 0.2 | 3.3 | GO:0001103 | RNA polymerase II repressing transcription factor binding(GO:0001103) |
| 0.2 | 5.5 | GO:0019239 | deaminase activity(GO:0019239) |
| 0.2 | 1.0 | GO:0061731 | ribonucleoside-diphosphate reductase activity, thioredoxin disulfide as acceptor(GO:0004748) oxidoreductase activity, acting on CH or CH2 groups(GO:0016725) oxidoreductase activity, acting on CH or CH2 groups, disulfide as acceptor(GO:0016728) ribonucleoside-diphosphate reductase activity(GO:0061731) |
| 0.2 | 1.2 | GO:0008597 | calcium-dependent protein serine/threonine phosphatase regulator activity(GO:0008597) |
| 0.2 | 0.8 | GO:0004066 | asparagine synthase (glutamine-hydrolyzing) activity(GO:0004066) |
| 0.2 | 5.1 | GO:0004879 | RNA polymerase II transcription factor activity, ligand-activated sequence-specific DNA binding(GO:0004879) transcription factor activity, direct ligand regulated sequence-specific DNA binding(GO:0098531) |
| 0.2 | 8.0 | GO:0004867 | serine-type endopeptidase inhibitor activity(GO:0004867) |
| 0.2 | 0.4 | GO:0038085 | vascular endothelial growth factor binding(GO:0038085) |
| 0.2 | 0.9 | GO:0004809 | tRNA (guanine-N2-)-methyltransferase activity(GO:0004809) |
| 0.2 | 0.9 | GO:0019104 | DNA N-glycosylase activity(GO:0019104) |
| 0.2 | 0.7 | GO:0038191 | neuropilin binding(GO:0038191) |
| 0.2 | 0.5 | GO:0030158 | protein xylosyltransferase activity(GO:0030158) |
| 0.2 | 6.1 | GO:0030544 | Hsp70 protein binding(GO:0030544) |
| 0.2 | 3.3 | GO:0032183 | SUMO binding(GO:0032183) |
| 0.2 | 0.7 | GO:0004673 | phosphorelay sensor kinase activity(GO:0000155) protein histidine kinase activity(GO:0004673) |
| 0.2 | 0.5 | GO:0022833 | mechanically-gated ion channel activity(GO:0008381) mechanically gated channel activity(GO:0022833) |
| 0.2 | 2.1 | GO:0019855 | calcium channel inhibitor activity(GO:0019855) |
| 0.2 | 0.7 | GO:0015111 | iodide transmembrane transporter activity(GO:0015111) |
| 0.2 | 0.2 | GO:0005171 | hepatocyte growth factor receptor binding(GO:0005171) |
| 0.2 | 0.5 | GO:0048039 | ubiquinone binding(GO:0048039) |
| 0.2 | 2.5 | GO:0008266 | poly(U) RNA binding(GO:0008266) |
| 0.2 | 2.6 | GO:0016860 | intramolecular oxidoreductase activity(GO:0016860) |
| 0.2 | 0.3 | GO:0043891 | glyceraldehyde-3-phosphate dehydrogenase (NAD+) (phosphorylating) activity(GO:0004365) glyceraldehyde-3-phosphate dehydrogenase (NAD(P)+) (phosphorylating) activity(GO:0043891) |
| 0.2 | 0.6 | GO:0033883 | pyridoxal phosphatase activity(GO:0033883) |
| 0.2 | 3.8 | GO:0043325 | phosphatidylinositol-3,4-bisphosphate binding(GO:0043325) |
| 0.2 | 0.8 | GO:0070568 | guanylyltransferase activity(GO:0070568) |
| 0.2 | 0.5 | GO:0016309 | 1-phosphatidylinositol-5-phosphate 4-kinase activity(GO:0016309) |
| 0.2 | 0.8 | GO:0034711 | inhibin binding(GO:0034711) |
| 0.2 | 1.2 | GO:0042809 | vitamin D receptor binding(GO:0042809) |
| 0.2 | 14.2 | GO:0008083 | growth factor activity(GO:0008083) |
| 0.1 | 0.7 | GO:0008545 | JUN kinase kinase activity(GO:0008545) |
| 0.1 | 2.8 | GO:0016881 | acid-amino acid ligase activity(GO:0016881) |
| 0.1 | 0.7 | GO:0016018 | cyclosporin A binding(GO:0016018) |
| 0.1 | 1.3 | GO:0005007 | fibroblast growth factor-activated receptor activity(GO:0005007) |
| 0.1 | 0.9 | GO:0000213 | tRNA-intron endonuclease activity(GO:0000213) endoribonuclease activity, producing 3'-phosphomonoesters(GO:0016892) |
| 0.1 | 9.2 | GO:0008186 | RNA helicase activity(GO:0003724) ATP-dependent RNA helicase activity(GO:0004004) RNA-dependent ATPase activity(GO:0008186) |
| 0.1 | 2.2 | GO:0034987 | immunoglobulin receptor binding(GO:0034987) |
| 0.1 | 1.0 | GO:0033764 | steroid dehydrogenase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor(GO:0033764) |
| 0.1 | 0.4 | GO:0035497 | cAMP response element binding(GO:0035497) |
| 0.1 | 1.0 | GO:0097153 | cysteine-type endopeptidase activity involved in apoptotic process(GO:0097153) |
| 0.1 | 6.5 | GO:0001540 | beta-amyloid binding(GO:0001540) |
| 0.1 | 1.5 | GO:0017176 | phosphatidylinositol N-acetylglucosaminyltransferase activity(GO:0017176) |
| 0.1 | 2.2 | GO:0005164 | tumor necrosis factor receptor binding(GO:0005164) |
| 0.1 | 0.5 | GO:0031727 | CCR2 chemokine receptor binding(GO:0031727) |
| 0.1 | 0.9 | GO:0001609 | G-protein coupled adenosine receptor activity(GO:0001609) |
| 0.1 | 0.4 | GO:0003858 | 3-hydroxybutyrate dehydrogenase activity(GO:0003858) |
| 0.1 | 0.9 | GO:0015929 | hexosaminidase activity(GO:0015929) |
| 0.1 | 4.5 | GO:0050699 | WW domain binding(GO:0050699) |
| 0.1 | 0.4 | GO:0003977 | UDP-N-acetylglucosamine diphosphorylase activity(GO:0003977) |
| 0.1 | 0.4 | GO:0001849 | complement component C1q binding(GO:0001849) |
| 0.1 | 5.4 | GO:0005484 | SNAP receptor activity(GO:0005484) |
| 0.1 | 2.6 | GO:0051059 | NF-kappaB binding(GO:0051059) |
| 0.1 | 3.6 | GO:0001671 | ATPase activator activity(GO:0001671) |
| 0.1 | 3.7 | GO:0005112 | Notch binding(GO:0005112) |
| 0.1 | 0.6 | GO:0008297 | single-stranded DNA exodeoxyribonuclease activity(GO:0008297) |
| 0.1 | 0.4 | GO:0019166 | trans-2-enoyl-CoA reductase (NADPH) activity(GO:0019166) |
| 0.1 | 2.8 | GO:0042605 | peptide antigen binding(GO:0042605) |
| 0.1 | 2.4 | GO:0070006 | metalloaminopeptidase activity(GO:0070006) |
| 0.1 | 0.5 | GO:0016433 | rRNA (adenine) methyltransferase activity(GO:0016433) |
| 0.1 | 0.6 | GO:0032453 | histone demethylase activity (H3-K4 specific)(GO:0032453) |
| 0.1 | 0.6 | GO:0004565 | beta-galactosidase activity(GO:0004565) |
| 0.1 | 3.6 | GO:0003725 | double-stranded RNA binding(GO:0003725) |
| 0.1 | 2.3 | GO:0048029 | monosaccharide binding(GO:0048029) |
| 0.1 | 1.6 | GO:0016857 | racemase and epimerase activity, acting on carbohydrates and derivatives(GO:0016857) |
| 0.1 | 1.8 | GO:0008307 | structural constituent of muscle(GO:0008307) |
| 0.1 | 3.9 | GO:0005070 | SH3/SH2 adaptor activity(GO:0005070) |
| 0.1 | 1.0 | GO:0008191 | metalloendopeptidase inhibitor activity(GO:0008191) |
| 0.1 | 1.5 | GO:0005537 | mannose binding(GO:0005537) |
| 0.1 | 0.3 | GO:0016934 | extracellular-glycine-gated ion channel activity(GO:0016933) extracellular-glycine-gated chloride channel activity(GO:0016934) |
| 0.1 | 0.6 | GO:0016891 | endoribonuclease activity, producing 5'-phosphomonoesters(GO:0016891) |
| 0.1 | 5.7 | GO:0004402 | histone acetyltransferase activity(GO:0004402) |
| 0.1 | 0.3 | GO:0004605 | phosphatidate cytidylyltransferase activity(GO:0004605) |
| 0.1 | 0.4 | GO:0016812 | hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in cyclic amides(GO:0016812) |
| 0.1 | 0.3 | GO:0004568 | chitinase activity(GO:0004568) |
| 0.1 | 0.5 | GO:0004095 | carnitine O-palmitoyltransferase activity(GO:0004095) O-palmitoyltransferase activity(GO:0016416) |
| 0.1 | 1.7 | GO:0004198 | calcium-dependent cysteine-type endopeptidase activity(GO:0004198) |
| 0.1 | 1.2 | GO:0004089 | carbonate dehydratase activity(GO:0004089) |
| 0.1 | 1.5 | GO:0017069 | snRNA binding(GO:0017069) |
| 0.1 | 1.5 | GO:0048020 | CCR chemokine receptor binding(GO:0048020) |
| 0.1 | 1.6 | GO:0004364 | glutathione transferase activity(GO:0004364) |
| 0.1 | 1.2 | GO:0070410 | co-SMAD binding(GO:0070410) |
| 0.1 | 0.8 | GO:0004634 | phosphopyruvate hydratase activity(GO:0004634) |
| 0.1 | 1.4 | GO:0008188 | neuropeptide receptor activity(GO:0008188) |
| 0.1 | 1.4 | GO:0042169 | SH2 domain binding(GO:0042169) |
| 0.1 | 0.3 | GO:0045028 | G-protein coupled nucleotide receptor activity(GO:0001608) G-protein coupled purinergic nucleotide receptor activity(GO:0045028) |
| 0.1 | 0.8 | GO:0008143 | poly(A) binding(GO:0008143) |
| 0.1 | 0.9 | GO:0005247 | voltage-gated chloride channel activity(GO:0005247) |
| 0.1 | 0.7 | GO:0008499 | UDP-galactose:beta-N-acetylglucosamine beta-1,3-galactosyltransferase activity(GO:0008499) |
| 0.1 | 0.5 | GO:0003886 | DNA (cytosine-5-)-methyltransferase activity(GO:0003886) |
| 0.1 | 0.5 | GO:0005229 | intracellular calcium activated chloride channel activity(GO:0005229) |
| 0.1 | 0.7 | GO:0030550 | acetylcholine receptor inhibitor activity(GO:0030550) |
| 0.1 | 2.8 | GO:0048306 | calcium-dependent protein binding(GO:0048306) |
| 0.1 | 0.3 | GO:0031720 | haptoglobin binding(GO:0031720) |
| 0.1 | 3.5 | GO:0005080 | protein kinase C binding(GO:0005080) |
| 0.1 | 0.3 | GO:0051731 | polynucleotide 5'-hydroxyl-kinase activity(GO:0051731) |
| 0.1 | 0.3 | GO:0034481 | N-acetylgalactosamine 4-O-sulfotransferase activity(GO:0001537) chondroitin sulfotransferase activity(GO:0034481) |
| 0.1 | 0.5 | GO:0051864 | histone demethylase activity (H3-K36 specific)(GO:0051864) |
| 0.1 | 0.5 | GO:0017075 | syntaxin-1 binding(GO:0017075) |
| 0.1 | 0.5 | GO:0005212 | structural constituent of eye lens(GO:0005212) |
| 0.1 | 1.2 | GO:0035591 | signaling adaptor activity(GO:0035591) |
| 0.1 | 1.0 | GO:0005540 | hyaluronic acid binding(GO:0005540) |
| 0.1 | 0.3 | GO:0008476 | protein-tyrosine sulfotransferase activity(GO:0008476) |
| 0.1 | 0.3 | GO:0004515 | nicotinamide-nucleotide adenylyltransferase activity(GO:0000309) nicotinate-nucleotide adenylyltransferase activity(GO:0004515) |
| 0.1 | 0.3 | GO:0035925 | mRNA 3'-UTR AU-rich region binding(GO:0035925) |
| 0.1 | 0.1 | GO:0016422 | mRNA (2'-O-methyladenosine-N6-)-methyltransferase activity(GO:0016422) |
| 0.1 | 0.5 | GO:0050780 | dopamine receptor binding(GO:0050780) |
| 0.1 | 0.7 | GO:0001223 | transcription coactivator binding(GO:0001223) |
| 0.1 | 3.5 | GO:0016810 | hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds(GO:0016810) |
| 0.1 | 0.2 | GO:0003953 | NAD+ nucleosidase activity(GO:0003953) NAD(P)+-protein-arginine ADP-ribosyltransferase activity(GO:0003956) |
| 0.1 | 0.5 | GO:0008525 | phosphatidylcholine transporter activity(GO:0008525) |
| 0.1 | 0.9 | GO:0045504 | dynein heavy chain binding(GO:0045504) |
| 0.1 | 0.6 | GO:0004745 | retinol dehydrogenase activity(GO:0004745) |
| 0.1 | 2.6 | GO:0005518 | collagen binding(GO:0005518) |
| 0.1 | 0.2 | GO:0004875 | complement receptor activity(GO:0004875) |
| 0.1 | 0.2 | GO:0010340 | carboxyl-O-methyltransferase activity(GO:0010340) protein carboxyl O-methyltransferase activity(GO:0051998) |
| 0.1 | 0.2 | GO:0070051 | fibrinogen binding(GO:0070051) |
| 0.1 | 0.6 | GO:0020037 | heme binding(GO:0020037) |
| 0.1 | 9.5 | GO:0003924 | GTPase activity(GO:0003924) |
| 0.1 | 0.4 | GO:0016646 | oxidoreductase activity, acting on the CH-NH group of donors, NAD or NADP as acceptor(GO:0016646) |
| 0.0 | 1.0 | GO:0035254 | glutamate receptor binding(GO:0035254) |
| 0.0 | 1.1 | GO:0043531 | ADP binding(GO:0043531) |
| 0.0 | 0.7 | GO:0043539 | protein serine/threonine kinase activator activity(GO:0043539) |
| 0.0 | 1.4 | GO:0031490 | chromatin DNA binding(GO:0031490) |
| 0.0 | 0.2 | GO:0043138 | 3'-5' DNA helicase activity(GO:0043138) |
| 0.0 | 1.6 | GO:0004197 | cysteine-type endopeptidase activity(GO:0004197) |
| 0.0 | 0.2 | GO:0008603 | cAMP-dependent protein kinase regulator activity(GO:0008603) |
| 0.0 | 0.1 | GO:0045127 | N-acylmannosamine kinase activity(GO:0009384) N-acetylglucosamine kinase activity(GO:0045127) |
| 0.0 | 0.3 | GO:0046703 | natural killer cell lectin-like receptor binding(GO:0046703) |
| 0.0 | 0.3 | GO:0043423 | 3-phosphoinositide-dependent protein kinase binding(GO:0043423) |
| 0.0 | 0.3 | GO:0008227 | G-protein coupled amine receptor activity(GO:0008227) |
| 0.0 | 0.5 | GO:0004029 | aldehyde dehydrogenase (NAD) activity(GO:0004029) |
| 0.0 | 0.7 | GO:0043274 | phospholipase binding(GO:0043274) |
| 0.0 | 0.8 | GO:0008028 | monocarboxylic acid transmembrane transporter activity(GO:0008028) |
| 0.0 | 0.1 | GO:0005114 | type II transforming growth factor beta receptor binding(GO:0005114) |
| 0.0 | 0.5 | GO:0015020 | glucuronosyltransferase activity(GO:0015020) |
| 0.0 | 0.2 | GO:0031683 | G-protein beta/gamma-subunit complex binding(GO:0031683) |
| 0.0 | 0.3 | GO:0048407 | platelet-derived growth factor binding(GO:0048407) |
| 0.0 | 0.2 | GO:0000150 | recombinase activity(GO:0000150) |
| 0.0 | 3.2 | GO:0051015 | actin filament binding(GO:0051015) |
| 0.0 | 0.2 | GO:0005044 | scavenger receptor activity(GO:0005044) |
| 0.0 | 0.0 | GO:0052650 | NADP-retinol dehydrogenase activity(GO:0052650) |
| 0.0 | 0.3 | GO:0035612 | AP-2 adaptor complex binding(GO:0035612) |
| 0.0 | 0.9 | GO:0032934 | cholesterol binding(GO:0015485) sterol binding(GO:0032934) |
| 0.0 | 0.5 | GO:0008146 | sulfotransferase activity(GO:0008146) |
| 0.0 | 0.0 | GO:0070324 | thyroid hormone binding(GO:0070324) |
| 0.0 | 0.3 | GO:0005388 | calcium-transporting ATPase activity(GO:0005388) |
| 0.0 | 0.1 | GO:0016206 | catechol O-methyltransferase activity(GO:0016206) |
| 0.0 | 0.6 | GO:0043621 | protein self-association(GO:0043621) |
| 0.0 | 0.1 | GO:0004594 | pantothenate kinase activity(GO:0004594) |
| 0.0 | 0.4 | GO:0016835 | carbon-oxygen lyase activity(GO:0016835) |
| 0.0 | 0.1 | GO:0003883 | CTP synthase activity(GO:0003883) |
| 0.0 | 0.1 | GO:0005542 | folic acid binding(GO:0005542) |
| 0.0 | 0.1 | GO:0047372 | acylglycerol lipase activity(GO:0047372) |
| 0.0 | 0.1 | GO:0008568 | microtubule-severing ATPase activity(GO:0008568) |
| 0.0 | 0.0 | GO:0008732 | threonine aldolase activity(GO:0004793) L-allo-threonine aldolase activity(GO:0008732) |
| 0.0 | 0.3 | GO:0004003 | ATP-dependent DNA helicase activity(GO:0004003) |
| 0.0 | 0.1 | GO:0003835 | beta-galactoside alpha-2,6-sialyltransferase activity(GO:0003835) |
| 0.0 | 0.1 | GO:0030247 | pattern binding(GO:0001871) polysaccharide binding(GO:0030247) |
| 0.0 | 0.1 | GO:0016209 | antioxidant activity(GO:0016209) |
Gene overrepresentation in C2:CP category:
| Log-likelihood per target | Total log-likelihood | Term | Description |
|---|---|---|---|
| 2.7 | 2.7 | PID_IFNG_PATHWAY | IFN-gamma pathway |
| 1.4 | 53.0 | PID_P38_MK2_PATHWAY | p38 signaling mediated by MAPKAP kinases |
| 1.1 | 1.1 | PID_TCR_JNK_PATHWAY | JNK signaling in the CD4+ TCR pathway |
| 1.0 | 36.1 | PID_AURORA_A_PATHWAY | Aurora A signaling |
| 0.9 | 42.9 | SIG_REGULATION_OF_THE_ACTIN_CYTOSKELETON_BY_RHO_GTPASES | Genes related to regulation of the actin cytoskeleton |
| 0.9 | 19.9 | PID_HIF1A_PATHWAY | Hypoxic and oxygen homeostasis regulation of HIF-1-alpha |
| 0.7 | 1.5 | ST_IL_13_PATHWAY | Interleukin 13 (IL-13) Pathway |
| 0.7 | 2.2 | PID_SYNDECAN_2_PATHWAY | Syndecan-2-mediated signaling events |
| 0.7 | 10.1 | SA_REG_CASCADE_OF_CYCLIN_EXPR | Expression of cyclins regulates progression through the cell cycle by activating cyclin-dependent kinases. |
| 0.6 | 3.2 | PID_S1P_S1P2_PATHWAY | S1P2 pathway |
| 0.6 | 21.2 | PID_IL3_PATHWAY | IL3-mediated signaling events |
| 0.6 | 18.6 | PID_WNT_SIGNALING_PATHWAY | Wnt signaling network |
| 0.6 | 14.7 | PID_ECADHERIN_KERATINOCYTE_PATHWAY | E-cadherin signaling in keratinocytes |
| 0.6 | 14.2 | PID_PI3K_PLC_TRK_PATHWAY | Trk receptor signaling mediated by PI3K and PLC-gamma |
| 0.5 | 19.3 | PID_A6B1_A6B4_INTEGRIN_PATHWAY | a6b1 and a6b4 Integrin signaling |
| 0.5 | 6.2 | PID_S1P_S1P4_PATHWAY | S1P4 pathway |
| 0.5 | 38.3 | PID_P73PATHWAY | p73 transcription factor network |
| 0.5 | 20.8 | PID_ATR_PATHWAY | ATR signaling pathway |
| 0.5 | 9.3 | PID_IL2_PI3K_PATHWAY | IL2 signaling events mediated by PI3K |
| 0.5 | 33.3 | PID_HDAC_CLASSI_PATHWAY | Signaling events mediated by HDAC Class I |
| 0.5 | 9.7 | PID_FOXM1_PATHWAY | FOXM1 transcription factor network |
| 0.4 | 2.7 | PID_ATF2_PATHWAY | ATF-2 transcription factor network |
| 0.4 | 17.8 | PID_HIV_NEF_PATHWAY | HIV-1 Nef: Negative effector of Fas and TNF-alpha |
| 0.4 | 14.1 | PID_HES_HEY_PATHWAY | Notch-mediated HES/HEY network |
| 0.4 | 1.3 | ST_STAT3_PATHWAY | STAT3 Pathway |
| 0.4 | 9.7 | PID_HEDGEHOG_2PATHWAY | Signaling events mediated by the Hedgehog family |
| 0.4 | 39.4 | PID_MYC_ACTIV_PATHWAY | Validated targets of C-MYC transcriptional activation |
| 0.4 | 6.3 | PID_ERB_GENOMIC_PATHWAY | Validated nuclear estrogen receptor beta network |
| 0.4 | 22.3 | PID_MYC_REPRESS_PATHWAY | Validated targets of C-MYC transcriptional repression |
| 0.4 | 8.8 | PID_FRA_PATHWAY | Validated transcriptional targets of AP1 family members Fra1 and Fra2 |
| 0.4 | 4.3 | PID_EPHA2_FWD_PATHWAY | EPHA2 forward signaling |
| 0.4 | 2.3 | PID_THROMBIN_PAR4_PATHWAY | PAR4-mediated thrombin signaling events |
| 0.4 | 4.9 | PID_SMAD2_3PATHWAY | Regulation of cytoplasmic and nuclear SMAD2/3 signaling |
| 0.4 | 5.3 | PID_S1P_META_PATHWAY | Sphingosine 1-phosphate (S1P) pathway |
| 0.4 | 0.4 | SIG_IL4RECEPTOR_IN_B_LYPHOCYTES | Genes related to IL4 rceptor signaling in B lymphocytes |
| 0.4 | 10.0 | PID_ARF_3PATHWAY | Arf1 pathway |
| 0.4 | 1.5 | ST_TYPE_I_INTERFERON_PATHWAY | Type I Interferon (alpha/beta IFN) Pathway |
| 0.3 | 8.8 | PID_P38_ALPHA_BETA_DOWNSTREAM_PATHWAY | Signaling mediated by p38-alpha and p38-beta |
| 0.3 | 18.1 | PID_E2F_PATHWAY | E2F transcription factor network |
| 0.3 | 4.3 | PID_INSULIN_GLUCOSE_PATHWAY | Insulin-mediated glucose transport |
| 0.3 | 18.5 | PID_NOTCH_PATHWAY | Notch signaling pathway |
| 0.3 | 4.9 | PID_CIRCADIAN_PATHWAY | Circadian rhythm pathway |
| 0.3 | 1.6 | ST_INTERFERON_GAMMA_PATHWAY | Interferon gamma pathway. |
| 0.3 | 4.5 | PID_RETINOIC_ACID_PATHWAY | Retinoic acid receptors-mediated signaling |
| 0.3 | 1.6 | PID_WNT_CANONICAL_PATHWAY | Canonical Wnt signaling pathway |
| 0.3 | 2.5 | SA_PTEN_PATHWAY | PTEN is a tumor suppressor that dephosphorylates the lipid messenger phosphatidylinositol triphosphate. |
| 0.3 | 1.5 | ST_ERK1_ERK2_MAPK_PATHWAY | ERK1/ERK2 MAPK Pathway |
| 0.3 | 1.5 | SA_CASPASE_CASCADE | Apoptosis is mediated by caspases, cysteine proteases arranged in a proteolytic cascade. |
| 0.3 | 5.8 | PID_ILK_PATHWAY | Integrin-linked kinase signaling |
| 0.3 | 8.7 | ST_T_CELL_SIGNAL_TRANSDUCTION | T Cell Signal Transduction |
| 0.3 | 6.3 | PID_FAK_PATHWAY | Signaling events mediated by focal adhesion kinase |
| 0.3 | 10.2 | SIG_CD40PATHWAYMAP | Genes related to CD40 signaling |
| 0.3 | 16.7 | PID_ERA_GENOMIC_PATHWAY | Validated nuclear estrogen receptor alpha network |
| 0.3 | 0.5 | PID_S1P_S1P1_PATHWAY | S1P1 pathway |
| 0.3 | 1.6 | PID_VEGFR1_2_PATHWAY | Signaling events mediated by VEGFR1 and VEGFR2 |
| 0.3 | 2.9 | PID_VEGF_VEGFR_PATHWAY | VEGF and VEGFR signaling network |
| 0.3 | 3.7 | PID_P38_ALPHA_BETA_PATHWAY | Regulation of p38-alpha and p38-beta |
| 0.3 | 2.1 | PID_SYNDECAN_3_PATHWAY | Syndecan-3-mediated signaling events |
| 0.3 | 8.1 | NABA_PROTEOGLYCANS | Genes encoding proteoglycans |
| 0.3 | 5.0 | PID_IL1_PATHWAY | IL1-mediated signaling events |
| 0.2 | 2.7 | PID_TOLL_ENDOGENOUS_PATHWAY | Endogenous TLR signaling |
| 0.2 | 5.9 | PID_SMAD2_3NUCLEAR_PATHWAY | Regulation of nuclear SMAD2/3 signaling |
| 0.2 | 4.4 | PID_MAPK_TRK_PATHWAY | Trk receptor signaling mediated by the MAPK pathway |
| 0.2 | 0.9 | ST_G_ALPHA_I_PATHWAY | G alpha i Pathway |
| 0.2 | 3.0 | PID_RXR_VDR_PATHWAY | RXR and RAR heterodimerization with other nuclear receptor |
| 0.2 | 3.4 | PID_PDGFRA_PATHWAY | PDGFR-alpha signaling pathway |
| 0.2 | 13.7 | PID_MTOR_4PATHWAY | mTOR signaling pathway |
| 0.2 | 2.9 | PID_INTEGRIN2_PATHWAY | Beta2 integrin cell surface interactions |
| 0.2 | 6.0 | PID_ERBB1_DOWNSTREAM_PATHWAY | ErbB1 downstream signaling |
| 0.2 | 4.2 | PID_P75_NTR_PATHWAY | p75(NTR)-mediated signaling |
| 0.2 | 6.7 | PID_AJDISS_2PATHWAY | Posttranslational regulation of adherens junction stability and dissassembly |
| 0.2 | 0.4 | SA_B_CELL_RECEPTOR_COMPLEXES | Antigen binding to B cell receptors activates protein tyrosine kinases, such as the Src family, which ultimate activate MAP kinases. |
| 0.2 | 1.7 | NABA_COLLAGENS | Genes encoding collagen proteins |
| 0.2 | 4.4 | SIG_PIP3_SIGNALING_IN_CARDIAC_MYOCTES | Genes related to PIP3 signaling in cardiac myocytes |
| 0.2 | 1.0 | PID_FOXO_PATHWAY | FoxO family signaling |
| 0.2 | 6.4 | PID_AURORA_B_PATHWAY | Aurora B signaling |
| 0.2 | 1.6 | PID_IGF1_PATHWAY | IGF1 pathway |
| 0.2 | 8.4 | PID_CMYB_PATHWAY | C-MYB transcription factor network |
| 0.2 | 3.0 | PID_HDAC_CLASSII_PATHWAY | Signaling events mediated by HDAC Class II |
| 0.2 | 5.5 | PID_AR_TF_PATHWAY | Regulation of Androgen receptor activity |
| 0.2 | 2.9 | PID_SYNDECAN_4_PATHWAY | Syndecan-4-mediated signaling events |
| 0.2 | 4.4 | PID_HIF1_TFPATHWAY | HIF-1-alpha transcription factor network |
| 0.2 | 2.3 | PID_TRAIL_PATHWAY | TRAIL signaling pathway |
| 0.2 | 5.4 | PID_RAC1_PATHWAY | RAC1 signaling pathway |
| 0.2 | 2.9 | PID_HIF2PATHWAY | HIF-2-alpha transcription factor network |
| 0.2 | 0.9 | PID_CD40_PATHWAY | CD40/CD40L signaling |
| 0.2 | 3.1 | ST_GA13_PATHWAY | G alpha 13 Pathway |
| 0.2 | 3.2 | PID_ALPHA_SYNUCLEIN_PATHWAY | Alpha-synuclein signaling |
| 0.2 | 0.3 | SIG_CHEMOTAXIS | Genes related to chemotaxis |
| 0.2 | 6.2 | PID_P53_REGULATION_PATHWAY | p53 pathway |
| 0.2 | 0.3 | ST_PAC1_RECEPTOR_PATHWAY | PAC1 Receptor Pathway |
| 0.2 | 0.3 | ST_INTERLEUKIN_4_PATHWAY | Interleukin 4 (IL-4) Pathway |
| 0.2 | 1.5 | PID_ERBB2_ERBB3_PATHWAY | ErbB2/ErbB3 signaling events |
| 0.1 | 3.2 | PID_IL12_2PATHWAY | IL12-mediated signaling events |
| 0.1 | 0.9 | ST_GAQ_PATHWAY | G alpha q Pathway |
| 0.1 | 0.7 | PID_HDAC_CLASSIII_PATHWAY | Signaling events mediated by HDAC Class III |
| 0.1 | 14.1 | NABA_ECM_REGULATORS | Genes encoding enzymes and their regulators involved in the remodeling of the extracellular matrix |
| 0.1 | 4.2 | PID_SYNDECAN_1_PATHWAY | Syndecan-1-mediated signaling events |
| 0.1 | 1.3 | PID_EPHA_FWDPATHWAY | EPHA forward signaling |
| 0.1 | 1.5 | PID_BCR_5PATHWAY | BCR signaling pathway |
| 0.1 | 1.4 | PID_RB_1PATHWAY | Regulation of retinoblastoma protein |
| 0.1 | 10.0 | NABA_ECM_AFFILIATED | Genes encoding proteins affiliated structurally or functionally to extracellular matrix proteins |
| 0.1 | 0.9 | PID_PI3KCI_PATHWAY | Class I PI3K signaling events |
| 0.1 | 0.3 | PID_GLYPICAN_1PATHWAY | Glypican 1 network |
| 0.1 | 1.0 | PID_RAS_PATHWAY | Regulation of Ras family activation |
| 0.1 | 0.6 | PID_WNT_NONCANONICAL_PATHWAY | Noncanonical Wnt signaling pathway |
| 0.1 | 2.1 | PID_PLK1_PATHWAY | PLK1 signaling events |
| 0.1 | 1.1 | PID_FGF_PATHWAY | FGF signaling pathway |
| 0.0 | 0.6 | PID_INTEGRIN3_PATHWAY | Beta3 integrin cell surface interactions |
| 0.0 | 1.2 | PID_CASPASE_PATHWAY | Caspase cascade in apoptosis |
| 0.0 | 0.7 | PID_NFAT_TFPATHWAY | Calcineurin-regulated NFAT-dependent transcription in lymphocytes |
| 0.0 | 0.1 | PID_CXCR3_PATHWAY | CXCR3-mediated signaling events |
Gene overrepresentation in C2:CP:REACTOME category:
| Log-likelihood per target | Total log-likelihood | Term | Description |
|---|---|---|---|
| 3.3 | 356.7 | REACTOME_PEPTIDE_CHAIN_ELONGATION | Genes involved in Peptide chain elongation |
| 3.2 | 3.2 | REACTOME_INTERACTIONS_OF_VPR_WITH_HOST_CELLULAR_PROTEINS | Genes involved in Interactions of Vpr with host cellular proteins |
| 2.3 | 120.4 | REACTOME_RNA_POL_I_PROMOTER_OPENING | Genes involved in RNA Polymerase I Promoter Opening |
| 2.2 | 38.9 | REACTOME_FORMATION_OF_ATP_BY_CHEMIOSMOTIC_COUPLING | Genes involved in Formation of ATP by chemiosmotic coupling |
| 2.1 | 113.9 | REACTOME_VIF_MEDIATED_DEGRADATION_OF_APOBEC3G | Genes involved in Vif-mediated degradation of APOBEC3G |
| 2.0 | 138.8 | REACTOME_RESPIRATORY_ELECTRON_TRANSPORT | Genes involved in Respiratory electron transport |
| 1.9 | 1.9 | REACTOME_3_UTR_MEDIATED_TRANSLATIONAL_REGULATION | Genes involved in 3' -UTR-mediated translational regulation |
| 1.4 | 15.8 | REACTOME_PURINE_CATABOLISM | Genes involved in Purine catabolism |
| 1.3 | 22.4 | REACTOME_MITOCHONDRIAL_FATTY_ACID_BETA_OXIDATION | Genes involved in Mitochondrial Fatty Acid Beta-Oxidation |
| 1.3 | 2.6 | REACTOME_APC_C_CDC20_MEDIATED_DEGRADATION_OF_CYCLIN_B | Genes involved in APC/C:Cdc20 mediated degradation of Cyclin B |
| 1.3 | 15.3 | REACTOME_ER_PHAGOSOME_PATHWAY | Genes involved in ER-Phagosome pathway |
| 1.2 | 4.9 | REACTOME_INHIBITION_OF_THE_PROTEOLYTIC_ACTIVITY_OF_APC_C_REQUIRED_FOR_THE_ONSET_OF_ANAPHASE_BY_MITOTIC_SPINDLE_CHECKPOINT_COMPONENTS | Genes involved in Inhibition of the proteolytic activity of APC/C required for the onset of anaphase by mitotic spindle checkpoint components |
| 1.2 | 4.8 | REACTOME_RESPIRATORY_ELECTRON_TRANSPORT_ATP_SYNTHESIS_BY_CHEMIOSMOTIC_COUPLING_AND_HEAT_PRODUCTION_BY_UNCOUPLING_PROTEINS_ | Genes involved in Respiratory electron transport, ATP synthesis by chemiosmotic coupling, and heat production by uncoupling proteins. |
| 1.2 | 12.0 | REACTOME_MRNA_DECAY_BY_3_TO_5_EXORIBONUCLEASE | Genes involved in mRNA Decay by 3' to 5' Exoribonuclease |
| 1.2 | 32.0 | REACTOME_AKT_PHOSPHORYLATES_TARGETS_IN_THE_CYTOSOL | Genes involved in AKT phosphorylates targets in the cytosol |
| 1.2 | 25.8 | REACTOME_APC_C_CDH1_MEDIATED_DEGRADATION_OF_CDC20_AND_OTHER_APC_C_CDH1_TARGETED_PROTEINS_IN_LATE_MITOSIS_EARLY_G1 | Genes involved in APC/C:Cdh1 mediated degradation of Cdc20 and other APC/C:Cdh1 targeted proteins in late mitosis/early G1 |
| 1.2 | 24.2 | REACTOME_RNA_POL_III_CHAIN_ELONGATION | Genes involved in RNA Polymerase III Chain Elongation |
| 1.0 | 15.4 | REACTOME_FORMATION_OF_THE_TERNARY_COMPLEX_AND_SUBSEQUENTLY_THE_43S_COMPLEX | Genes involved in Formation of the ternary complex, and subsequently, the 43S complex |
| 1.0 | 47.9 | REACTOME_MITOCHONDRIAL_PROTEIN_IMPORT | Genes involved in Mitochondrial Protein Import |
| 1.0 | 21.3 | REACTOME_MITOCHONDRIAL_TRNA_AMINOACYLATION | Genes involved in Mitochondrial tRNA aminoacylation |
| 0.9 | 11.4 | REACTOME_SLBP_DEPENDENT_PROCESSING_OF_REPLICATION_DEPENDENT_HISTONE_PRE_MRNAS | Genes involved in SLBP Dependent Processing of Replication-Dependent Histone Pre-mRNAs |
| 0.9 | 2.8 | REACTOME_EICOSANOID_LIGAND_BINDING_RECEPTORS | Genes involved in Eicosanoid ligand-binding receptors |
| 0.9 | 9.3 | REACTOME_REMOVAL_OF_THE_FLAP_INTERMEDIATE_FROM_THE_C_STRAND | Genes involved in Removal of the Flap Intermediate from the C-strand |
| 0.9 | 7.4 | REACTOME_APOBEC3G_MEDIATED_RESISTANCE_TO_HIV1_INFECTION | Genes involved in APOBEC3G mediated resistance to HIV-1 infection |
| 0.9 | 5.2 | REACTOME_POST_CHAPERONIN_TUBULIN_FOLDING_PATHWAY | Genes involved in Post-chaperonin tubulin folding pathway |
| 0.9 | 14.5 | REACTOME_ZINC_TRANSPORTERS | Genes involved in Zinc transporters |
| 0.8 | 32.1 | REACTOME_GLUCONEOGENESIS | Genes involved in Gluconeogenesis |
| 0.8 | 20.7 | REACTOME_STRIATED_MUSCLE_CONTRACTION | Genes involved in Striated Muscle Contraction |
| 0.8 | 8.4 | REACTOME_BASE_FREE_SUGAR_PHOSPHATE_REMOVAL_VIA_THE_SINGLE_NUCLEOTIDE_REPLACEMENT_PATHWAY | Genes involved in Base-free sugar-phosphate removal via the single-nucleotide replacement pathway |
| 0.7 | 5.9 | REACTOME_RNA_POL_III_TRANSCRIPTION_INITIATION_FROM_TYPE_2_PROMOTER | Genes involved in RNA Polymerase III Transcription Initiation From Type 2 Promoter |
| 0.7 | 8.8 | REACTOME_N_GLYCAN_TRIMMING_IN_THE_ER_AND_CALNEXIN_CALRETICULIN_CYCLE | Genes involved in N-glycan trimming in the ER and Calnexin/Calreticulin cycle |
| 0.7 | 3.6 | REACTOME_ANDROGEN_BIOSYNTHESIS | Genes involved in Androgen biosynthesis |
| 0.7 | 17.1 | REACTOME_CYTOSOLIC_TRNA_AMINOACYLATION | Genes involved in Cytosolic tRNA aminoacylation |
| 0.7 | 15.3 | REACTOME_INSULIN_RECEPTOR_RECYCLING | Genes involved in Insulin receptor recycling |
| 0.7 | 15.1 | REACTOME_METABOLISM_OF_PORPHYRINS | Genes involved in Metabolism of porphyrins |
| 0.7 | 8.6 | REACTOME_NONSENSE_MEDIATED_DECAY_ENHANCED_BY_THE_EXON_JUNCTION_COMPLEX | Genes involved in Nonsense Mediated Decay Enhanced by the Exon Junction Complex |
| 0.7 | 10.5 | REACTOME_UNWINDING_OF_DNA | Genes involved in Unwinding of DNA |
| 0.6 | 6.4 | REACTOME_HYALURONAN_UPTAKE_AND_DEGRADATION | Genes involved in Hyaluronan uptake and degradation |
| 0.6 | 9.0 | REACTOME_CYCLIN_A_B1_ASSOCIATED_EVENTS_DURING_G2_M_TRANSITION | Genes involved in Cyclin A/B1 associated events during G2/M transition |
| 0.6 | 7.6 | REACTOME_RAF_MAP_KINASE_CASCADE | Genes involved in RAF/MAP kinase cascade |
| 0.6 | 14.6 | REACTOME_SRP_DEPENDENT_COTRANSLATIONAL_PROTEIN_TARGETING_TO_MEMBRANE | Genes involved in SRP-dependent cotranslational protein targeting to membrane |
| 0.6 | 4.4 | REACTOME_APOPTOTIC_CLEAVAGE_OF_CELL_ADHESION_PROTEINS | Genes involved in Apoptotic cleavage of cell adhesion proteins |
| 0.6 | 6.2 | REACTOME_COPI_MEDIATED_TRANSPORT | Genes involved in COPI Mediated Transport |
| 0.6 | 9.3 | REACTOME_CD28_DEPENDENT_VAV1_PATHWAY | Genes involved in CD28 dependent Vav1 pathway |
| 0.6 | 32.4 | REACTOME_ACTIVATION_OF_CHAPERONE_GENES_BY_XBP1S | Genes involved in Activation of Chaperone Genes by XBP1(S) |
| 0.6 | 9.1 | REACTOME_APOPTOSIS_INDUCED_DNA_FRAGMENTATION | Genes involved in Apoptosis induced DNA fragmentation |
| 0.6 | 4.8 | REACTOME_MICRORNA_MIRNA_BIOGENESIS | Genes involved in MicroRNA (miRNA) Biogenesis |
| 0.6 | 1.8 | REACTOME_REGULATED_PROTEOLYSIS_OF_P75NTR | Genes involved in Regulated proteolysis of p75NTR |
| 0.6 | 21.5 | REACTOME_MRNA_SPLICING_MINOR_PATHWAY | Genes involved in mRNA Splicing - Minor Pathway |
| 0.6 | 4.6 | REACTOME_SYNTHESIS_OF_BILE_ACIDS_AND_BILE_SALTS_VIA_24_HYDROXYCHOLESTEROL | Genes involved in Synthesis of bile acids and bile salts via 24-hydroxycholesterol |
| 0.6 | 19.0 | REACTOME_PREFOLDIN_MEDIATED_TRANSFER_OF_SUBSTRATE_TO_CCT_TRIC | Genes involved in Prefoldin mediated transfer of substrate to CCT/TriC |
| 0.6 | 2.8 | REACTOME_DESTABILIZATION_OF_MRNA_BY_BRF1 | Genes involved in Destabilization of mRNA by Butyrate Response Factor 1 (BRF1) |
| 0.5 | 8.2 | REACTOME_REGULATION_OF_GENE_EXPRESSION_IN_BETA_CELLS | Genes involved in Regulation of gene expression in beta cells |
| 0.5 | 6.4 | REACTOME_IL_7_SIGNALING | Genes involved in Interleukin-7 signaling |
| 0.5 | 36.1 | REACTOME_NUCLEAR_RECEPTOR_TRANSCRIPTION_PATHWAY | Genes involved in Nuclear Receptor transcription pathway |
| 0.5 | 3.1 | REACTOME_ADVANCED_GLYCOSYLATION_ENDPRODUCT_RECEPTOR_SIGNALING | Genes involved in Advanced glycosylation endproduct receptor signaling |
| 0.5 | 4.1 | REACTOME_REGULATION_OF_BETA_CELL_DEVELOPMENT | Genes involved in Regulation of beta-cell development |
| 0.5 | 0.5 | REACTOME_ACTIVATION_OF_THE_MRNA_UPON_BINDING_OF_THE_CAP_BINDING_COMPLEX_AND_EIFS_AND_SUBSEQUENT_BINDING_TO_43S | Genes involved in Activation of the mRNA upon binding of the cap-binding complex and eIFs, and subsequent binding to 43S |
| 0.5 | 6.1 | REACTOME_GAP_JUNCTION_ASSEMBLY | Genes involved in Gap junction assembly |
| 0.5 | 17.6 | REACTOME_ACTIVATED_NOTCH1_TRANSMITS_SIGNAL_TO_THE_NUCLEUS | Genes involved in Activated NOTCH1 Transmits Signal to the Nucleus |
| 0.5 | 9.8 | REACTOME_PYRIMIDINE_METABOLISM | Genes involved in Pyrimidine metabolism |
| 0.5 | 8.2 | REACTOME_SIGNALING_BY_NODAL | Genes involved in Signaling by NODAL |
| 0.5 | 12.6 | REACTOME_SYNTHESIS_AND_INTERCONVERSION_OF_NUCLEOTIDE_DI_AND_TRIPHOSPHATES | Genes involved in Synthesis and interconversion of nucleotide di- and triphosphates |
| 0.5 | 1.0 | REACTOME_FORMATION_OF_TRANSCRIPTION_COUPLED_NER_TC_NER_REPAIR_COMPLEX | Genes involved in Formation of transcription-coupled NER (TC-NER) repair complex |
| 0.5 | 1.4 | REACTOME_TETRAHYDROBIOPTERIN_BH4_SYNTHESIS_RECYCLING_SALVAGE_AND_REGULATION | Genes involved in Tetrahydrobiopterin (BH4) synthesis, recycling, salvage and regulation |
| 0.5 | 7.1 | REACTOME_GLYCOLYSIS | Genes involved in Glycolysis |
| 0.5 | 12.1 | REACTOME_PTM_GAMMA_CARBOXYLATION_HYPUSINE_FORMATION_AND_ARYLSULFATASE_ACTIVATION | Genes involved in PTM: gamma carboxylation, hypusine formation and arylsulfatase activation |
| 0.5 | 15.7 | REACTOME_ADP_SIGNALLING_THROUGH_P2RY12 | Genes involved in ADP signalling through P2Y purinoceptor 12 |
| 0.5 | 12.9 | REACTOME_DEADENYLATION_OF_MRNA | Genes involved in Deadenylation of mRNA |
| 0.5 | 11.5 | REACTOME_SIGNALING_BY_HIPPO | Genes involved in Signaling by Hippo |
| 0.5 | 5.0 | REACTOME_FACILITATIVE_NA_INDEPENDENT_GLUCOSE_TRANSPORTERS | Genes involved in Facilitative Na+-independent glucose transporters |
| 0.4 | 4.9 | REACTOME_AMYLOIDS | Genes involved in Amyloids |
| 0.4 | 11.8 | REACTOME_ENDOSOMAL_SORTING_COMPLEX_REQUIRED_FOR_TRANSPORT_ESCRT | Genes involved in Endosomal Sorting Complex Required For Transport (ESCRT) |
| 0.4 | 3.5 | REACTOME_POL_SWITCHING | Genes involved in Polymerase switching |
| 0.4 | 7.7 | REACTOME_RNA_POL_I_TRANSCRIPTION_INITIATION | Genes involved in RNA Polymerase I Transcription Initiation |
| 0.4 | 7.3 | REACTOME_IL_RECEPTOR_SHC_SIGNALING | Genes involved in Interleukin receptor SHC signaling |
| 0.4 | 9.4 | REACTOME_SULFUR_AMINO_ACID_METABOLISM | Genes involved in Sulfur amino acid metabolism |
| 0.4 | 9.6 | REACTOME_CHOLESTEROL_BIOSYNTHESIS | Genes involved in Cholesterol biosynthesis |
| 0.4 | 8.3 | REACTOME_G0_AND_EARLY_G1 | Genes involved in G0 and Early G1 |
| 0.4 | 9.4 | REACTOME_RAP1_SIGNALLING | Genes involved in Rap1 signalling |
| 0.4 | 8.9 | REACTOME_PYRUVATE_METABOLISM | Genes involved in Pyruvate metabolism |
| 0.4 | 3.5 | REACTOME_TRYPTOPHAN_CATABOLISM | Genes involved in Tryptophan catabolism |
| 0.4 | 2.7 | REACTOME_REGULATION_OF_ORNITHINE_DECARBOXYLASE_ODC | Genes involved in Regulation of ornithine decarboxylase (ODC) |
| 0.4 | 6.1 | REACTOME_SYNTHESIS_OF_SUBSTRATES_IN_N_GLYCAN_BIOSYTHESIS | Genes involved in Synthesis of substrates in N-glycan biosythesis |
| 0.4 | 1.5 | REACTOME_RECYCLING_PATHWAY_OF_L1 | Genes involved in Recycling pathway of L1 |
| 0.4 | 3.3 | REACTOME_INTRINSIC_PATHWAY | Genes involved in Intrinsic Pathway |
| 0.4 | 12.7 | REACTOME_CA_DEPENDENT_EVENTS | Genes involved in Ca-dependent events |
| 0.4 | 8.6 | REACTOME_G1_PHASE | Genes involved in G1 Phase |
| 0.4 | 4.6 | REACTOME_PIP3_ACTIVATES_AKT_SIGNALING | Genes involved in PIP3 activates AKT signaling |
| 0.4 | 12.8 | REACTOME_SIGNALING_BY_ROBO_RECEPTOR | Genes involved in Signaling by Robo receptor |
| 0.4 | 1.8 | REACTOME_CIRCADIAN_CLOCK | Genes involved in Circadian Clock |
| 0.3 | 7.0 | REACTOME_ABCA_TRANSPORTERS_IN_LIPID_HOMEOSTASIS | Genes involved in ABCA transporters in lipid homeostasis |
| 0.3 | 1.6 | REACTOME_ACTIVATION_OF_ATR_IN_RESPONSE_TO_REPLICATION_STRESS | Genes involved in Activation of ATR in response to replication stress |
| 0.3 | 8.2 | REACTOME_TGF_BETA_RECEPTOR_SIGNALING_ACTIVATES_SMADS | Genes involved in TGF-beta receptor signaling activates SMADs |
| 0.3 | 4.5 | REACTOME_RIP_MEDIATED_NFKB_ACTIVATION_VIA_DAI | Genes involved in RIP-mediated NFkB activation via DAI |
| 0.3 | 4.1 | REACTOME_CITRIC_ACID_CYCLE_TCA_CYCLE | Genes involved in Citric acid cycle (TCA cycle) |
| 0.3 | 1.8 | REACTOME_INHIBITION_OF_INSULIN_SECRETION_BY_ADRENALINE_NORADRENALINE | Genes involved in Inhibition of Insulin Secretion by Adrenaline/Noradrenaline |
| 0.3 | 5.8 | REACTOME_RNA_POL_II_TRANSCRIPTION_PRE_INITIATION_AND_PROMOTER_OPENING | Genes involved in RNA Polymerase II Transcription Pre-Initiation And Promoter Opening |
| 0.3 | 0.6 | REACTOME_RESOLUTION_OF_AP_SITES_VIA_THE_SINGLE_NUCLEOTIDE_REPLACEMENT_PATHWAY | Genes involved in Resolution of AP sites via the single-nucleotide replacement pathway |
| 0.3 | 6.6 | REACTOME_SMAD2_SMAD3_SMAD4_HETEROTRIMER_REGULATES_TRANSCRIPTION | Genes involved in SMAD2/SMAD3:SMAD4 heterotrimer regulates transcription |
| 0.3 | 3.5 | REACTOME_NOTCH_HLH_TRANSCRIPTION_PATHWAY | Genes involved in Notch-HLH transcription pathway |
| 0.3 | 1.8 | REACTOME_CREATION_OF_C4_AND_C2_ACTIVATORS | Genes involved in Creation of C4 and C2 activators |
| 0.3 | 13.9 | REACTOME_CLASS_B_2_SECRETIN_FAMILY_RECEPTORS | Genes involved in Class B/2 (Secretin family receptors) |
| 0.3 | 3.7 | REACTOME_BIOSYNTHESIS_OF_THE_N_GLYCAN_PRECURSOR_DOLICHOL_LIPID_LINKED_OLIGOSACCHARIDE_LLO_AND_TRANSFER_TO_A_NASCENT_PROTEIN | Genes involved in Biosynthesis of the N-glycan precursor (dolichol lipid-linked oligosaccharide, LLO) and transfer to a nascent protein |
| 0.3 | 3.0 | REACTOME_AMINE_DERIVED_HORMONES | Genes involved in Amine-derived hormones |
| 0.3 | 2.4 | REACTOME_FORMATION_OF_INCISION_COMPLEX_IN_GG_NER | Genes involved in Formation of incision complex in GG-NER |
| 0.3 | 8.9 | REACTOME_SYNTHESIS_OF_PA | Genes involved in Synthesis of PA |
| 0.3 | 1.6 | REACTOME_G_ALPHA1213_SIGNALLING_EVENTS | Genes involved in G alpha (12/13) signalling events |
| 0.3 | 4.7 | REACTOME_CRMPS_IN_SEMA3A_SIGNALING | Genes involved in CRMPs in Sema3A signaling |
| 0.3 | 3.5 | REACTOME_ACTIVATION_OF_BH3_ONLY_PROTEINS | Genes involved in Activation of BH3-only proteins |
| 0.2 | 3.2 | REACTOME_ACTIVATION_OF_GENES_BY_ATF4 | Genes involved in Activation of Genes by ATF4 |
| 0.2 | 0.7 | REACTOME_LYSOSOME_VESICLE_BIOGENESIS | Genes involved in Lysosome Vesicle Biogenesis |
| 0.2 | 15.3 | REACTOME_GOLGI_ASSOCIATED_VESICLE_BIOGENESIS | Genes involved in Golgi Associated Vesicle Biogenesis |
| 0.2 | 10.9 | REACTOME_METABOLISM_OF_NON_CODING_RNA | Genes involved in Metabolism of non-coding RNA |
| 0.2 | 0.9 | REACTOME_PLATELET_SENSITIZATION_BY_LDL | Genes involved in Platelet sensitization by LDL |
| 0.2 | 14.7 | REACTOME_TRANSCRIPTIONAL_REGULATION_OF_WHITE_ADIPOCYTE_DIFFERENTIATION | Genes involved in Transcriptional Regulation of White Adipocyte Differentiation |
| 0.2 | 6.4 | REACTOME_SEMA4D_INDUCED_CELL_MIGRATION_AND_GROWTH_CONE_COLLAPSE | Genes involved in Sema4D induced cell migration and growth-cone collapse |
| 0.2 | 4.4 | REACTOME_HOST_INTERACTIONS_OF_HIV_FACTORS | Genes involved in Host Interactions of HIV factors |
| 0.2 | 0.4 | REACTOME_NRIF_SIGNALS_CELL_DEATH_FROM_THE_NUCLEUS | Genes involved in NRIF signals cell death from the nucleus |
| 0.2 | 12.7 | REACTOME_METABOLISM_OF_VITAMINS_AND_COFACTORS | Genes involved in Metabolism of vitamins and cofactors |
| 0.2 | 2.9 | REACTOME_P38MAPK_EVENTS | Genes involved in p38MAPK events |
| 0.2 | 16.7 | REACTOME_PEPTIDE_LIGAND_BINDING_RECEPTORS | Genes involved in Peptide ligand-binding receptors |
| 0.2 | 1.4 | REACTOME_OXYGEN_DEPENDENT_PROLINE_HYDROXYLATION_OF_HYPOXIA_INDUCIBLE_FACTOR_ALPHA | Genes involved in Oxygen-dependent Proline Hydroxylation of Hypoxia-inducible Factor Alpha |
| 0.2 | 3.2 | REACTOME_TRANSLATION | Genes involved in Translation |
| 0.2 | 7.3 | REACTOME_INTERFERON_ALPHA_BETA_SIGNALING | Genes involved in Interferon alpha/beta signaling |
| 0.2 | 34.4 | REACTOME_ANTIGEN_PROCESSING_UBIQUITINATION_PROTEASOME_DEGRADATION | Genes involved in Antigen processing: Ubiquitination & Proteasome degradation |
| 0.2 | 3.4 | REACTOME_IMMUNOREGULATORY_INTERACTIONS_BETWEEN_A_LYMPHOID_AND_A_NON_LYMPHOID_CELL | Genes involved in Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell |
| 0.2 | 5.0 | REACTOME_GLYCOSPHINGOLIPID_METABOLISM | Genes involved in Glycosphingolipid metabolism |
| 0.2 | 15.0 | REACTOME_METABOLISM_OF_AMINO_ACIDS_AND_DERIVATIVES | Genes involved in Metabolism of amino acids and derivatives |
| 0.2 | 6.7 | REACTOME_HS_GAG_BIOSYNTHESIS | Genes involved in HS-GAG biosynthesis |
| 0.2 | 7.9 | REACTOME_NCAM1_INTERACTIONS | Genes involved in NCAM1 interactions |
| 0.2 | 2.0 | REACTOME_ROLE_OF_DCC_IN_REGULATING_APOPTOSIS | Genes involved in Role of DCC in regulating apoptosis |
| 0.2 | 2.9 | REACTOME_P75_NTR_RECEPTOR_MEDIATED_SIGNALLING | Genes involved in p75 NTR receptor-mediated signalling |
| 0.2 | 0.7 | REACTOME_ETHANOL_OXIDATION | Genes involved in Ethanol oxidation |
| 0.2 | 4.2 | REACTOME_NEGATIVE_REGULATORS_OF_RIG_I_MDA5_SIGNALING | Genes involved in Negative regulators of RIG-I/MDA5 signaling |
| 0.2 | 1.5 | REACTOME_CDT1_ASSOCIATION_WITH_THE_CDC6_ORC_ORIGIN_COMPLEX | Genes involved in CDT1 association with the CDC6:ORC:origin complex |
| 0.2 | 1.2 | REACTOME_RNA_POL_II_PRE_TRANSCRIPTION_EVENTS | Genes involved in RNA Polymerase II Pre-transcription Events |
| 0.2 | 0.2 | REACTOME_REGULATION_OF_APOPTOSIS | Genes involved in Regulation of Apoptosis |
| 0.2 | 1.7 | REACTOME_DEGRADATION_OF_THE_EXTRACELLULAR_MATRIX | Genes involved in Degradation of the extracellular matrix |
| 0.1 | 0.7 | REACTOME_DAG_AND_IP3_SIGNALING | Genes involved in DAG and IP3 signaling |
| 0.1 | 1.3 | REACTOME_CYTOCHROME_P450_ARRANGED_BY_SUBSTRATE_TYPE | Genes involved in Cytochrome P450 - arranged by substrate type |
| 0.1 | 1.7 | REACTOME_AMINE_LIGAND_BINDING_RECEPTORS | Genes involved in Amine ligand-binding receptors |
| 0.1 | 0.4 | REACTOME_NFKB_ACTIVATION_THROUGH_FADD_RIP1_PATHWAY_MEDIATED_BY_CASPASE_8_AND10 | Genes involved in NF-kB activation through FADD/RIP-1 pathway mediated by caspase-8 and -10 |
| 0.1 | 1.3 | REACTOME_NUCLEOTIDE_LIKE_PURINERGIC_RECEPTORS | Genes involved in Nucleotide-like (purinergic) receptors |
| 0.1 | 0.5 | REACTOME_REGULATION_OF_HYPOXIA_INDUCIBLE_FACTOR_HIF_BY_OXYGEN | Genes involved in Regulation of Hypoxia-inducible Factor (HIF) by Oxygen |
| 0.1 | 4.1 | REACTOME_O_LINKED_GLYCOSYLATION_OF_MUCINS | Genes involved in O-linked glycosylation of mucins |
| 0.1 | 4.1 | REACTOME_SIGNALING_BY_NOTCH1 | Genes involved in Signaling by NOTCH1 |
| 0.1 | 0.8 | REACTOME_GLUCOSE_TRANSPORT | Genes involved in Glucose transport |
| 0.1 | 0.2 | REACTOME_TRAF6_MEDIATED_NFKB_ACTIVATION | Genes involved in TRAF6 mediated NF-kB activation |
| 0.1 | 0.8 | REACTOME_DOWNREGULATION_OF_SMAD2_3_SMAD4_TRANSCRIPTIONAL_ACTIVITY | Genes involved in Downregulation of SMAD2/3:SMAD4 transcriptional activity |
| 0.1 | 2.4 | REACTOME_BASIGIN_INTERACTIONS | Genes involved in Basigin interactions |
| 0.1 | 9.5 | REACTOME_MITOTIC_M_M_G1_PHASES | Genes involved in Mitotic M-M/G1 phases |
| 0.1 | 0.7 | REACTOME_LATENT_INFECTION_OF_HOMO_SAPIENS_WITH_MYCOBACTERIUM_TUBERCULOSIS | Genes involved in Latent infection of Homo sapiens with Mycobacterium tuberculosis |
| 0.1 | 15.9 | REACTOME_SIGNALING_BY_RHO_GTPASES | Genes involved in Signaling by Rho GTPases |
| 0.1 | 0.6 | REACTOME_SYNTHESIS_OF_BILE_ACIDS_AND_BILE_SALTS_VIA_7ALPHA_HYDROXYCHOLESTEROL | Genes involved in Synthesis of bile acids and bile salts via 7alpha-hydroxycholesterol |
| 0.1 | 0.8 | REACTOME_METAL_ION_SLC_TRANSPORTERS | Genes involved in Metal ion SLC transporters |
| 0.1 | 1.8 | REACTOME_GLUTATHIONE_CONJUGATION | Genes involved in Glutathione conjugation |
| 0.1 | 0.1 | REACTOME_ENDOSOMAL_VACUOLAR_PATHWAY | Genes involved in Endosomal/Vacuolar pathway |
| 0.1 | 1.0 | REACTOME_BMAL1_CLOCK_NPAS2_ACTIVATES_CIRCADIAN_EXPRESSION | Genes involved in BMAL1:CLOCK/NPAS2 Activates Circadian Expression |
| 0.1 | 0.5 | REACTOME_ERKS_ARE_INACTIVATED | Genes involved in ERKs are inactivated |
| 0.1 | 0.3 | REACTOME_DESTABILIZATION_OF_MRNA_BY_AUF1_HNRNP_D0 | Genes involved in Destabilization of mRNA by AUF1 (hnRNP D0) |
| 0.1 | 0.2 | REACTOME_ANTIGEN_ACTIVATES_B_CELL_RECEPTOR_LEADING_TO_GENERATION_OF_SECOND_MESSENGERS | Genes involved in Antigen Activates B Cell Receptor Leading to Generation of Second Messengers |
| 0.1 | 0.6 | REACTOME_FGFR4_LIGAND_BINDING_AND_ACTIVATION | Genes involved in FGFR4 ligand binding and activation |
| 0.1 | 1.8 | REACTOME_KERATAN_SULFATE_BIOSYNTHESIS | Genes involved in Keratan sulfate biosynthesis |
| 0.1 | 0.5 | REACTOME_CYTOSOLIC_SULFONATION_OF_SMALL_MOLECULES | Genes involved in Cytosolic sulfonation of small molecules |
| 0.1 | 2.7 | REACTOME_PPARA_ACTIVATES_GENE_EXPRESSION | Genes involved in PPARA Activates Gene Expression |
| 0.1 | 6.7 | REACTOME_PROCESSING_OF_CAPPED_INTRON_CONTAINING_PRE_MRNA | Genes involved in Processing of Capped Intron-Containing Pre-mRNA |
| 0.1 | 1.5 | REACTOME_OTHER_SEMAPHORIN_INTERACTIONS | Genes involved in Other semaphorin interactions |
| 0.1 | 0.7 | REACTOME_DEADENYLATION_DEPENDENT_MRNA_DECAY | Genes involved in Deadenylation-dependent mRNA decay |
| 0.1 | 0.6 | REACTOME_PRE_NOTCH_PROCESSING_IN_GOLGI | Genes involved in Pre-NOTCH Processing in Golgi |
| 0.1 | 0.2 | REACTOME_PROLACTIN_RECEPTOR_SIGNALING | Genes involved in Prolactin receptor signaling |
| 0.1 | 0.4 | REACTOME_SIGNAL_REGULATORY_PROTEIN_SIRP_FAMILY_INTERACTIONS | Genes involved in Signal regulatory protein (SIRP) family interactions |
| 0.1 | 0.6 | REACTOME_SIGNAL_ATTENUATION | Genes involved in Signal attenuation |
| 0.1 | 1.8 | REACTOME_INTEGRIN_CELL_SURFACE_INTERACTIONS | Genes involved in Integrin cell surface interactions |
| 0.1 | 0.5 | REACTOME_VEGF_LIGAND_RECEPTOR_INTERACTIONS | Genes involved in VEGF ligand-receptor interactions |
| 0.1 | 0.7 | REACTOME_CLASS_C_3_METABOTROPIC_GLUTAMATE_PHEROMONE_RECEPTORS | Genes involved in Class C/3 (Metabotropic glutamate/pheromone receptors) |
| 0.0 | 0.0 | REACTOME_P53_DEPENDENT_G1_DNA_DAMAGE_RESPONSE | Genes involved in p53-Dependent G1 DNA Damage Response |
| 0.0 | 1.1 | REACTOME_INTERFERON_GAMMA_SIGNALING | Genes involved in Interferon gamma signaling |
| 0.0 | 0.4 | REACTOME_HORMONE_SENSITIVE_LIPASE_HSL_MEDIATED_TRIACYLGLYCEROL_HYDROLYSIS | Genes involved in Hormone-sensitive lipase (HSL)-mediated triacylglycerol hydrolysis |
| 0.0 | 0.4 | REACTOME_METABOLISM_OF_RNA | Genes involved in Metabolism of RNA |
| 0.0 | 1.3 | REACTOME_POST_TRANSLATIONAL_MODIFICATION_SYNTHESIS_OF_GPI_ANCHORED_PROTEINS | Genes involved in Post-translational modification: synthesis of GPI-anchored proteins |
| 0.0 | 0.1 | REACTOME_HORMONE_LIGAND_BINDING_RECEPTORS | Genes involved in Hormone ligand-binding receptors |
| 0.0 | 0.2 | REACTOME_ACYL_CHAIN_REMODELLING_OF_PG | Genes involved in Acyl chain remodelling of PG |
| 0.0 | 3.3 | REACTOME_METABOLISM_OF_CARBOHYDRATES | Genes involved in Metabolism of carbohydrates |
| 0.0 | 0.6 | REACTOME_REGULATION_OF_INSULIN_LIKE_GROWTH_FACTOR_IGF_ACTIVITY_BY_INSULIN_LIKE_GROWTH_FACTOR_BINDING_PROTEINS_IGFBPS | Genes involved in Regulation of Insulin-like Growth Factor (IGF) Activity by Insulin-like Growth Factor Binding Proteins (IGFBPs) |
| 0.0 | 0.5 | REACTOME_TRAFFICKING_OF_GLUR2_CONTAINING_AMPA_RECEPTORS | Genes involved in Trafficking of GluR2-containing AMPA receptors |
| 0.0 | 0.3 | REACTOME_SMOOTH_MUSCLE_CONTRACTION | Genes involved in Smooth Muscle Contraction |
| 0.0 | 0.1 | REACTOME_ABACAVIR_TRANSPORT_AND_METABOLISM | Genes involved in Abacavir transport and metabolism |
| 0.0 | 0.3 | REACTOME_PURINE_RIBONUCLEOSIDE_MONOPHOSPHATE_BIOSYNTHESIS | Genes involved in Purine ribonucleoside monophosphate biosynthesis |
| 0.0 | 0.1 | REACTOME_P53_INDEPENDENT_G1_S_DNA_DAMAGE_CHECKPOINT | Genes involved in p53-Independent G1/S DNA damage checkpoint |
| 0.0 | 0.4 | REACTOME_GPCR_LIGAND_BINDING | Genes involved in GPCR ligand binding |
| 0.0 | 0.2 | REACTOME_REGULATION_OF_WATER_BALANCE_BY_RENAL_AQUAPORINS | Genes involved in Regulation of Water Balance by Renal Aquaporins |
| 0.0 | 0.2 | REACTOME_GROWTH_HORMONE_RECEPTOR_SIGNALING | Genes involved in Growth hormone receptor signaling |
| 0.0 | 0.2 | REACTOME_CASPASE_MEDIATED_CLEAVAGE_OF_CYTOSKELETAL_PROTEINS | Genes involved in Caspase-mediated cleavage of cytoskeletal proteins |
| 0.0 | 0.2 | REACTOME_MEIOTIC_RECOMBINATION | Genes involved in Meiotic Recombination |
| 0.0 | 0.1 | REACTOME_ALPHA_LINOLENIC_ACID_ALA_METABOLISM | Genes involved in alpha-linolenic acid (ALA) metabolism |
|
|
|